First Name,Last Name,Full Name,Job Title,Company Name,Location,Employee Count,Phone,Industry,URL,LinkedIn URL,Facebook URL,Twitter URL,Company LinkedIn URL,Company URL,Keywords,Email 1,Email 2
"Tommy","Duncan","Tommy Duncan","Chief Business Officer","Touchlight","London, United Kingdom","160","(442) 084-819200","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2c94820117a01c6276139","http://www.linkedin.com/in/tommy-duncan-ph-d-2b834b24",,"https://twitter.com/touchlightdna","http://www.linkedin.com/company/touchlight-ltd","http://www.touchlight.com/","genetic medicine, dna therapeutics, dna vaccines, dna vectors, dna amplification, enzymatic technology, contract manufacturing, innovation, oncology, infectious diseases, aav, mrna, cdmo, enzymatic dna, synthetic dna, lentivirus, gene therapy, dna, genome editing, biotechnology",tommy.duncan@touchlight.com,
"Josh","Bilenker","Josh Bilenker","CEO and Co-Founder","Treeline Biosciences","Stamford, Connecticut","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270337","http://www.linkedin.com/in/josh-bilenker-58655b14",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",jbilenker@treelinebiosciences.com,
"Conrad","Wueller","Conrad Wueller","Director of Strategy & Operations","ARTBIO","Geneva, Switzerland","33","(916) 445-1254","Research","https://app.apollo.io/#/contacts/65f2c9f320117a0302271ebd","http://www.linkedin.com/in/conrad-w%c3%bcller-6a762066",,"https://twitter.com/artbio_inc","http://www.linkedin.com/company/artbio-inc","http://www.artbio.com/","N/A",conrad.wueller@artbio.com,
"Pete","O'Heeron","Pete O'Heeron","Chairman/CEO/Founder","FibroBiologics","Houston, Texas","9","(281) 461-6211","Research","https://app.apollo.io/#/contacts/65f2d817c6652806d5ea9942","http://www.linkedin.com/in/peteoheeron","https://facebook.com/FibroBiologics",,"http://www.linkedin.com/company/fibrobiologics","http://www.fibrobiologics.com/","N/A",pete.oheeron@fibrobiologics.com,
"Shane","M","Shane M","CEO","Celmatix","Henderson, Nevada","25","(646) 568-3234","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d481434e0802ffa799c2","","https://www.facebook.com/Celmatix/","https://twitter.com/celmatix","http://www.linkedin.com/company/celmatix","http://www.celmatix.com/","saas, biotechnology, diagnostics, life sciences, enterprise software, software, information technology, reproductive biology & medicine, genomics, bioinformatics, biotech, womens health, drug development",shane@scalpmed.com,shaaaahin@yahoo.com
"Ralph","Grosswald","Ralph Grosswald","Vice President Operations","Virios Therapeutics","Alpharetta, Georgia","7","(866) 620-8655","Biotechnology","https://app.apollo.io/#/contacts/65f2d391434e0801c6a7a441","http://www.linkedin.com/in/ralph-grosswald-8168177","http://www.facebook.com/innovativemedconcepts","https://twitter.com/ViriosBiotech","http://www.linkedin.com/company/viriosbiotech","http://www.virios.com/","software, information technology",ralph@virios.com,
"Kristen","L","Kristen L","Chief Operating Officer","Deciduous Therapeutics","San Francisco, California","15","(650) 206-9082","Research","https://app.apollo.io/#/contacts/65f2d34d434e0801c6a7a3a1","",,,"http://www.linkedin.com/company/deciduous-therapeutics","http://www.deciduoustx.com/","N/A",kristen@deciduoustx.com,
"Richard","Labaudiniere","Richard Labaudiniere","Chief Executive Officer","Protego Biopharma","Sherborn, Massachusetts","28","(858) 242-1518","Research","https://app.apollo.io/#/contacts/65f2cf8ee458f10421367307","http://www.linkedin.com/in/richard-labaudiniere-2287a05",,,"http://www.linkedin.com/company/protego-biopharma","http://www.protegobiopharma.com/","N/A",labaudiniere@protegobiopharma.com,labaudiniere@gmail.com
"Jak","Knowles","Jak Knowles","Co-founder, President & CEO","Affini-T Therapeutics","Cambridge, Massachusetts","93","(619) 826-4657","Research","https://app.apollo.io/#/contacts/65f2d05de458f102e8367757","http://www.linkedin.com/in/jak-knowles-8b0bb83b",,"https://twitter.com/affinit_tx","http://www.linkedin.com/company/affini-t-therapeutics","http://www.affinittx.com/","N/A",jak@affinittx.com,jak.knowles@gmail.com
"Anna","Todd","Anna Todd","Senior Manager, Business and Administration Operations","Upstream Bio","Waltham, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de026","http://www.linkedin.com/in/annatodd",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",anna.todd@upstreambio.com,
"Shelton","Cochran","Shelton Cochran","Senior Manager, Business Excellence & Strategy","Chroma Medicine","Boston, Massachusetts","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc9f","http://www.linkedin.com/in/shelton-cochran-728966112",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",shelton.cochran@chromamedicine.com,
"Anastasiya","Kelly","Anastasiya Kelly","Business Associate","Nested Therapeutics","Boston, Massachusetts","51","","Research","https://app.apollo.io/#/contacts/65f2cad820117a0302272038","http://www.linkedin.com/in/anastasiyakelly",,"https://twitter.com/nestedtx","http://www.linkedin.com/company/nestedtx","http://www.nestedtx.com/","oncology & precision medicine",akelly@nestedtx.com,anastasiyakelly@msn.com
"Priya","P","Priya P","Head of Corporate Strategy and Business Operations","CARGO Therapeutics","San Francisco, California","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eead","",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",pparameswaran@cargo-tx.com,priyankaparameswaran@yahoo.com
"Tanja","Weber","Tanja Weber","Chief Business Officer","Nested Therapeutics","Cambridge, Massachusetts","51","","Research","https://app.apollo.io/#/contacts/65f2cad820117a0302272039","http://www.linkedin.com/in/tanja-stephanie-weber-21a20b1",,"https://twitter.com/nestedtx","http://www.linkedin.com/company/nestedtx","http://www.nestedtx.com/","oncology & precision medicine",tweber@nestedtx.com,
"Sofia","Carlton","Sofia Carlton","Business Development & Strategy","Dyno Therapeutics","Boston, Massachusetts","130","(914) 204-6412","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d6b768a36e06b05bb575","http://www.linkedin.com/in/sofia-carlton-aa40b830",,"https://twitter.com/dyno_tx","http://www.linkedin.com/company/dynotx","http://www.dynotx.com/","aav engineering, machine learning, synthetic biology, ngs, data science, gene therapy, genome editing, aav, software engineering",,
"Sean","McLoughlin","Sean McLoughlin","Chief Operating Officer","HilleVax","Philadelphia, Pennsylvania","88","(888) 340-4544","Research","https://app.apollo.io/#/contacts/65f2cb3c20117a01c6276769","http://www.linkedin.com/in/sean-mcloughlin-9877a36",,"https://twitter.com/HilleVax","http://www.linkedin.com/company/hillevax","http://www.hillevax.com/","N/A",smcloughlin@hillevax.com,
"Noah","L","Noah L","Operations Manager","Trailhead Biosystems","Cleveland, Ohio","27","(216) 445-3835","Research","https://app.apollo.io/#/contacts/65f6a3305a323101c6615f7a","",,,"http://www.linkedin.com/company/trailhead-biosystems-inc-","http://www.trailbio.com/","systems developmental biology, regenerative medicine, human development, stem cell differentiation, qualitybydesign, morphogens & growth factors, cell culture optimization, mathematical modeling, disease modeling, designofexperiments, big data 2 knowledge, cell therapy, gene expression & genotyping",nlapeyre@trailbio.com,
"Sheri","M","Sheri M","Vice President, Clinical Operations and Develoment","Neurona Therapeutics","Dana Point, California","52","(650) 799-6465","Research","https://app.apollo.io/#/contacts/65f6a4155a3231043b614aec","",,,"http://www.linkedin.com/company/neurona-therapeutics","http://www.neuronatherapeutics.com/","N/A",sheri@neuronatx.com,
"Leandro","Vetcher","Leandro Vetcher","Chief Operating Officer","Clade Therapeutics","Cambridge, Massachusetts","61","(415) 886-7710","Research","https://app.apollo.io/#/contacts/65f6a913c95d0d01aed120e7","http://www.linkedin.com/in/leandro-vetcher-1a68352",,"https://twitter.com/CladeTx","http://www.linkedin.com/company/clade-therapeutics","http://www.cladetx.com/","N/A",leandro.vetcher@cladetx.com,lvetcher@gmail.com
"Andrew","M","Andrew M","Corporate Development and Operations","Lassen Therapeutics","San Diego, California","26","(858) 251-7528","Research","https://app.apollo.io/#/contacts/65f6a990aac76702eac0615d","","https://facebook.com/pages/Lassen-Therapeutics/2237543336507073",,"http://www.linkedin.com/company/lassen-therapeutics","http://www.lassentherapeutics.com/","N/A",amaleki@lassentherapeutics.com,
"Karen","B","Karen B","Director of Operations","Totus Medicines","San Francisco, California","35","(617) 221-7784","Research","https://app.apollo.io/#/contacts/65f6a95ec95d0d0301d0e5c1","",,"https://twitter.com/Totus_Medicines","http://www.linkedin.com/company/totusmedicines","http://www.totusmedicines.com/","N/A",karen@totusmedicines.com,karen_bach@yahoo.com
"Lloyd","Segal","Lloyd Segal","President & Chief Executive Officer","Repare Therapeutics","Montreal, Canada","190","(857) 412-7018","Research","https://app.apollo.io/#/contacts/65f6a6767a4b69044d1f6e6c","http://www.linkedin.com/in/lloyd-mitchell-segal-804755a",,"https://twitter.com/reparerx","http://www.linkedin.com/company/repare-therapeutics","http://www.reparerx.com/","N/A",lsegal@reparerx.com,
"Sarah","Moffett-Hills","Sarah Moffett-Hills","Project Lead Marketing","Cellectar Biosciences, Inc.","Madison, Wisconsin","29","(608) 441-8120","Biotechnology","https://app.apollo.io/#/contacts/65f6a57f7a4b6901c61fee61","http://www.linkedin.com/in/sarah-moffett-hills-m-s-0700b536","https://facebook.com/cellectarbiosciences/","https://twitter.com/cellectarbio","http://www.linkedin.com/company/cellectar-biosciences-inc","http://www.cellectar.com/","biotechnology, life sciences, pdc cancer therapeutics & diagnostics, targeted delivery of oncologic payloads, earlystage chemotherapeutic drug conjugates, hematologic malignancies",sarah.moffett-hills@cellectar.com,
"Kim","Seth","Kim Seth","EVP, Chief Business Officer","Repare Therapeutics","Boston, Massachusetts","190","(857) 412-7018","Research","https://app.apollo.io/#/contacts/65f6a6767a4b69044d1f6e66","http://www.linkedin.com/in/kim-seth-ph-d-12b387",,"https://twitter.com/reparerx","http://www.linkedin.com/company/repare-therapeutics","http://www.reparerx.com/","N/A",kseth@reparerx.com,kimaseth@gmail.com
"Amanda","Anderson","Amanda Anderson","Senior Director, Commercial Development and Business Operations","Lexeo Therapeutics","New York, New York","65","(212) 547-9879","Research","https://app.apollo.io/#/contacts/65f6a4cd5a323101c66162f3","http://www.linkedin.com/in/amanda-wyatt-anderson-9208a5b",,,"http://www.linkedin.com/company/lexeo-therapeutics","http://www.lexeotx.com/","N/A",awanderson@lexeotx.com,amandabwyatt@gmail.com
"Shaina","O","Shaina O","Business and Corporate Development Lead","A2 Biotherapeutics, Inc.","Los Angeles, California","140","(805) 491-1988","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a4785a323101c6616293","",,,"http://www.linkedin.com/company/a2-biotherapeutics","http://www.a2bio.com/","biotechnology, immunotherapy, oncology, research, target identification, cell therapy, manufacturing, drug development",soake@a2bio.com,
"Nolan","Townsend","Nolan Townsend","Chief Executive Officer","Lexeo Therapeutics","New York, New York","65","(212) 547-9879","Research","https://app.apollo.io/#/contacts/65f6a4cd5a323101c66162ef","http://www.linkedin.com/in/nolan-townsend-5713125",,,"http://www.linkedin.com/company/lexeo-therapeutics","http://www.lexeotx.com/","N/A",rntownsend@lexeotx.com,
"Shriya","Bhushan","Shriya Bhushan","Head of Marketing","Abeona Therapeutics","Jersey City, New Jersey","110","(646) 813-4701","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a2be5a32310300615580","http://www.linkedin.com/in/shriyabhushan","https://www.facebook.com/AbeonaBio/","https://twitter.com/abeonabio","http://www.linkedin.com/company/abeonatherapeutics","http://www.abeonatherapeutics.com/","gene therapy, infantile batten disease, biotechnology, cell therapy, rare disease, epidermolysis bullosa, lysosomal storage disease, sanfiippo syndrome type a, sanfiippo syndrome type b, juvenile batten disease, pediatric rare diseases, manufacturing",sbhushan@abeonatherapeutics.com,shriyabhushan@gmail.com
"Aetna","T","Aetna T","Chief Executive Officer","Lycia Therapeutics","South San Francisco, California","40","(858) 224-7766","Research","https://app.apollo.io/#/contacts/65f6a8b7c95d0d05a3d09505","","https://facebook.com/weinrichsschokoladenbruchbude/","https://twitter.com/LyciaTx","http://www.linkedin.com/company/lycia-therapeutics","http://www.lyciatx.com/","N/A",atrombley@lyciatx.com,
"Marina","Udier-Blagovic","Marina Udier-Blagovic","Chief Executive Officer","Nouscom AG","Basel, Switzerland","45","(416) 120-11831","Research","https://app.apollo.io/#/contacts/65f6c05863db900300ecec99","http://www.linkedin.com/in/marinaudier",,,"http://www.linkedin.com/company/nouscom-ag","http://www.nouscom.com/","N/A",m.udier@nouscom.com,
"David","Raben","David Raben","CMO, Bicara Therapeutics","Bicara Therapeutics","Englewood, Colorado","35","(212) 362-1200","Research","https://app.apollo.io/#/contacts/65f6bf7f63db9001c6ecf9e9","http://www.linkedin.com/in/david-raben-44a5a811",,"https://twitter.com/bicaratx?lang=en","http://www.linkedin.com/company/bicara-therapeutics","http://www.bicara.com/","immunotherapy, targeted oncology, drug discovery",david.raben@bicara.com,
"Ben","Rigby","Ben Rigby","Vice President Business Operations & Company Director","Beacon Therapeutics","Welwyn, United Kingdom","89","(800) 546-5141","Research","https://app.apollo.io/#/contacts/65f6cea172334001c6369d3f","http://www.linkedin.com/in/ben-rigby-2b7145215","https://www.facebook.com/BeaconTx",,"http://www.linkedin.com/company/beacon-therapeutics","http://www.beacontx.com/","N/A",ben.rigby@beacontx.com,
"Timothy","Miller","Timothy Miller","Senior Director Business Development","HiFiBiO Therapeutics","Cambridge, Massachusetts","78","","Biotechnology","https://app.apollo.io/#/contacts/65f6d19597cfd00302939ff4","http://www.linkedin.com/in/timothy-miller-b6b90611",,"https://twitter.com/hifibio","http://www.linkedin.com/company/hifibiotherapeutics","http://www.hifibio.com/","microfluidics, singlecell, antibodies, therapeutics, drug discovery, target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation",t.miller@hifibio.com,timgo4@aol.com
"Elie","Toledano","Elie Toledano","Head of Scientific Affairs and Business Intelligence","Acticor Biotech","Île-de-France, France","37","(339) 704-68640","Biotechnology","https://app.apollo.io/#/contacts/65f6d11097cfd00302939e28","http://www.linkedin.com/in/proelietoledano",,"https://twitter.com/acticorbiotech","http://www.linkedin.com/company/acticor-biotech","http://www.acticor-biotech.com/","biotechnology, monoclonal antibody, drug development, thrombosis, stroke, tia, avc, healthcare",elie.toledano@acticor-biotech.com,
"Nicolas","Poirier","Nicolas Poirier","Chief Executive Officer","OSE Immunotherapeutics","Nantes, France","64","(332) 282-91010","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d1d497cfd001c693c9f7","http://www.linkedin.com/in/nicolas-poirier-2203a919",,"https://twitter.com/oseimmuno","http://www.linkedin.com/company/ose-immunotherapeutics","http://www.ose-immuno.com/","immunooncologie, immunotherapie, maladies autoimmunes, nsclc, checkpoint inhibitor, developpement clinique, biotechnologie, neoepitopes, sirpalpha, mdsc, rectocolite hemorragique, polyarthrite rhumatoide",nicolas.poirier@ose-immuno.com,
"Neil","Weir","Neil Weir","Chief Executive Officer","Sitryx","United Kingdom","49","(442) 037-095700","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b4","http://www.linkedin.com/in/neil-weir-72b97b171",,,"http://www.linkedin.com/company/sitryx-therapeutics-limited","http://www.sitryx.com/","N/A",neil@sitryx.com,
"Julio","Benedicto","Julio Benedicto","Vice President Marketing","GenSight Biologics","Paris, France","49","(331) 762-17220","Research","https://app.apollo.io/#/contacts/65f6d2f91fb3c701c64ca2e7","http://www.linkedin.com/in/julio-j-p-benedicto-7abb123","https://fr-fr.facebook.com/pages/Gensight-Biologics/1573223462897947","https://twitter.com/gensightbio","http://www.linkedin.com/company/gensight-biologics-sa","http://www.gensight-biologics.com/","N/A",jbenedicto@gensight-biologics.com,
"Olivier","Soula","Olivier Soula","co-founder, Chief Executive Officer, Director of Research & Development at ADOCIA","ADOCIA","Lyon, France","88","(334) 726-10610","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d24c1fb3c704394c68a3","http://www.linkedin.com/in/oliviersoula-adocia-glowbl-innovation",,"https://twitter.com/Adocia_Biotech","http://www.linkedin.com/company/adocia","http://www.adocia.com/","biotechnology, life sciences, therapeutic proteins, biochaperone, nextgeneration injectables for diabetes treatment, ultrarapid insulin, multiagents injectable combination, diabetes, metabolic diseases, amylin, innovative protein formulations, glucagon",o.soula@adocia.com,
"Asa","Hillsten","Asa Hillsten","Head of Investor Relations & Sustainability","Calliditas Therapeutics","Sweden","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69bf","http://www.linkedin.com/in/asahillsten",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",asa.hillsten@calliditas.com,
"Renee","Aguiar-Lucander","Renee Aguiar-Lucander","Chief Executive Officer","Calliditas Therapeutics","Sweden","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69cd","http://www.linkedin.com/in/renee-aguiar-lucander-63373418",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",renee.lucander@calliditas.com,
"Andy","S","Andy S","Chief Executive Officer","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2715","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",andrew.scharenberg@umoja-biopharma.com,
"Mike","F","Mike F","Vice President of Business Development & Operations","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2719","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",mike.fitzpatrick@umoja-biopharma.com,
"Rebecca","Listfield","Rebecca Listfield","Vice President of Business Development","Tune Therapeutics","Cambridge, Massachusetts","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb0","http://www.linkedin.com/in/rebeccalistfield",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",rebecca.listfield@tunetx.com,
"Adrienne","L","Adrienne L","Associate Director, Business Development","Lyell Immunopharma","South San Francisco, California","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9f2","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",avli@lyell.com,
"Stephen","H","Stephen H","Chief Operating Officer","Lyell Immunopharma","Seattle, Washington","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9ee","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",shill@lyell.com,
"Craig","T","Craig T","Chief Executive Officer","Cerevance","San Diego, California","58","(408) 220-5722","Research","https://app.apollo.io/#/contacts/65f6dcb48a58670302f72ad8","",,"https://twitter.com/cerevance","http://www.linkedin.com/company/cerevance","http://www.cerevance.com/","N/A",craig.thompson@cerevance.com,
"Stephanie","Gillis","Stephanie Gillis","Director of Operations","Nocion Therapeutics, Inc.","Boston, Massachusetts","14","(781) 819-2877","Biotechnology","https://app.apollo.io/#/contacts/65f6e4b3a9b03301c6723abf","http://www.linkedin.com/in/stephanie-gillis-78966941",,,"http://www.linkedin.com/company/nocion-therapeutics-inc","http://www.nociontx.com/","N/A",stephanie@nociontx.com,sgillis21@gmail.com
"Assaf","Oron","Assaf Oron","Chief Business Officer","BiomX Inc","Ramat Hasharon, Israel","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c72","http://www.linkedin.com/in/assaf-oron-a997b911","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",assafo@biomx.com,
"Stephen","Hurly","Stephen Hurly","CEO, President, Director","LAVA Therapeutics N.V.","Philadelphia, Pennsylvania","55","(316) 300-03035","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e5e7a9b033043b7206e2","http://www.linkedin.com/in/stephen-hurly-7469813",,"https://twitter.com/LAVAtx","http://www.linkedin.com/company/lavatherapeutics","http://www.lavatherapeutics.com/","biotechnology, gamma delta t cells, bispecific antibodies, oncology",s.hurly@lavatherapeutics.com,steve.hurly@gmail.com
"Nathan","Quillen","Nathan Quillen","Director, Marketing","Cerevel Therapeutics","North Carolina, US","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a17597","http://www.linkedin.com/in/nathan-quillen-912ba920","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",nathan.quillen@cerevel.com,
"Neil","Weir","Neil Weir","Chief Executive Officer","Sitryx","United Kingdom","49","(442) 037-095700","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b4","http://www.linkedin.com/in/neil-weir-72b97b171",,,"http://www.linkedin.com/company/sitryx-therapeutics-limited","http://www.sitryx.com/","N/A",neil@sitryx.com,
"Claudia","Escher","Claudia Escher","Chief Operating Officer","TOLREMO therapeutics","N/A","10","","Research","https://app.apollo.io/#/contacts/65f6d07497cfd008389394f4","http://www.linkedin.com/in/claudia-escher-52310842",,"https://twitter.com/tolremo","http://www.linkedin.com/company/tolremo-therapeutics","http://www.tolremo.com/","drug discovery, drug development, cancer drug resistance, nongenetic cancer drug resistance, biotech",claudia.escher@tolremo.com,claudiaescher@gmail.com
"Marcel","Deken","Marcel Deken","Project Manager and Business Development","iOnctura","Amsterdam, Netherlands","23","","Research","https://app.apollo.io/#/contacts/65f6d66c40263f01c6c3dd2b","http://www.linkedin.com/in/marceldeken",,"https://twitter.com/ionctura","http://www.linkedin.com/company/ionctura","http://www.ionctura.com/","oncology, drug development, clinical development",m.deken@ionctura.com,
"Andy","S","Andy S","Chief Executive Officer","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2715","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",andrew.scharenberg@umoja-biopharma.com,
"Mike","F","Mike F","Vice President of Business Development & Operations","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2719","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",mike.fitzpatrick@umoja-biopharma.com,
"Rebecca","Listfield","Rebecca Listfield","Vice President of Business Development","Tune Therapeutics","Cambridge, Massachusetts","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb0","http://www.linkedin.com/in/rebeccalistfield",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",rebecca.listfield@tunetx.com,
"Adrienne","L","Adrienne L","Associate Director, Business Development","Lyell Immunopharma","South San Francisco, California","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9f2","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",avli@lyell.com,
"Stephen","H","Stephen H","Chief Operating Officer","Lyell Immunopharma","Seattle, Washington","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9ee","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",shill@lyell.com,
"Craig","T","Craig T","Chief Executive Officer","Cerevance","San Diego, California","58","(408) 220-5722","Research","https://app.apollo.io/#/contacts/65f6dcb48a58670302f72ad8","",,"https://twitter.com/cerevance","http://www.linkedin.com/company/cerevance","http://www.cerevance.com/","N/A",craig.thompson@cerevance.com,
"Aram","Mangasarian","Aram Mangasarian","CEO and Co-founder","EraCal Therapeutics","Berlin, Germany","11","","Research","https://app.apollo.io/#/contacts/65f6d6f840263f01c6c3ddc2","http://www.linkedin.com/in/josua-jordi-096ab016",,"https://twitter.com/era_cal","http://www.linkedin.com/company/eracal-therapeutics","http://www.eracal.ch/","N/A",josua.jordi@eracal.ch,
"Saryah","Azmat","Saryah Azmat","Chief Business Officer","Turnstone Biologics","New York, New York","97","(613) 421-8930","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6daf2f0664f04391df9ac","http://www.linkedin.com/in/saryah-azmat-67b46a25",,"https://twitter.com/turnstonebio","http://www.linkedin.com/company/turnstone-biologics","http://www.turnstonebio.com/","biotechnology, immunooncology, til therapy, cell therapy, cancer immunotherapy, immunotherapy, cancer, cancer research, viral immunotherapy, oncolytic virus",saryah.azmat@turnstonebio.com,saryah.azmat@gmail.com
"Kathryn","Holderness","Kathryn Holderness","Director, CMC Operations and Strategy","Obsidian Therapeutics","Cambridge, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1f00","http://www.linkedin.com/in/kathryn-holderness-72480012a",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",kholderness@obsidiantx.com,
"David","G","David G","Vice President Of Business Development","Sonoma Biotherapeutics","San Francisco, California","130","(415) 992-6245","Research","https://app.apollo.io/#/contacts/65f6db56f0664f01c61e23f6","",,"https://twitter.com/sonomabio","http://www.linkedin.com/company/sonoma-biotherapeutics","http://www.sonomabio.com/","N/A",dgold@sonomabio.com,davidgoldphd@gmail.com
"Qasim","Rizvi","Qasim Rizvi","Chief Executive Officer","KSQ Therapeutics, Inc.","United States","79","(617) 990-4642","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dac7f0664f04391df938","http://www.linkedin.com/in/qasim-rizvi-44054a59",,"https://twitter.com/KSQ_TX","http://www.linkedin.com/company/ksq-therapeutics-inc-","http://www.ksqtx.com/","functional genomics, drug discovery, crispr, immunooncology, therapeutics",qrizvi@ksqtx.com,
"Peter","D","Peter D","Chief Business and Strategy Officer","Sonoma Biotherapeutics","San Francisco, California","130","(415) 992-6245","Research","https://app.apollo.io/#/contacts/65f6db56f0664f01c61e23f4","",,"https://twitter.com/sonomabio","http://www.linkedin.com/company/sonoma-biotherapeutics","http://www.sonomabio.com/","N/A",pdilaura@sonomabio.com,peter.dilaura@gmail.com
"John","Trzupek","John Trzupek","Chief Operating Officer","Abata Therapeutics","Boston, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec8","http://www.linkedin.com/in/john-trzupek-9214a46",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",jtrzupek@abatatx.com,john.trzupek@gmail.com
"Gairik","Sachdeva","Gairik Sachdeva","Senior Director, Business Development","Abata Therapeutics","Cambridge, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec6","http://www.linkedin.com/in/gairik-sachdeva-54a00758",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",gsachdeva@abatatx.com,gairik.sachdeva@gmail.com
"Samuel","Perry","Samuel Perry","Senior Director of Operations","Remix Therapeutics","Arlington, Massachusetts","66","(202) 930-4762","Research","https://app.apollo.io/#/contacts/65f2d0aee458f101ae368080","http://www.linkedin.com/in/samuel-perry-30951027",,"https://twitter.com/RemixThera","http://www.linkedin.com/company/remix-therapeutics","http://www.remixtx.com/","N/A",sperry@remixtx.com,sam.r.perry@gmail.com
"Chris","Halpin","Chris Halpin","Director of Operations","TRIANA Biomedicines","Waltham, Massachusetts","42","(781) 317-4414","Research","https://app.apollo.io/#/contacts/65f2cfd9e458f101ae367b25","http://www.linkedin.com/in/chris-halpin-1999a6231",,,"http://www.linkedin.com/company/trianabio","http://www.trianabio.com/","N/A",chris.halpin@trianabio.com,
"Jordi","Mata-Fink","Jordi Mata-Fink","Co-Founder and CEO","Gate Bioscience","Portland, Oregon","29","","Research","https://app.apollo.io/#/contacts/65f2d324434e0801c6a7a306","http://www.linkedin.com/in/jordi-mata-fink-8a677918",,,"http://www.linkedin.com/company/gatebio","http://www.gatebio.com/","N/A",jmatafink@gatebio.com,jmatafink@gmail.com
"Omid","F","Omid F","Chair, CEO and Founder","Seer","San Francisco, California","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b28","",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",of@seer.bio,
"Brittany","S","Brittany S","Operations Manager","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765de","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",brittany@neomorph.com,
"Marla","B","Marla B","Vice President, Business Development","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765dc","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",mbornstein@neomorph.com,marlabornstein@hotmail.com
"Graeme","Fielder","Graeme Fielder","Chief Operating Officer","AviadoBio","London, United Kingdom","69","(443) 125-432881","Research","https://app.apollo.io/#/contacts/65f2c99320117a01c6276284","http://www.linkedin.com/in/gfielder",,"https://twitter.com/AviadoBio","http://www.linkedin.com/company/aviadobio","http://www.aviadobio.com/","N/A",gfielder@aviadobio.com,
"Karen","Fallen","Karen Fallen","Chief Executive Officer","Touchlight","London, United Kingdom","160","(442) 084-819200","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2c94820117a01c6276135","http://www.linkedin.com/in/karenfallen",,"https://twitter.com/touchlightdna","http://www.linkedin.com/company/touchlight-ltd","http://www.touchlight.com/","genetic medicine, dna therapeutics, dna vaccines, dna vectors, dna amplification, enzymatic technology, contract manufacturing, innovation, oncology, infectious diseases, aav, mrna, cdmo, enzymatic dna, synthetic dna, lentivirus, gene therapy, dna, genome editing, biotechnology",karen.fallen@touchlight.com,
"Neil","Weir","Neil Weir","Chief Executive Officer","Sitryx","United Kingdom","49","(442) 037-095700","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b4","http://www.linkedin.com/in/neil-weir-72b97b171",,,"http://www.linkedin.com/company/sitryx-therapeutics-limited","http://www.sitryx.com/","N/A",neil@sitryx.com,
"Claudia","Escher","Claudia Escher","Chief Operating Officer","TOLREMO therapeutics","N/A","10","","Research","https://app.apollo.io/#/contacts/65f6d07497cfd008389394f4","http://www.linkedin.com/in/claudia-escher-52310842",,"https://twitter.com/tolremo","http://www.linkedin.com/company/tolremo-therapeutics","http://www.tolremo.com/","drug discovery, drug development, cancer drug resistance, nongenetic cancer drug resistance, biotech",claudia.escher@tolremo.com,claudiaescher@gmail.com
"Marcel","Deken","Marcel Deken","Project Manager and Business Development","iOnctura","Amsterdam, Netherlands","23","","Research","https://app.apollo.io/#/contacts/65f6d66c40263f01c6c3dd2b","http://www.linkedin.com/in/marceldeken",,"https://twitter.com/ionctura","http://www.linkedin.com/company/ionctura","http://www.ionctura.com/","oncology, drug development, clinical development",m.deken@ionctura.com,
"Andy","S","Andy S","Chief Executive Officer","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2715","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",andrew.scharenberg@umoja-biopharma.com,
"Mike","F","Mike F","Vice President of Business Development & Operations","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2719","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",mike.fitzpatrick@umoja-biopharma.com,
"Rebecca","Listfield","Rebecca Listfield","Vice President of Business Development","Tune Therapeutics","Cambridge, Massachusetts","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb0","http://www.linkedin.com/in/rebeccalistfield",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",rebecca.listfield@tunetx.com,
"Adrienne","L","Adrienne L","Associate Director, Business Development","Lyell Immunopharma","South San Francisco, California","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9f2","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",avli@lyell.com,
"Stephen","H","Stephen H","Chief Operating Officer","Lyell Immunopharma","Seattle, Washington","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9ee","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",shill@lyell.com,
"Craig","T","Craig T","Chief Executive Officer","Cerevance","San Diego, California","58","(408) 220-5722","Research","https://app.apollo.io/#/contacts/65f6dcb48a58670302f72ad8","",,"https://twitter.com/cerevance","http://www.linkedin.com/company/cerevance","http://www.cerevance.com/","N/A",craig.thompson@cerevance.com,
"Aram","Mangasarian","Aram Mangasarian","CEO and Co-founder","EraCal Therapeutics","Berlin, Germany","11","","Research","https://app.apollo.io/#/contacts/65f6d6f840263f01c6c3ddc2","http://www.linkedin.com/in/josua-jordi-096ab016",,"https://twitter.com/era_cal","http://www.linkedin.com/company/eracal-therapeutics","http://www.eracal.ch/","N/A",josua.jordi@eracal.ch,
"Saryah","Azmat","Saryah Azmat","Chief Business Officer","Turnstone Biologics","New York, New York","97","(613) 421-8930","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6daf2f0664f04391df9ac","http://www.linkedin.com/in/saryah-azmat-67b46a25",,"https://twitter.com/turnstonebio","http://www.linkedin.com/company/turnstone-biologics","http://www.turnstonebio.com/","biotechnology, immunooncology, til therapy, cell therapy, cancer immunotherapy, immunotherapy, cancer, cancer research, viral immunotherapy, oncolytic virus",saryah.azmat@turnstonebio.com,saryah.azmat@gmail.com
"Kathryn","Holderness","Kathryn Holderness","Director, CMC Operations and Strategy","Obsidian Therapeutics","Cambridge, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1f00","http://www.linkedin.com/in/kathryn-holderness-72480012a",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",kholderness@obsidiantx.com,
"David","G","David G","Vice President Of Business Development","Sonoma Biotherapeutics","San Francisco, California","130","(415) 992-6245","Research","https://app.apollo.io/#/contacts/65f6db56f0664f01c61e23f6","",,"https://twitter.com/sonomabio","http://www.linkedin.com/company/sonoma-biotherapeutics","http://www.sonomabio.com/","N/A",dgold@sonomabio.com,davidgoldphd@gmail.com
"Qasim","Rizvi","Qasim Rizvi","Chief Executive Officer","KSQ Therapeutics, Inc.","United States","79","(617) 990-4642","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dac7f0664f04391df938","http://www.linkedin.com/in/qasim-rizvi-44054a59",,"https://twitter.com/KSQ_TX","http://www.linkedin.com/company/ksq-therapeutics-inc-","http://www.ksqtx.com/","functional genomics, drug discovery, crispr, immunooncology, therapeutics",qrizvi@ksqtx.com,
"Peter","D","Peter D","Chief Business and Strategy Officer","Sonoma Biotherapeutics","San Francisco, California","130","(415) 992-6245","Research","https://app.apollo.io/#/contacts/65f6db56f0664f01c61e23f4","",,"https://twitter.com/sonomabio","http://www.linkedin.com/company/sonoma-biotherapeutics","http://www.sonomabio.com/","N/A",pdilaura@sonomabio.com,peter.dilaura@gmail.com
"John","Trzupek","John Trzupek","Chief Operating Officer","Abata Therapeutics","Boston, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec8","http://www.linkedin.com/in/john-trzupek-9214a46",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",jtrzupek@abatatx.com,john.trzupek@gmail.com
"Gairik","Sachdeva","Gairik Sachdeva","Senior Director, Business Development","Abata Therapeutics","Cambridge, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec6","http://www.linkedin.com/in/gairik-sachdeva-54a00758",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",gsachdeva@abatatx.com,gairik.sachdeva@gmail.com
"Samuel","Perry","Samuel Perry","Senior Director of Operations","Remix Therapeutics","Arlington, Massachusetts","66","(202) 930-4762","Research","https://app.apollo.io/#/contacts/65f2d0aee458f101ae368080","http://www.linkedin.com/in/samuel-perry-30951027",,"https://twitter.com/RemixThera","http://www.linkedin.com/company/remix-therapeutics","http://www.remixtx.com/","N/A",sperry@remixtx.com,sam.r.perry@gmail.com
"Chris","Halpin","Chris Halpin","Director of Operations","TRIANA Biomedicines","Waltham, Massachusetts","42","(781) 317-4414","Research","https://app.apollo.io/#/contacts/65f2cfd9e458f101ae367b25","http://www.linkedin.com/in/chris-halpin-1999a6231",,,"http://www.linkedin.com/company/trianabio","http://www.trianabio.com/","N/A",chris.halpin@trianabio.com,
"Jordi","Mata-Fink","Jordi Mata-Fink","Co-Founder and CEO","Gate Bioscience","Portland, Oregon","29","","Research","https://app.apollo.io/#/contacts/65f2d324434e0801c6a7a306","http://www.linkedin.com/in/jordi-mata-fink-8a677918",,,"http://www.linkedin.com/company/gatebio","http://www.gatebio.com/","N/A",jmatafink@gatebio.com,jmatafink@gmail.com
"Omid","F","Omid F","Chair, CEO and Founder","Seer","San Francisco, California","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b28","",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",of@seer.bio,
"Brittany","S","Brittany S","Operations Manager","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765de","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",brittany@neomorph.com,
"Marla","B","Marla B","Vice President, Business Development","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765dc","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",mbornstein@neomorph.com,marlabornstein@hotmail.com
"Graeme","Fielder","Graeme Fielder","Chief Operating Officer","AviadoBio","London, United Kingdom","69","(443) 125-432881","Research","https://app.apollo.io/#/contacts/65f2c99320117a01c6276284","http://www.linkedin.com/in/gfielder",,"https://twitter.com/AviadoBio","http://www.linkedin.com/company/aviadobio","http://www.aviadobio.com/","N/A",gfielder@aviadobio.com,
"Karen","Fallen","Karen Fallen","Chief Executive Officer","Touchlight","London, United Kingdom","160","(442) 084-819200","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2c94820117a01c6276135","http://www.linkedin.com/in/karenfallen",,"https://twitter.com/touchlightdna","http://www.linkedin.com/company/touchlight-ltd","http://www.touchlight.com/","genetic medicine, dna therapeutics, dna vaccines, dna vectors, dna amplification, enzymatic technology, contract manufacturing, innovation, oncology, infectious diseases, aav, mrna, cdmo, enzymatic dna, synthetic dna, lentivirus, gene therapy, dna, genome editing, biotechnology",karen.fallen@touchlight.com,
"Lance","Ostrom","Lance Ostrom","Chief Business Officer","KSQ Therapeutics, Inc.","United States","79","(617) 990-4642","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dac7f0664f04391df93a","http://www.linkedin.com/in/lance-ostrom-119b251",,"https://twitter.com/KSQ_TX","http://www.linkedin.com/company/ksq-therapeutics-inc-","http://www.ksqtx.com/","functional genomics, drug discovery, crispr, immunooncology, therapeutics",lostrom@ksqtx.com,ostrom97@gmail.com
"Philippe","Moyen","Philippe Moyen","COO","MaaT Pharma","Paris, France","76","(334) 282-91400","Research","https://app.apollo.io/#/contacts/65f6d28b1fb3c701c64ca1fe","http://www.linkedin.com/in/philippe-moyen-74710711","https://facebook.com/MaaTPharma/","https://twitter.com/MaaT_Pharma","http://www.linkedin.com/company/maat-pharma","http://www.maatpharma.com/","microbiome, microbiota, microbiology, microbiotech, pharma, gvhd, leukemia, dysbiosis, symbiosis, biotech, oncology, cancer, gut microbiota",philippe.moyen@maatpharma.com,
"Thibaut","Fayet","Thibaut Fayet","Chief Executive Officer (CEO)","PHAXIAM Therapeutics","Paris, France","90","(334) 787-44438","Biotechnology","https://app.apollo.io/#/contacts/65f6d26b1fb3c703004c7a8d","http://www.linkedin.com/in/thibaut-du-fayet-b4601312",,"https://twitter.com/PHAXIAM","http://www.linkedin.com/company/phaxiam","http://www.phaxiam.com/","biotechnology, phage, innovation, bacterial infection, viruses, staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, phxm",thibaut.dufayet@phaxiam.com,
"David","V","David V","Co-Founder & Chief Operating Officer","Tr1X","San Francisco, California","27","","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6dc718a586701c6f750f6","",,,"http://www.linkedin.com/company/tr1x","http://www.tr1x.bio/","immunology, immunotherapy, cell therapy, genetic engineering, biotechnology, autoimmune disease, inflammatory disease, research, t cells, tolerance",ddevries@tr1x.bio,d.devries.italy@gmail.com
"Jonathan","Solomon","Jonathan Solomon","CEO","BiomX Inc","Cambridge, Massachusetts","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c6c","http://www.linkedin.com/in/jonathan-solomon-4683521","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",jonathans@biomx.com,
"Meghan","Bagshaw","Meghan Bagshaw","Vice President Program, Portfolio & Operations","Sionna Therapeutics","Hanover, Massachusetts","30","(212) 253-8881","Biotechnology, Research, Pharmaceuticals","https://app.apollo.io/#/contacts/65f6e3813b1dca041d0656e6","http://www.linkedin.com/in/meghan-bagshaw-57410244",,"https://twitter.com/sionna_tx","http://www.linkedin.com/company/sionna-therapeutics","http://www.sionnatx.com/","life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, rare disease",meghan.bagshaw@sionnatx.com,meghanrbagshaw@gmail.com
"Douglas","Kling","Douglas Kling","Chief Operating Officer","NewAmsterdam Pharma","Bernards, New Jersey","32","(313) 520-62971","Biotechnology","https://app.apollo.io/#/contacts/65f6d3d61fb3c704394c696f","http://www.linkedin.com/in/douglas-kling-25229b1",,"https://twitter.com/NewAmsPharma","http://www.linkedin.com/company/new-amsterdam-pharma","http://www.newamsterdampharma.com/","N/A",douglas.kling@newamsterdampharma.com,douglaskling@gmail.com
"Torsten","Madsen","Torsten Madsen","Chief Executive Officer","Hoba Therapeutics","Copenhagen, Denmark","15","(453) 110-1285","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d3461fb3c704394c692f","http://www.linkedin.com/in/torsten-m-madsen-4844a34",,,"http://www.linkedin.com/company/hoba-therapeutics","http://www.hobatherapeutics.com/","biotechnology, biologics, pharmaceutical industry, pain, cns, neurophatic pain, hearing loss, cipn",tmma@hobatherapeutics.com,
"Jeremy","Beauchamp","Jeremy Beauchamp","Director Of Operations","Bright Peak Therapeutics","Basel, Switzerland","56","","Research","https://app.apollo.io/#/contacts/65f6d4bf40263f01c6c3d7c6","http://www.linkedin.com/in/jeremybeauchamp",,,"http://www.linkedin.com/company/bright-peak-therapeutics","http://www.brightpeaktx.com/","N/A",jbeauchamp@brightpeaktx.com,
"Kalyn","D.","Kalyn D.","Senior Manager, Marketing and Communications","Genprex, Inc.","Fort Worth, Texas","28","(512) 537-7997","Biotechnology","https://app.apollo.io/#/contacts/65f6d987f0664f01c61e1be4","http://www.linkedin.com/in/kalyn-d-10049147","https://www.facebook.com/genprexinc/","https://twitter.com/genprex","http://www.linkedin.com/company/genprex","http://www.genprex.com/","immunogene cancer biotechnology",kalyn.d@genprex.com,
"Pier","Piazza","Pier Piazza","MD, PhD, Neuroscientist, CEO","AELIS FARMA","Bordeaux, France","26","(335) 575-73770","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d13697cfd00302939e7a","http://www.linkedin.com/in/pier-vincenzo-piazza-ab91695",,"https://twitter.com/AelisFarma","http://www.linkedin.com/company/aelis-farma","http://www.aelisfarma.com/","biotechnology, central nervous system, innovative signaling specific drugs, cb1 receptor, allosteric modulator, cannabis addiction, cognitive disorders, down syndrome, fragil x syndrom",pv.piazza@aelisfarma.com,
"Liang","Schweizer","Liang Schweizer","Founder, Chairperson and CEO","HiFiBiO Therapeutics","Cambridge, Massachusetts","78","","Biotechnology","https://app.apollo.io/#/contacts/65f6d19597cfd00302939ff5","http://www.linkedin.com/in/liangschweizer",,"https://twitter.com/hifibio","http://www.linkedin.com/company/hifibiotherapeutics","http://www.hifibio.com/","microfluidics, singlecell, antibodies, therapeutics, drug discovery, target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation",l.schweizer@hifibio.com,
"Gordon","Dingwall","Gordon Dingwall","Vice President, Development Operations","Mission Therapeutics","Cambridge, United Kingdom","38","(441) 223-607340","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b0","http://www.linkedin.com/in/gordon-dingwall-ab9a713",,"https://twitter.com/missiontherapeu","http://www.linkedin.com/company/mission-therapeutics","http://www.missiontherapeutics.com/","drug discovery, oncology, neurodegeneration, ubiquitin, deubiquitylating enzymes, cancer",gdingwall@missiontherapeutics.com,
"Oliver","Middendorp","Oliver Middendorp","Chief Business Officer","Numab Therapeutics AG","Zürich, Switzerland","78","(414) 453-30471","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d6bb40263f0300c3bcb9","http://www.linkedin.com/in/oliver-middendorp-6544b71",,"https://twitter.com/Numab_Tx","http://www.linkedin.com/company/numab-ag","http://www.numab.com/","N/A",o.middendorp@numab.com,
"Simon","Breitler","Simon Breitler","Chief Operating Officer","EraCal Therapeutics","Zürich, Switzerland","11","","Research","https://app.apollo.io/#/contacts/65f6d6f840263f01c6c3ddc3","http://www.linkedin.com/in/simon-breitler",,"https://twitter.com/era_cal","http://www.linkedin.com/company/eracal-therapeutics","http://www.eracal.ch/","N/A",simon.breitler@eracal.ch,
"Heather","Dibenedetto","Heather Dibenedetto","SVP, Development Operations","Tango Therapeutics","Boston, Massachusetts","170","(857) 320-4900","Research","https://app.apollo.io/#/contacts/65f6dd5bf0664f06b31dea6a","http://www.linkedin.com/in/heather-dibenedetto-0257b810",,,"http://www.linkedin.com/company/tango-therapeutics","http://www.tangotx.com/","cancer, pharmaceutical research, functional genomics, drug discovery, synthetic lethality",hdibenedetto@tangotx.com,jake2771@comcast.net
"Julian","Hanak","Julian Hanak","CEO at Purespring Therapeitics","Purespring Therapeutics","London, United Kingdom","47","(442) 038-556324","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6cf5b72334002ff3690a3","http://www.linkedin.com/in/julian-hanak-23b1474",,"https://twitter.com/PURESPRINGTX","http://www.linkedin.com/company/purespring-therapeutics","http://www.purespringtx.com/","biotechnology, gene therapy, kidney diseases",j.hanak@purespringtx.com,
"Marion","Pierfitte","Marion Pierfitte","Chief Operating Officer","Qubit Pharmaceuticals","Paris, France","56","","Information Technology & Services","https://app.apollo.io/#/contacts/65f6cf1072334002ff368f26","http://www.linkedin.com/in/mpierfitte",,"https://twitter.com/qubit_pharma","http://www.linkedin.com/company/qubit-pharmaceuticals","http://www.qubit-pharmaceuticals.com/","drug discover, computational chemistry, molecular dynamics simulation, quantum physics",marion.pierfitte@qubit-pharmaceuticals.com,
"Mark","Gaffney","Mark Gaffney","Chief Executive Officer","Oxular","Boston, Massachusetts","20","(441) 865-636200","Biotechnology","https://app.apollo.io/#/contacts/65cb0ac3805b590001ae6304","http://www.linkedin.com/in/mark-gaffney-b97a7812b",,"https://twitter.com/OxularLtd","http://www.linkedin.com/company/oxular","http://www.oxular.com/","ophthalmology, biotechnology, ocular, dme, diabetic macular edema, retinoblastoma, microreservoirs, oxulumis, oxuflo, amd, agerelated macular degeneration, retinal disease, therapeutics, treatment, antivegf, gene therapy, uveitis, uveal melanoma, retinal inflammation",mark.gaffney@oxular.com,
"Samir","Ounzain","Samir Ounzain","Co-founder, Chief Executive Officer and Board Director","HAYA Therapeutics","Lausanne, Switzerland","41","","Research","https://app.apollo.io/#/contacts/65f6d09397cfd0098e9394cb","http://www.linkedin.com/in/samirounzain",,"https://twitter.com/HAYA_lncRNA","http://www.linkedin.com/company/haya-therapeutics","http://www.hayatx.com/","lncrna, genomic medicines, fibrosis",samir@hayatx.com,
"Alvin","Shih","Alvin Shih","President and Chief Executive Officer","Catamaran Bio","United States","29","(617) 620-9709","Research","https://app.apollo.io/#/contacts/65f6da81f0664f01c61e1f82","http://www.linkedin.com/in/alvinshih",,"https://twitter.com/CatamaranBio","http://www.linkedin.com/company/catamaran-bio","http://www.catamaranbio.com/","N/A",ashih@catamaranbio.com,alvinvshih@gmail.com
"Per","Walday","Per Walday","Chief Executive Officer","EXACT Therapeutics","Oslo, Norway","18","","Research","https://app.apollo.io/#/contacts/65f6ce5572334001c6369c29","http://www.linkedin.com/in/walday",,"https://twitter.com/ExactTx","http://www.linkedin.com/company/exact-tx","http://www.exact-tx.com/","microbubbles, ultrasound, research, cancertherapy, drugdelivery, precisionhealth, act",per.walday@exact-tx.com,
"Margaux","Duchamp","Margaux Duchamp","CEO and co-founder at ArcoScreen","arcoscreen","Lausanne, Switzerland","2","(417) 820-96148","Research","https://app.apollo.io/#/contacts/65f6d7188211c20300ca1d29","http://www.linkedin.com/in/margauxduchamp",,,"http://www.linkedin.com/company/arcoscreen","http://www.arcoscreen.ch/","N/A",margaux.duchamp@arcoscreen.ch,
"Andrew","Morris","Andrew Morris","VP Business Development","ProQR Therapeutics","Cambridge, Massachusetts","170","(318) 816-67000","Research","https://app.apollo.io/#/contacts/65f6e65fa9b03301c672444d","http://www.linkedin.com/in/proqrbusinessdevelopment","https://www.facebook.com/ProQRTx","https://twitter.com/proqr","http://www.linkedin.com/company/proqr-therapeutics","http://www.proqr.com/","rna therapeutics, drug development, rare diseases, genetic diseases, orphan drugs, pharmaceuticals, rna editing",amorris@proqr.com,ajmorris007@gmail.com
"Robert","M","Robert M","Co-Founder & CEO","Felix Biotechnology","San Francisco, California","5","(858) 366-2331","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d59268a36e02ff5c0672","",,"https://twitter.com/felixbiotech","http://www.linkedin.com/company/felixbt","http://www.felixbt.com/","biotech, phage, phage therapeutics, biotherapeutics, biotherapy, synthetic biology",rob@felixbt.com,robcmcbride@gmail.com
"Lance","Ostrom","Lance Ostrom","Chief Business Officer","KSQ Therapeutics, Inc.","United States","79","(617) 990-4642","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dac7f0664f04391df93a","http://www.linkedin.com/in/lance-ostrom-119b251",,"https://twitter.com/KSQ_TX","http://www.linkedin.com/company/ksq-therapeutics-inc-","http://www.ksqtx.com/","functional genomics, drug discovery, crispr, immunooncology, therapeutics",lostrom@ksqtx.com,ostrom97@gmail.com
"Philippe","Moyen","Philippe Moyen","COO","MaaT Pharma","Paris, France","76","(334) 282-91400","Research","https://app.apollo.io/#/contacts/65f6d28b1fb3c701c64ca1fe","http://www.linkedin.com/in/philippe-moyen-74710711","https://facebook.com/MaaTPharma/","https://twitter.com/MaaT_Pharma","http://www.linkedin.com/company/maat-pharma","http://www.maatpharma.com/","microbiome, microbiota, microbiology, microbiotech, pharma, gvhd, leukemia, dysbiosis, symbiosis, biotech, oncology, cancer, gut microbiota",philippe.moyen@maatpharma.com,
"Thibaut","Fayet","Thibaut Fayet","Chief Executive Officer (CEO)","PHAXIAM Therapeutics","Paris, France","90","(334) 787-44438","Biotechnology","https://app.apollo.io/#/contacts/65f6d26b1fb3c703004c7a8d","http://www.linkedin.com/in/thibaut-du-fayet-b4601312",,"https://twitter.com/PHAXIAM","http://www.linkedin.com/company/phaxiam","http://www.phaxiam.com/","biotechnology, phage, innovation, bacterial infection, viruses, staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, phxm",thibaut.dufayet@phaxiam.com,
"David","V","David V","Co-Founder & Chief Operating Officer","Tr1X","San Francisco, California","27","","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6dc718a586701c6f750f6","",,,"http://www.linkedin.com/company/tr1x","http://www.tr1x.bio/","immunology, immunotherapy, cell therapy, genetic engineering, biotechnology, autoimmune disease, inflammatory disease, research, t cells, tolerance",ddevries@tr1x.bio,d.devries.italy@gmail.com
"Jonathan","Solomon","Jonathan Solomon","CEO","BiomX Inc","Cambridge, Massachusetts","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c6c","http://www.linkedin.com/in/jonathan-solomon-4683521","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",jonathans@biomx.com,
"Meghan","Bagshaw","Meghan Bagshaw","Vice President Program, Portfolio & Operations","Sionna Therapeutics","Hanover, Massachusetts","30","(212) 253-8881","Biotechnology, Research, Pharmaceuticals","https://app.apollo.io/#/contacts/65f6e3813b1dca041d0656e6","http://www.linkedin.com/in/meghan-bagshaw-57410244",,"https://twitter.com/sionna_tx","http://www.linkedin.com/company/sionna-therapeutics","http://www.sionnatx.com/","life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, rare disease",meghan.bagshaw@sionnatx.com,meghanrbagshaw@gmail.com
"Douglas","Kling","Douglas Kling","Chief Operating Officer","NewAmsterdam Pharma","Bernards, New Jersey","32","(313) 520-62971","Biotechnology","https://app.apollo.io/#/contacts/65f6d3d61fb3c704394c696f","http://www.linkedin.com/in/douglas-kling-25229b1",,"https://twitter.com/NewAmsPharma","http://www.linkedin.com/company/new-amsterdam-pharma","http://www.newamsterdampharma.com/","N/A",douglas.kling@newamsterdampharma.com,douglaskling@gmail.com
"Torsten","Madsen","Torsten Madsen","Chief Executive Officer","Hoba Therapeutics","Copenhagen, Denmark","15","(453) 110-1285","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d3461fb3c704394c692f","http://www.linkedin.com/in/torsten-m-madsen-4844a34",,,"http://www.linkedin.com/company/hoba-therapeutics","http://www.hobatherapeutics.com/","biotechnology, biologics, pharmaceutical industry, pain, cns, neurophatic pain, hearing loss, cipn",tmma@hobatherapeutics.com,
"Jeremy","Beauchamp","Jeremy Beauchamp","Director Of Operations","Bright Peak Therapeutics","Basel, Switzerland","56","","Research","https://app.apollo.io/#/contacts/65f6d4bf40263f01c6c3d7c6","http://www.linkedin.com/in/jeremybeauchamp",,,"http://www.linkedin.com/company/bright-peak-therapeutics","http://www.brightpeaktx.com/","N/A",jbeauchamp@brightpeaktx.com,
"Kalyn","D.","Kalyn D.","Senior Manager, Marketing and Communications","Genprex, Inc.","Fort Worth, Texas","28","(512) 537-7997","Biotechnology","https://app.apollo.io/#/contacts/65f6d987f0664f01c61e1be4","http://www.linkedin.com/in/kalyn-d-10049147","https://www.facebook.com/genprexinc/","https://twitter.com/genprex","http://www.linkedin.com/company/genprex","http://www.genprex.com/","immunogene cancer biotechnology",kalyn.d@genprex.com,
"Pier","Piazza","Pier Piazza","MD, PhD, Neuroscientist, CEO","AELIS FARMA","Bordeaux, France","26","(335) 575-73770","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d13697cfd00302939e7a","http://www.linkedin.com/in/pier-vincenzo-piazza-ab91695",,"https://twitter.com/AelisFarma","http://www.linkedin.com/company/aelis-farma","http://www.aelisfarma.com/","biotechnology, central nervous system, innovative signaling specific drugs, cb1 receptor, allosteric modulator, cannabis addiction, cognitive disorders, down syndrome, fragil x syndrom",pv.piazza@aelisfarma.com,
"Liang","Schweizer","Liang Schweizer","Founder, Chairperson and CEO","HiFiBiO Therapeutics","Cambridge, Massachusetts","78","","Biotechnology","https://app.apollo.io/#/contacts/65f6d19597cfd00302939ff5","http://www.linkedin.com/in/liangschweizer",,"https://twitter.com/hifibio","http://www.linkedin.com/company/hifibiotherapeutics","http://www.hifibio.com/","microfluidics, singlecell, antibodies, therapeutics, drug discovery, target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation",l.schweizer@hifibio.com,
"Gordon","Dingwall","Gordon Dingwall","Vice President, Development Operations","Mission Therapeutics","Cambridge, United Kingdom","38","(441) 223-607340","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b0","http://www.linkedin.com/in/gordon-dingwall-ab9a713",,"https://twitter.com/missiontherapeu","http://www.linkedin.com/company/mission-therapeutics","http://www.missiontherapeutics.com/","drug discovery, oncology, neurodegeneration, ubiquitin, deubiquitylating enzymes, cancer",gdingwall@missiontherapeutics.com,
"Oliver","Middendorp","Oliver Middendorp","Chief Business Officer","Numab Therapeutics AG","Zürich, Switzerland","78","(414) 453-30471","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d6bb40263f0300c3bcb9","http://www.linkedin.com/in/oliver-middendorp-6544b71",,"https://twitter.com/Numab_Tx","http://www.linkedin.com/company/numab-ag","http://www.numab.com/","N/A",o.middendorp@numab.com,
"Simon","Breitler","Simon Breitler","Chief Operating Officer","EraCal Therapeutics","Zürich, Switzerland","11","","Research","https://app.apollo.io/#/contacts/65f6d6f840263f01c6c3ddc3","http://www.linkedin.com/in/simon-breitler",,"https://twitter.com/era_cal","http://www.linkedin.com/company/eracal-therapeutics","http://www.eracal.ch/","N/A",simon.breitler@eracal.ch,
"Heather","Dibenedetto","Heather Dibenedetto","SVP, Development Operations","Tango Therapeutics","Boston, Massachusetts","170","(857) 320-4900","Research","https://app.apollo.io/#/contacts/65f6dd5bf0664f06b31dea6a","http://www.linkedin.com/in/heather-dibenedetto-0257b810",,,"http://www.linkedin.com/company/tango-therapeutics","http://www.tangotx.com/","cancer, pharmaceutical research, functional genomics, drug discovery, synthetic lethality",hdibenedetto@tangotx.com,jake2771@comcast.net
"Julian","Hanak","Julian Hanak","CEO at Purespring Therapeitics","Purespring Therapeutics","London, United Kingdom","47","(442) 038-556324","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6cf5b72334002ff3690a3","http://www.linkedin.com/in/julian-hanak-23b1474",,"https://twitter.com/PURESPRINGTX","http://www.linkedin.com/company/purespring-therapeutics","http://www.purespringtx.com/","biotechnology, gene therapy, kidney diseases",j.hanak@purespringtx.com,
"Marion","Pierfitte","Marion Pierfitte","Chief Operating Officer","Qubit Pharmaceuticals","Paris, France","56","","Information Technology & Services","https://app.apollo.io/#/contacts/65f6cf1072334002ff368f26","http://www.linkedin.com/in/mpierfitte",,"https://twitter.com/qubit_pharma","http://www.linkedin.com/company/qubit-pharmaceuticals","http://www.qubit-pharmaceuticals.com/","drug discover, computational chemistry, molecular dynamics simulation, quantum physics",marion.pierfitte@qubit-pharmaceuticals.com,
"Mark","Gaffney","Mark Gaffney","Chief Executive Officer","Oxular","Boston, Massachusetts","20","(441) 865-636200","Biotechnology","https://app.apollo.io/#/contacts/65cb0ac3805b590001ae6304","http://www.linkedin.com/in/mark-gaffney-b97a7812b",,"https://twitter.com/OxularLtd","http://www.linkedin.com/company/oxular","http://www.oxular.com/","ophthalmology, biotechnology, ocular, dme, diabetic macular edema, retinoblastoma, microreservoirs, oxulumis, oxuflo, amd, agerelated macular degeneration, retinal disease, therapeutics, treatment, antivegf, gene therapy, uveitis, uveal melanoma, retinal inflammation",mark.gaffney@oxular.com,
"Samir","Ounzain","Samir Ounzain","Co-founder, Chief Executive Officer and Board Director","HAYA Therapeutics","Lausanne, Switzerland","41","","Research","https://app.apollo.io/#/contacts/65f6d09397cfd0098e9394cb","http://www.linkedin.com/in/samirounzain",,"https://twitter.com/HAYA_lncRNA","http://www.linkedin.com/company/haya-therapeutics","http://www.hayatx.com/","lncrna, genomic medicines, fibrosis",samir@hayatx.com,
"Alvin","Shih","Alvin Shih","President and Chief Executive Officer","Catamaran Bio","United States","29","(617) 620-9709","Research","https://app.apollo.io/#/contacts/65f6da81f0664f01c61e1f82","http://www.linkedin.com/in/alvinshih",,"https://twitter.com/CatamaranBio","http://www.linkedin.com/company/catamaran-bio","http://www.catamaranbio.com/","N/A",ashih@catamaranbio.com,alvinvshih@gmail.com
"Per","Walday","Per Walday","Chief Executive Officer","EXACT Therapeutics","Oslo, Norway","18","","Research","https://app.apollo.io/#/contacts/65f6ce5572334001c6369c29","http://www.linkedin.com/in/walday",,"https://twitter.com/ExactTx","http://www.linkedin.com/company/exact-tx","http://www.exact-tx.com/","microbubbles, ultrasound, research, cancertherapy, drugdelivery, precisionhealth, act",per.walday@exact-tx.com,
"Margaux","Duchamp","Margaux Duchamp","CEO and co-founder at ArcoScreen","arcoscreen","Lausanne, Switzerland","2","(417) 820-96148","Research","https://app.apollo.io/#/contacts/65f6d7188211c20300ca1d29","http://www.linkedin.com/in/margauxduchamp",,,"http://www.linkedin.com/company/arcoscreen","http://www.arcoscreen.ch/","N/A",margaux.duchamp@arcoscreen.ch,
"Andrew","Morris","Andrew Morris","VP Business Development","ProQR Therapeutics","Cambridge, Massachusetts","170","(318) 816-67000","Research","https://app.apollo.io/#/contacts/65f6e65fa9b03301c672444d","http://www.linkedin.com/in/proqrbusinessdevelopment","https://www.facebook.com/ProQRTx","https://twitter.com/proqr","http://www.linkedin.com/company/proqr-therapeutics","http://www.proqr.com/","rna therapeutics, drug development, rare diseases, genetic diseases, orphan drugs, pharmaceuticals, rna editing",amorris@proqr.com,ajmorris007@gmail.com
"Robert","M","Robert M","Co-Founder & CEO","Felix Biotechnology","San Francisco, California","5","(858) 366-2331","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d59268a36e02ff5c0672","",,"https://twitter.com/felixbiotech","http://www.linkedin.com/company/felixbt","http://www.felixbt.com/","biotech, phage, phage therapeutics, biotherapeutics, biotherapy, synthetic biology",rob@felixbt.com,robcmcbride@gmail.com
"Zack","R","Zack R","Business Development Manager","Ansa Biotechnologies, Inc.","San Diego, California","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb9","",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",z.raborn@ansabio.com,
"Robin","M","Robin M","CEO","Deciduous Therapeutics","San Francisco, California","15","(650) 206-9082","Research","https://app.apollo.io/#/contacts/65f2d34d434e0801c6a7a39f","",,,"http://www.linkedin.com/company/deciduous-therapeutics","http://www.deciduoustx.com/","N/A",robin@deciduoustx.com,robin.mansukhani@gmail.com
"Michel","Wathier","Michel Wathier","Vice President CMC Operations","Life Biosciences","Boston, Massachusetts","23","(800) 778-7879","Biotechnology","https://app.apollo.io/#/contacts/65f2d3ff434e0801c6a7a50f","http://www.linkedin.com/in/michel-wathier-67790a33",,"https://twitter.com/lifebiosciences","http://www.linkedin.com/company/lifebiosciences","http://www.lifebiosciences.com/","healthspan, aging research, longevity research, biotechnology, aging, agerelated diseases, biology of aging",michel@lifebiosciences.com,
"Dee","D","Dee D","Co-Founder and CEO","Switch Therapeutics","San Francisco, California","40","(415) 518-9678","Research","https://app.apollo.io/#/contacts/65f2d377434e0802ffa79907","",,,"http://www.linkedin.com/company/switch-therapeutics","http://www.switchthera.com/","N/A",dee@switchthera.com,dee.datta@gmail.com
"Robert","M","Robert M","Co-Founder & CEO","Felix Biotechnology","San Francisco, California","5","(858) 366-2331","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d59268a36e02ff5c0672","",,"https://twitter.com/felixbiotech","http://www.linkedin.com/company/felixbt","http://www.felixbt.com/","biotech, phage, phage therapeutics, biotherapeutics, biotherapy, synthetic biology",rob@felixbt.com,robcmcbride@gmail.com
"Kathy","N","Kathy N","Operations Manager","64x Bio","San Francisco, California","21","","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d5a768a36e01c65c7778","","https://www.facebook.com/64xbio","https://twitter.com/64xbio","http://www.linkedin.com/company/64xbio","http://www.64xbio.com/","gene therapy, synthetic biology, genome engineering, functional genomics",kathy.nunez@64xbio.com,
"Francisco","L","Francisco L","Co-founder, CEO","Gordian Biotechnology","San Francisco, California","33","(714) 599-1305","Research","https://app.apollo.io/#/contacts/65f2d339434e0801c6a7a34f","",,"https://twitter.com/GordianBio","http://www.linkedin.com/company/gordian-biotechnology","http://www.gordian.bio/","N/A",francisco@gordian.bio,leportfr@gmail.com
"Cheri","Ackerman","Cheri Ackerman","Cofounder & CEO","Concerto Biosciences","Cambridge, Massachusetts","31","(617) 544-7044","Research","https://app.apollo.io/#/contacts/65f2d5fa68a36e01c65c7847","http://www.linkedin.com/in/cheri-ackerman-3552a7132",,"https://twitter.com/concertobio","http://www.linkedin.com/company/concerto-biosciences","http://www.concertobio.com/","N/A",cheri@concertobio.com,
"Mary","R","Mary R","Executive Director, CMC Operations & Strategy","CARGO Therapeutics","Seattle, Washington","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeb1","",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",mrodley@cargo-tx.com,
"Gina","C","Gina C","President & Chief Executive Officer","CARGO Therapeutics","San Francisco, California","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeaf","",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",gchapman@cargo-tx.com,
"John","Richard","John Richard","Co-Founder, Chief Business Officer","Mereo BioPharma","Atlanta, Georgia","43","(443) 330-237300","Research","https://app.apollo.io/#/contacts/65f2c9ae20117a01c627631e","http://www.linkedin.com/in/john-richard-4144b4",,,"http://www.linkedin.com/company/mereo-biopharma","http://www.mereobiopharma.com/","speciality biopharmaceuticals",jr@mereobiopharma.com,
"Adam","R","Adam R","CEO and Founder","Star Therapeutics","San Francisco, California","39","(888) 742-1338","Research","https://app.apollo.io/#/contacts/65f2cf0ae458f101ae36783c","",,"https://twitter.com/STAR_Biotech","http://www.linkedin.com/company/star-tx","http://www.star-therapeutics.com/","N/A",adam@star-therapeutics.com,adam.d.rosenthal@gmail.com
"Carrie","Wager","Carrie Wager","Senior Vice President Head of Operations","Ascidian Therapeutics","Cambridge, Massachusetts","43","(717) 329-2455","Biotechnology","https://app.apollo.io/#/contacts/65f2d118e99fbe03000dbbea","http://www.linkedin.com/in/carrie-wager-84b4544",,"https://twitter.com/AscidianTx","http://www.linkedin.com/company/ascidian-therapeutics","http://www.ascidian-tx.com/","gene therapy, biotechnology, rna therapeutics",carrie@ascidian-tx.com,
"Adam","Muzikant","Adam Muzikant","Chief Business Officer","Avilar Therapeutics","Boston, Massachusetts","25","(617) 475-8493","Biotechnology","https://app.apollo.io/#/contacts/65f2cff1e458f101ae367ba6","http://www.linkedin.com/in/adammuzikant",,"https://twitter.com/Avilar_Tx","http://www.linkedin.com/company/avilar-therapeutics","http://www.avilar-tx.com/","N/A",adam.muzikant@avilar-tx.com,adam_muzikant@hotmail.com
"Jeff","J","Jeff J","CEO","Belharra Therapeutics","South San Francisco, California","61","(858) 800-4340","Research","https://app.apollo.io/#/contacts/65f2cf76e458f101ae3679ab","",,,"http://www.linkedin.com/company/belharra-therapeutics","http://www.belharratx.com/","chemoproteomics, research, drug discovery",jjonker@belharratx.com,jeffjonker@gmail.com
"Nivi","Nagaraj","Nivi Nagaraj","Business Development","Chroma Medicine","Boston, Massachusetts","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc95","http://www.linkedin.com/in/nivi-nagaraj",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",nivi.nagaraj@chromamedicine.com,
"Cyrill","K","Cyrill K","COO","Andelyn Biosciences","Columbus, Ohio","220","(844) 228-2366","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a2ee5a323106c56146a4","","https://www.facebook.com/AndelynBiosciences","https://twitter.com/AndelynBio","http://www.linkedin.com/company/andelyn-biosciences","http://www.andelynbio.com/","biotechnology, pharmaceuticals, gene therapy, biological sciences, research",cyrill.kellerhals@andelynbiosciences.com,
"Veronica","Hall","Veronica Hall","Chief Operating Officer","Clarametyx Biosciences","New Market, Maryland","16","(614) 686-2689","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a30f5a32310ab861430e","http://www.linkedin.com/in/veronica-hall-leading-strategic-results",,,"http://www.linkedin.com/company/clarametyx-biosciences","http://www.clarametyx.com/","biotechnology, antibiotics, antibiotic resistance, biofilms, infectious disease",vhall@clarametyx.com,
"Jason","W","Jason W","Sr. Director, Strategy and Business Development","Scribe Therapeutics","San Francisco, California","120","(908) 642-7374","Research","https://app.apollo.io/#/contacts/65f6a7adc95d0d01aed11f06","",,"https://twitter.com/scribetx","http://www.linkedin.com/company/scribe-therapeutics","http://www.scribetx.com/","N/A",wang@scribetx.com,
"Jacob","C","Jacob C","CEO","ORIC Pharmaceuticals Inc.","San Diego, California","110","(650) 388-5600","Research","https://app.apollo.io/#/contacts/65f6a6c7b6d3560572a3af83","",,"https://twitter.com/oricpharma","http://www.linkedin.com/company/oric-pharmaceuticals-inc","http://www.oricpharma.com/","cancer resistance, immunotherapy, oncology",jacob.chacko@oricpharma.com,jmchacko@gmail.com
"Jim","Caruso","Jim Caruso","President, Chief Executive Officer & Director","Cellectar Biosciences, Inc.","New York, New York","29","(608) 441-8120","Biotechnology","https://app.apollo.io/#/contacts/65f6a57f7a4b6901c61fee5f","http://www.linkedin.com/in/jim-caruso-618ba7a4","https://facebook.com/cellectarbiosciences/","https://twitter.com/cellectarbio","http://www.linkedin.com/company/cellectar-biosciences-inc","http://www.cellectar.com/","biotechnology, life sciences, pdc cancer therapeutics & diagnostics, targeted delivery of oncologic payloads, earlystage chemotherapeutic drug conjugates, hematologic malignancies",jcaruso@cellectar.com,
"Amos","Hedt","Amos Hedt","Chief Business Strategy Officer","Perspective Therapeutics","Coralville, Iowa","68","(206) 676-0900","Medical Devices","https://app.apollo.io/#/contacts/65f6a5b57a4b6903141f99a4","http://www.linkedin.com/in/amos-hedt-146b8940",,"https://twitter.com/Perspective_Tx","http://www.linkedin.com/company/perspective-therapeutics","http://www.perspectivetherapeutics.com/","N/A",ahedt@perspectivetherapeutics.com,
"Jessica","Herbst","Jessica Herbst","Director Of Operations","Myrobalan Therapeutics","Boston, Massachusetts","18","(213) 447-4306","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a5d57a4b6903141f99d8","http://www.linkedin.com/in/jessica-herbst-0a5b62162",,,"http://www.linkedin.com/company/myrobalantx","http://www.myrotx.com/","nce, cns, drug discovery, neuroscience",jessica.herbst@myrotx.com,
"Paul","Garofolo","Paul Garofolo","Chief Executive Officer","Locus Biosciences, Inc.","North Carolina, US","56","(919) 495-4510","Biotechnology","https://app.apollo.io/#/contacts/65f6a6237a4b69044d1f6e4c","http://www.linkedin.com/in/paulgarofolo",,"https://twitter.com/locusbio?lang=en","http://www.linkedin.com/company/locus-biosciences-inc.","http://www.locus-bio.com/","crispr, bacterial infections, antibiotic resistance, biotechnology, microbiome, targeted therapeutics",paul.garofolo@locus-bio.com,
"Timothy","M","Timothy M","Cofounder, President & CEO","Forge Biologics","Cleveland, Ohio","310","(617) 792-3937","Research","https://app.apollo.io/#/contacts/65f6a3775a32310300615609","","https://facebook.com/forgebiologics",,"http://www.linkedin.com/company/forge-biologics","http://www.forgebiologics.com/","aav, gene therapy, biotech, cgmp",tmiller@forgebiologics.com,
"Jacob","C","Jacob C","CEO","ORIC Pharmaceuticals Inc.","San Diego, California","110","(650) 388-5600","Research","https://app.apollo.io/#/contacts/65f6a6c7b6d3560572a3af83","",,"https://twitter.com/oricpharma","http://www.linkedin.com/company/oric-pharmaceuticals-inc","http://www.oricpharma.com/","cancer resistance, immunotherapy, oncology",jacob.chacko@oricpharma.com,jmchacko@gmail.com
"Anders","Hinsby","Anders Hinsby","Chief Operating Officer","Muna Therapeutics","Copenhagen, Denmark","53","(452) 898-9056","Research","https://app.apollo.io/#/contacts/65f6c277fe160f01c60f7047","http://www.linkedin.com/in/anders-m%c3%b8rkeberg-hinsby-a55a84",,"https://twitter.com/muna_tx","http://www.linkedin.com/company/muna-therapeutics","http://www.munatherapeutics.com/","N/A",hinsby@munatherapeutics.com,
"Rami","E","Rami E","Chairman & CEO","Arcellx","San Francisco, California","150","(240) 723-6641","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d9ebf0664f03001e0dd7","",,"https://twitter.com/arcellx","http://www.linkedin.com/company/arcellx","http://www.arcellx.com/","biotechnology, cart, cell therapy, multiple myeloma, oncology",rami@arcellx.com,rami.elghandour@gmail.com
"Kamila","D","Kamila D","Associate Investor Relations and Corporate Communications","Arcellx","San Francisco, California","150","(240) 723-6641","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d9ebf0664f03001e0dd3","",,"https://twitter.com/arcellx","http://www.linkedin.com/company/arcellx","http://www.arcellx.com/","biotechnology, cart, cell therapy, multiple myeloma, oncology",kdmowska@arcellx.com,kamiladmowska@gmail.com
"Kirsten","Kester","Kirsten Kester","Senior Vice President, Business Development","Obsidian Therapeutics","Boston, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1efe","http://www.linkedin.com/in/kirsten-kester-06391614",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",kkester@obsidiantx.com,kirsten.kester@gmail.com
"Chad","Rubin","Chad Rubin","SVP Corporate Affairs and Investor Relations","NexImmune, Inc.","New York, New York","38","(301) 825-9810","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6da37f0664f01c61e1e25","http://www.linkedin.com/in/chad-rubin-7539141","https://facebook.com/NexImmune/","https://twitter.com/neximmune","http://www.linkedin.com/company/neximmune-inc.","http://www.neximmune.com/","biotechnology, life sciences",crubin@neximmune.com,
"Caroline","Code","Caroline Code","Senior Director, Corporate Development & Strategy","Obsidian Therapeutics","Boston, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1efa","http://www.linkedin.com/in/caroline-code-88a99983",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",ccode@obsidiantx.com,
"Jesper","Nissen","Jesper Nissen","Chief Operating Officer","Evaxion Biotech A/S","Copenhagen, Denmark","70","(455) 353-1850","Research","https://app.apollo.io/#/contacts/65f6cd4f72334002ff3687ca","http://www.linkedin.com/in/jesper-nyegaard-nissen-6019103",,"https://twitter.com/EvaxionBiotech","http://www.linkedin.com/company/evaxion-biotech","http://www.evaxion-biotech.com/","europe, usa, canada, immunoinformatics, bioinformatics, infectious diseases, immunooncology, vaccines, immunotherapy, artificial intelligence, antigen discovery, neo epitope discovery, aiimmunology, ai, biotech",jnn@evaxion-biotech.com,
"Valerie","Gabarre","Valerie Gabarre","Medico-Marketing Director","OSE Immunotherapeutics","Paris, France","64","(332) 282-91010","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d1d497cfd001c693c9f5","http://www.linkedin.com/in/val%c3%a9rie-gabarre-60a46527",,"https://twitter.com/oseimmuno","http://www.linkedin.com/company/ose-immunotherapeutics","http://www.ose-immuno.com/","immunooncologie, immunotherapie, maladies autoimmunes, nsclc, checkpoint inhibitor, developpement clinique, biotechnologie, neoepitopes, sirpalpha, mdsc, rectocolite hemorragique, polyarthrite rhumatoide",valerie.gabarre@ose-immuno.com,
"Trey","Landers","Trey Landers","Regional Business Director","Calliditas Therapeutics","Houston, Texas","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69bd","http://www.linkedin.com/in/trey-landers-88503b96",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",trey.landers@calliditas.com,
"Kreena","Bhatia","Kreena Bhatia","Associate Director, Thought Leader/ Strategic Marketing Liaison","Calliditas Therapeutics","Irving, Texas","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69bb","http://www.linkedin.com/in/kreena-bhatia-5b6a334",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",kreena.bhatia@calliditas.com,kreenabhatia19@gmail.com
"Karolina","Niewola","Karolina Niewola","Director of Business Development and Strategic Alliances","iOnctura","Geneva, Switzerland","23","","Research","https://app.apollo.io/#/contacts/65f6d66c40263f01c6c3dd29","http://www.linkedin.com/in/karolina-niewola-4a291b109",,"https://twitter.com/ionctura","http://www.linkedin.com/company/ionctura","http://www.ionctura.com/","oncology, drug development, clinical development",k.niewola@ionctura.com,
"Jeff","Abbey","Jeff Abbey","Chief Operating Officer & Chief Business Officer","ImmunOs Therapeutics AG","Brussels, Belgium","31","(414) 473-19035","Biotechnology, Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d68440263f01c6c3dd5f","http://www.linkedin.com/in/jeff-abbey",,,"http://www.linkedin.com/company/immunos-therapeutics-ag","http://www.immunostherapeutics.com/","immunooncology, oncology, biotech, pharmaceuticals, global, research & development, immunology, clinical research, business development, sales & marketing, leadership",jeff.abbey@immunostherapeutics.com,
"Dave","M","Dave M","Founder/COO @ Cofactor Genomics, GP Bio+Health Fund and SVP","Cofactor Genomics","San Diego, California","12","(314) 531-4647","Biotechnology","https://app.apollo.io/#/contacts/65f6d9b8f0664f04391df77a","","https://www.facebook.com/cofactorgenomics","https://twitter.com/cofactorgenomic","http://www.linkedin.com/company/cofactorgenomics","http://www.cofactorgenomics.com/","biotechnology, diagnostics, life sciences, rna, rnaseq, ngs, bioinformatics",david_messina@cofactorgenomics.com,
"Rachel","Wallace","Rachel Wallace","Executive Business Partner","LifeMine Therapeutics","Cambridge, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f7535e","http://www.linkedin.com/in/rachelannwallace",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",rwallace@lifeminetx.com,
"Karin","Hellsvik","Karin Hellsvik","Vice President, Corporate Affairs, Investor Communications, Chief of Staff to the CEO","Foghorn Therapeutics Inc.","Cambridge, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b5d","http://www.linkedin.com/in/karin-hellsvik-b823881",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",khellsvik@foghorntx.com,
"Anais","Gervais","Anais Gervais","Director, Business and Commercial Strategy","Foghorn Therapeutics Inc.","Boston, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b61","http://www.linkedin.com/in/anaisgervais",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",agervais@foghorntx.com,agervais2@gmail.com
"Cyrill","K","Cyrill K","COO","Andelyn Biosciences","Columbus, Ohio","220","(844) 228-2366","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a2ee5a323106c56146a4","","https://www.facebook.com/AndelynBiosciences","https://twitter.com/AndelynBio","http://www.linkedin.com/company/andelyn-biosciences","http://www.andelynbio.com/","biotechnology, pharmaceuticals, gene therapy, biological sciences, research",cyrill.kellerhals@andelynbiosciences.com,
"Veronica","Hall","Veronica Hall","Chief Operating Officer","Clarametyx Biosciences","New Market, Maryland","16","(614) 686-2689","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a30f5a32310ab861430e","http://www.linkedin.com/in/veronica-hall-leading-strategic-results",,,"http://www.linkedin.com/company/clarametyx-biosciences","http://www.clarametyx.com/","biotechnology, antibiotics, antibiotic resistance, biofilms, infectious disease",vhall@clarametyx.com,
"Alejandra","Tique","Alejandra Tique","Senior Business ERP Analyst","Wave Life Sciences","Boston, Massachusetts","320","(617) 949-2900","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6bebbe6063704246ff8e4","http://www.linkedin.com/in/alejandra-carrillo-tique-2b627913b",,"https://twitter.com/wavelifesci","http://www.linkedin.com/company/wave-life-sciences","http://www.wavelifesciences.com/","biotechnology, oligonucleotides, genetic medicines, rna editing, rnai",acarrillo@wavelifesci.com,
"Nicole","P","Nicole P","CEO & Founder","Siren Biotechnology","San Francisco, California","9","(509) 607-1274","Research","https://app.apollo.io/#/contacts/65f2d79b68a36e01c65c7d21","",,"https://twitter.com/sirenbio","http://www.linkedin.com/company/siren-biotechnology-inc","http://www.sirenbiotechnology.com/","N/A",npaulk@sirenbiotechnology.com,
"Brett","Masterson","Brett Masterson","Head of Marketing","CARGO Therapeutics","Austin, Texas","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeb7","http://www.linkedin.com/in/brett-masterson-485522",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",bmasterson@atarabio.com,
"Denise","Scots-Knight","Denise Scots-Knight","Chief Executive Officer","Mereo BioPharma","London, United Kingdom","43","(443) 330-237300","Research","https://app.apollo.io/#/contacts/65f2c9ae20117a01c6276320","http://www.linkedin.com/in/denise-scots-knight-678a114b",,,"http://www.linkedin.com/company/mereo-biopharma","http://www.mereobiopharma.com/","speciality biopharmaceuticals",dsk@mereobiopharma.com,
"Andrea","Sarasin","Andrea Sarasin","VP, Business Strategy & Integration","Chroma Medicine","Brookline, Massachusetts","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc97","http://www.linkedin.com/in/andrea-sarasin-a997745",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",andrea.sarasin@chromamedicine.com,
"Adam","Houghton","Adam Houghton","Chief Business Officer","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de022","http://www.linkedin.com/in/adam-houghton-96287b11",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",adam.houghton@upstreambio.com,
"Jacob","C","Jacob C","CEO","ORIC Pharmaceuticals Inc.","San Diego, California","110","(650) 388-5600","Research","https://app.apollo.io/#/contacts/65f6a6c7b6d3560572a3af83","",,"https://twitter.com/oricpharma","http://www.linkedin.com/company/oric-pharmaceuticals-inc","http://www.oricpharma.com/","cancer resistance, immunotherapy, oncology",jacob.chacko@oricpharma.com,jmchacko@gmail.com
"Anders","Hinsby","Anders Hinsby","Chief Operating Officer","Muna Therapeutics","Copenhagen, Denmark","53","(452) 898-9056","Research","https://app.apollo.io/#/contacts/65f6c277fe160f01c60f7047","http://www.linkedin.com/in/anders-m%c3%b8rkeberg-hinsby-a55a84",,"https://twitter.com/muna_tx","http://www.linkedin.com/company/muna-therapeutics","http://www.munatherapeutics.com/","N/A",hinsby@munatherapeutics.com,
"Rami","E","Rami E","Chairman & CEO","Arcellx","San Francisco, California","150","(240) 723-6641","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d9ebf0664f03001e0dd7","",,"https://twitter.com/arcellx","http://www.linkedin.com/company/arcellx","http://www.arcellx.com/","biotechnology, cart, cell therapy, multiple myeloma, oncology",rami@arcellx.com,rami.elghandour@gmail.com
"Kamila","D","Kamila D","Associate Investor Relations and Corporate Communications","Arcellx","San Francisco, California","150","(240) 723-6641","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d9ebf0664f03001e0dd3","",,"https://twitter.com/arcellx","http://www.linkedin.com/company/arcellx","http://www.arcellx.com/","biotechnology, cart, cell therapy, multiple myeloma, oncology",kdmowska@arcellx.com,kamiladmowska@gmail.com
"Kirsten","Kester","Kirsten Kester","Senior Vice President, Business Development","Obsidian Therapeutics","Boston, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1efe","http://www.linkedin.com/in/kirsten-kester-06391614",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",kkester@obsidiantx.com,kirsten.kester@gmail.com
"Chad","Rubin","Chad Rubin","SVP Corporate Affairs and Investor Relations","NexImmune, Inc.","New York, New York","38","(301) 825-9810","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6da37f0664f01c61e1e25","http://www.linkedin.com/in/chad-rubin-7539141","https://facebook.com/NexImmune/","https://twitter.com/neximmune","http://www.linkedin.com/company/neximmune-inc.","http://www.neximmune.com/","biotechnology, life sciences",crubin@neximmune.com,
"Caroline","Code","Caroline Code","Senior Director, Corporate Development & Strategy","Obsidian Therapeutics","Boston, Massachusetts","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1efa","http://www.linkedin.com/in/caroline-code-88a99983",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",ccode@obsidiantx.com,
"Jesper","Nissen","Jesper Nissen","Chief Operating Officer","Evaxion Biotech A/S","Copenhagen, Denmark","70","(455) 353-1850","Research","https://app.apollo.io/#/contacts/65f6cd4f72334002ff3687ca","http://www.linkedin.com/in/jesper-nyegaard-nissen-6019103",,"https://twitter.com/EvaxionBiotech","http://www.linkedin.com/company/evaxion-biotech","http://www.evaxion-biotech.com/","europe, usa, canada, immunoinformatics, bioinformatics, infectious diseases, immunooncology, vaccines, immunotherapy, artificial intelligence, antigen discovery, neo epitope discovery, aiimmunology, ai, biotech",jnn@evaxion-biotech.com,
"Valerie","Gabarre","Valerie Gabarre","Medico-Marketing Director","OSE Immunotherapeutics","Paris, France","64","(332) 282-91010","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d1d497cfd001c693c9f5","http://www.linkedin.com/in/val%c3%a9rie-gabarre-60a46527",,"https://twitter.com/oseimmuno","http://www.linkedin.com/company/ose-immunotherapeutics","http://www.ose-immuno.com/","immunooncologie, immunotherapie, maladies autoimmunes, nsclc, checkpoint inhibitor, developpement clinique, biotechnologie, neoepitopes, sirpalpha, mdsc, rectocolite hemorragique, polyarthrite rhumatoide",valerie.gabarre@ose-immuno.com,
"Trey","Landers","Trey Landers","Regional Business Director","Calliditas Therapeutics","Houston, Texas","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69bd","http://www.linkedin.com/in/trey-landers-88503b96",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",trey.landers@calliditas.com,
"Kreena","Bhatia","Kreena Bhatia","Associate Director, Thought Leader/ Strategic Marketing Liaison","Calliditas Therapeutics","Irving, Texas","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69bb","http://www.linkedin.com/in/kreena-bhatia-5b6a334",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",kreena.bhatia@calliditas.com,kreenabhatia19@gmail.com
"Karolina","Niewola","Karolina Niewola","Director of Business Development and Strategic Alliances","iOnctura","Geneva, Switzerland","23","","Research","https://app.apollo.io/#/contacts/65f6d66c40263f01c6c3dd29","http://www.linkedin.com/in/karolina-niewola-4a291b109",,"https://twitter.com/ionctura","http://www.linkedin.com/company/ionctura","http://www.ionctura.com/","oncology, drug development, clinical development",k.niewola@ionctura.com,
"Jeff","Abbey","Jeff Abbey","Chief Operating Officer & Chief Business Officer","ImmunOs Therapeutics AG","Brussels, Belgium","31","(414) 473-19035","Biotechnology, Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d68440263f01c6c3dd5f","http://www.linkedin.com/in/jeff-abbey",,,"http://www.linkedin.com/company/immunos-therapeutics-ag","http://www.immunostherapeutics.com/","immunooncology, oncology, biotech, pharmaceuticals, global, research & development, immunology, clinical research, business development, sales & marketing, leadership",jeff.abbey@immunostherapeutics.com,
"Dave","M","Dave M","Founder/COO @ Cofactor Genomics, GP Bio+Health Fund and SVP","Cofactor Genomics","San Diego, California","12","(314) 531-4647","Biotechnology","https://app.apollo.io/#/contacts/65f6d9b8f0664f04391df77a","","https://www.facebook.com/cofactorgenomics","https://twitter.com/cofactorgenomic","http://www.linkedin.com/company/cofactorgenomics","http://www.cofactorgenomics.com/","biotechnology, diagnostics, life sciences, rna, rnaseq, ngs, bioinformatics",david_messina@cofactorgenomics.com,
"Rachel","Wallace","Rachel Wallace","Executive Business Partner","LifeMine Therapeutics","Cambridge, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f7535e","http://www.linkedin.com/in/rachelannwallace",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",rwallace@lifeminetx.com,
"Karin","Hellsvik","Karin Hellsvik","Vice President, Corporate Affairs, Investor Communications, Chief of Staff to the CEO","Foghorn Therapeutics Inc.","Cambridge, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b5d","http://www.linkedin.com/in/karin-hellsvik-b823881",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",khellsvik@foghorntx.com,
"Anais","Gervais","Anais Gervais","Director, Business and Commercial Strategy","Foghorn Therapeutics Inc.","Boston, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b61","http://www.linkedin.com/in/anaisgervais",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",agervais@foghorntx.com,agervais2@gmail.com
"Cyrill","K","Cyrill K","COO","Andelyn Biosciences","Columbus, Ohio","220","(844) 228-2366","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a2ee5a323106c56146a4","","https://www.facebook.com/AndelynBiosciences","https://twitter.com/AndelynBio","http://www.linkedin.com/company/andelyn-biosciences","http://www.andelynbio.com/","biotechnology, pharmaceuticals, gene therapy, biological sciences, research",cyrill.kellerhals@andelynbiosciences.com,
"Veronica","Hall","Veronica Hall","Chief Operating Officer","Clarametyx Biosciences","New Market, Maryland","16","(614) 686-2689","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a30f5a32310ab861430e","http://www.linkedin.com/in/veronica-hall-leading-strategic-results",,,"http://www.linkedin.com/company/clarametyx-biosciences","http://www.clarametyx.com/","biotechnology, antibiotics, antibiotic resistance, biofilms, infectious disease",vhall@clarametyx.com,
"Alejandra","Tique","Alejandra Tique","Senior Business ERP Analyst","Wave Life Sciences","Boston, Massachusetts","320","(617) 949-2900","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6bebbe6063704246ff8e4","http://www.linkedin.com/in/alejandra-carrillo-tique-2b627913b",,"https://twitter.com/wavelifesci","http://www.linkedin.com/company/wave-life-sciences","http://www.wavelifesciences.com/","biotechnology, oligonucleotides, genetic medicines, rna editing, rnai",acarrillo@wavelifesci.com,
"Nicole","P","Nicole P","CEO & Founder","Siren Biotechnology","San Francisco, California","9","(509) 607-1274","Research","https://app.apollo.io/#/contacts/65f2d79b68a36e01c65c7d21","",,"https://twitter.com/sirenbio","http://www.linkedin.com/company/siren-biotechnology-inc","http://www.sirenbiotechnology.com/","N/A",npaulk@sirenbiotechnology.com,
"Brett","Masterson","Brett Masterson","Head of Marketing","CARGO Therapeutics","Austin, Texas","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeb7","http://www.linkedin.com/in/brett-masterson-485522",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",bmasterson@atarabio.com,
"Denise","Scots-Knight","Denise Scots-Knight","Chief Executive Officer","Mereo BioPharma","London, United Kingdom","43","(443) 330-237300","Research","https://app.apollo.io/#/contacts/65f2c9ae20117a01c6276320","http://www.linkedin.com/in/denise-scots-knight-678a114b",,,"http://www.linkedin.com/company/mereo-biopharma","http://www.mereobiopharma.com/","speciality biopharmaceuticals",dsk@mereobiopharma.com,
"Andrea","Sarasin","Andrea Sarasin","VP, Business Strategy & Integration","Chroma Medicine","Brookline, Massachusetts","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc97","http://www.linkedin.com/in/andrea-sarasin-a997745",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",andrea.sarasin@chromamedicine.com,
"Adam","Houghton","Adam Houghton","Chief Business Officer","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de022","http://www.linkedin.com/in/adam-houghton-96287b11",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",adam.houghton@upstreambio.com,
"Adam","Houghton","Adam Houghton","Chief Business Officer","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de022","http://www.linkedin.com/in/adam-houghton-96287b11",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",adam.houghton@upstreambio.com,
"Brandon","A.","Brandon A.","Senior Director, Clinical Development and Operations","MapLight Therapeutics, Inc.","New York, New York","65","(617) 984-6300","Research","https://app.apollo.io/#/contacts/65f2d1b1e99fbe01c60de1a6","http://www.linkedin.com/in/babbs",,"https://twitter.com/Maplightrx","http://www.linkedin.com/company/maplight-therapeutics-inc","http://www.maplightrx.com/","N/A",babbs@maplightrx.com,brandon.abbs@gmail.com
"William","Taft","William Taft","Director of Strategy and Business Development","Anagenex","Medfield, Massachusetts","32","(978) 444-2649","Biotechnology","https://app.apollo.io/#/contacts/65f2d72568a36e05715bc19e","http://www.linkedin.com/in/william-taft-66595a43",,"https://twitter.com/anagenex","http://www.linkedin.com/company/anagenex","http://www.anagenex.com/","N/A",will@anagenex.com,wtaft@comcast.net
"Didier","Vingadassalom","Didier Vingadassalom","Senior Director, Business Development","Concerto Biosciences","Boston, Massachusetts","31","(617) 544-7044","Research","https://app.apollo.io/#/contacts/65f2d5fa68a36e01c65c7849","http://www.linkedin.com/in/didiervingadassalom",,"https://twitter.com/concertobio","http://www.linkedin.com/company/concerto-biosciences","http://www.concertobio.com/","N/A",didier@concertobio.com,d.vingadassalom@gmail.com
"Ashlee","Dunston","Ashlee Dunston","Investor Relations and Public Affairs","aTyr Pharma","New York, New York","74","(858) 731-8389","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d68768a36e01c65c7927","http://www.linkedin.com/in/ashlee-dunston-7831821","https://facebook.com/atyrpharma","http://www.twitter.com/aTyrNews","http://www.linkedin.com/company/atyr-pharma","http://www.atyrpharma.com/","biotechnology, life sciences, biologics, drug discovery & development, rare & orphan diseases, autoimmune diseases",adunston@atyrpharma.com,
"Kevin","F","Kevin F","Chairman and CEO","Autobahn Therapeutics, Inc.","Carlsbad, California","22","(858) 257-3418","Research","https://app.apollo.io/#/contacts/65f2d65068a36e04385bde03","",,,"http://www.linkedin.com/company/autobahn-therapeutics-inc","http://www.autobahntx.com/","N/A",kfinney@autobahntx.com,
"Greg","Duncan","Greg Duncan","Chairman & CEO Virios Therapeutics","Virios Therapeutics","Atlanta, Georgia","7","(866) 620-8655","Biotechnology","https://app.apollo.io/#/contacts/65f2d391434e0801c6a7a443","http://www.linkedin.com/in/greg-duncan-94893616","http://www.facebook.com/innovativemedconcepts","https://twitter.com/ViriosBiotech","http://www.linkedin.com/company/viriosbiotech","http://www.virios.com/","software, information technology",greg@virios.com,
"Joel","B","Joel B","Senior Director -  Business Development","Switch Therapeutics","San Francisco, California","40","(415) 518-9678","Research","https://app.apollo.io/#/contacts/65f2d377434e0802ffa79905","",,,"http://www.linkedin.com/company/switch-therapeutics","http://www.switchthera.com/","N/A",joel@switchthera.com,joel.burrill@gmail.com
"Claire","Mazumdar","Claire Mazumdar","Chief Executive Officer","Bicara Therapeutics","Boston, Massachusetts","35","(212) 362-1200","Research","https://app.apollo.io/#/contacts/65f6bf7f63db9001c6ecf9e7","http://www.linkedin.com/in/claire-mazumdar-bb53815a",,"https://twitter.com/bicaratx?lang=en","http://www.linkedin.com/company/bicara-therapeutics","http://www.bicara.com/","immunotherapy, targeted oncology, drug discovery",claire@bicara.com,
"Xavier","Duportet","Xavier Duportet","CEO","Eligo Bioscience","Paris, France","42","","Research","https://app.apollo.io/#/contacts/65f6bdf9e6063701ae704e1d","http://www.linkedin.com/in/duportet","https://www.facebook.com/eligobioscience/","https://twitter.com/eligobio","http://www.linkedin.com/company/eligo-bioscience","http://www.eligo-bioscience.com/","N/A",xavier.duportet@eligo.bio,
"Peter","A","Peter A","Chief Executive Officer and Board Member","Capsida Biotherapeutics","Barrington, Illinois","130","(310) 403-8951","Biotechnology","https://app.apollo.io/#/contacts/65f6a43e5a32310300615705","",,"https://twitter.com/CapsidaBio","http://www.linkedin.com/company/capsida-biotherapeutics","http://www.capsida.com/","biotechnology, aav engineering, gene therapy, biopharmaceuticals, protein engineering, analytical development, process development, aav immunology",peter.anastasiou@capsida.com,panoanastas@yahoo.com
"Heather","H","Heather H","Senior Marketing Manager","Forge Biologics","Westerville, Ohio","310","(617) 792-3937","Research","https://app.apollo.io/#/contacts/65f6a3775a32310300615603","","https://facebook.com/forgebiologics",,"http://www.linkedin.com/company/forge-biologics","http://www.forgebiologics.com/","aav, gene therapy, biotech, cgmp",hharmon@forgebiologics.com,heatherbeers74@gmail.com
"Marina","C","Marina C","Associate Director, Marketing & Communications","Forge Biologics","Cleveland, Ohio","310","(617) 792-3937","Research","https://app.apollo.io/#/contacts/65f6a3775a3231030061560b","","https://facebook.com/forgebiologics",,"http://www.linkedin.com/company/forge-biologics","http://www.forgebiologics.com/","aav, gene therapy, biotech, cgmp",mcorleto@forgebiologics.com,
"Pietro","Bersani","Pietro Bersani","CEO and Executive Director","Kiromic Biopharma, Inc.","United States","37","(832) 968-4888","Research","https://app.apollo.io/#/contacts/65f6a48e5a3231043b614b55","http://www.linkedin.com/in/pietro-bersani-45a821a9","https://facebook.com/Kiromic","https://twitter.com/Kiromic1","http://www.linkedin.com/company/kiromic","http://www.kiromic.com/","cancer research, tumor immunology, cell culture, biopharmaceutical, nanotechnology",pbersani@kiromic.com,
"Asher","Page","Asher Page","Sr. Director, Business Development","Adicet Bio, Inc","Brookline, Massachusetts","160","(650) 542-0034","Research","https://app.apollo.io/#/contacts/65f6a63e7a4b6903141f9a2a","http://www.linkedin.com/in/asher-page-9b53bb3b",,"https://twitter.com/AdicetBio","http://www.linkedin.com/company/adicet-bio-inc","http://www.adicetbio.com/","N/A",apage@adicetbio.com,apage11@gmail.com
"Jing","Wang","Jing Wang","Co-Founder & CEO","Myrobalan Therapeutics","Lexington, Massachusetts","18","(213) 447-4306","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a5d57a4b6903141f99d4","http://www.linkedin.com/in/jing-wang-9309751",,,"http://www.linkedin.com/company/myrobalantx","http://www.myrotx.com/","nce, cns, drug discovery, neuroscience",jing.wang@myrotx.com,halcyonjing@yahoo.com
"Debarun","Gupta","Debarun Gupta","Head of Business Development","Myrobalan Therapeutics","Boston, Massachusetts","18","(213) 447-4306","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a5d57a4b6903141f99d6","http://www.linkedin.com/in/debarungupta",,,"http://www.linkedin.com/company/myrobalantx","http://www.myrotx.com/","nce, cns, drug discovery, neuroscience",debarun.gupta@myrotx.com,dgupta599@gmail.com
"Vikram","J","Vikram J","Chief Business Officer","A2 Biotherapeutics, Inc.","Agoura Hills, California","140","(805) 491-1988","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a4785a323101c6616295","",,,"http://www.linkedin.com/company/a2-biotherapeutics","http://www.a2bio.com/","biotechnology, immunotherapy, oncology, research, target identification, cell therapy, manufacturing, drug development",vjoshi@a2bio.com,
"Hanny","Kanafani","Hanny Kanafani","President and COO","Trait Biosciences Inc.","Plano, Texas","20","(604) 684-4535","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6a7fcc95d0d0301d0e46d","http://www.linkedin.com/in/hanny-kanafani-phd-0a896233",,"https://twitter.com/TraitBio","http://www.linkedin.com/company/traitbio","http://www.traitbio.com/","biotechnology",hanny@traitbio.com,
"Svetlana","L","Svetlana L","Chief Business Officer","Scribe Therapeutics","San Francisco, California","120","(908) 642-7374","Research","https://app.apollo.io/#/contacts/65f6a7adc95d0d01aed11f04","",,"https://twitter.com/scribetx","http://www.linkedin.com/company/scribe-therapeutics","http://www.scribetx.com/","N/A",slucas@scribetx.com,
"Scott","C","Scott C","CEO","Ambagon Therapeutics","San Francisco, California","52","(415) 235-6373","Research","https://app.apollo.io/#/contacts/65f6a8d3c95d0d01aed12079","",,"https://twitter.com/ambagontx","http://www.linkedin.com/company/ambagon-therapeutics","http://www.ambagontx.com/","N/A",sclarke@ambagontx.com,sclarke94040@gmail.com
"Nassim","U","Nassim U","President & CEO","Totus Medicines","South San Francisco, California","35","(617) 221-7784","Research","https://app.apollo.io/#/contacts/65f6a95ec95d0d0301d0e5c5","",,"https://twitter.com/Totus_Medicines","http://www.linkedin.com/company/totusmedicines","http://www.totusmedicines.com/","N/A",nassim@totusmedicines.com,
"Dario","Eklund","Dario Eklund","Chief Executive Officer","Santhera Pharmaceuticals","Zürich, Switzerland","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececfc","http://www.linkedin.com/in/darioeklund","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",dario.eklund@santhera.com,
"Ron","Renaud","Ron Renaud","President & CEO","Cerevel Therapeutics","Wellesley, Massachusetts","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a1759d","http://www.linkedin.com/in/ron-renaud-6949821","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",rrenaud@translate.bio,
"Antonino","Amato","Antonino Amato","Chief Executive Officer","PinCell srl","Rome, Italy","6","(390) 283-991300","Research","https://app.apollo.io/#/contacts/65f6c07763db9001c6ecfbf0","http://www.linkedin.com/in/tonyamato1",,,"http://www.linkedin.com/company/pincell-srl","http://www.pincell.it/","biotech & drug development",a.amato@pincell.it,
"Sonny","H","Sonny H","Founder and CEO","Acepodia","San Francisco, California","46","(415) 366-7822","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6cf7d72334002ff3690bf","",,"https://twitter.com/AcepodiaInc","http://www.linkedin.com/company/acepodia","http://www.acepodia.com/","oncology, cancer cell immunotherapy, allogeneic, offtheshelf, nk cells, biotechnology, interdisciplinary technology, car, cell therapy",sonny@acepodiabio.com,
"Kathi","Mujynya","Kathi Mujynya","Chief Operating Officer","CUTISS AG","Zürich, Switzerland","48","(414) 354-92110","Research","https://app.apollo.io/#/contacts/65f6d0bc97cfd00aeb9394a4","http://www.linkedin.com/in/kathi-mujynya-5202153","https://www.facebook.com/skingrafts/","https://twitter.com/Cutiss_AG","http://www.linkedin.com/company/cutiss-ag","http://www.cutiss.swiss/","N/A",kathi.mujynya@cutiss.swiss,
"Manfred","Ruediger","Manfred Ruediger","CEO of Ariceum Therapeutics GmbH","Ariceum Therapeutics","Germany","34","(493) 094-893360","Research","https://app.apollo.io/#/contacts/65f6d02e97cfd00302939da9","http://www.linkedin.com/in/manfred-ruediger-b034892",,"https://twitter.com/Ariceum_Tx","http://www.linkedin.com/company/ariceum-therapeutics","http://www.ariceum-therapeutics.com/","N/A",m.ruediger@ariceum-therapeutics.com,
"Julien","V.","Julien V.","Chief Business Development Officer","Theranexus","Paris, France","20","","Research","https://app.apollo.io/#/contacts/65f6d2cd1fb3c701c64ca299","http://www.linkedin.com/in/julien-v-98225a4",,"https://twitter.com/theranexus","http://www.linkedin.com/company/theranexus","http://www.theranexus.com/","N/A",julien.veys@theranexus.com,
"Lindsay","Reis","Lindsay Reis","Manager, Regulatory Operations","Cardurion Pharmaceuticals","Chesterfield, Missouri","44","(617) 996-1433","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d32c1fb3c703004c7b28","http://www.linkedin.com/in/lindsay-reis-9b6ba05b",,,"http://www.linkedin.com/company/cardurion","http://www.cardurion.com/","biotechnology, therapeutics, cardiovascular, heart failure, cardiology",lindsay.reis@cardurion.com,
"Dana","Smith","Dana Smith","Director, US Marketing","Calliditas Therapeutics","New York, New York","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69c1","http://www.linkedin.com/in/dana-nicole-smith-b7a9715",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",dana.smith@calliditas.com,dananicolesmith@gmail.com
"Alexandra","Goll","Alexandra Goll","Head of Business Development","Calliditas Therapeutics","Munich, Germany","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69c9","http://www.linkedin.com/in/alexandra-dr-goll-56648622",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",alexandra.goll@calliditas.com,
"Teona","Johnson","Teona Johnson","Vice President Marketing","Calliditas Therapeutics","New York, New York","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69c3","http://www.linkedin.com/in/teona-pipiya-johnson-a492562",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",teona.johnson@calliditas.com,
"Andrea","Chicca","Andrea Chicca","Co-Founder, CEO and CSO","Synendos Therapeutics AG","Zürich, Switzerland","12","","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d4691fb3c705764c669d","http://www.linkedin.com/in/andreachicca",,"https://twitter.com/synendos","http://www.linkedin.com/company/synendos","http://www.synendos.com/","N/A",andrea.chicca@synendos.com,
"Kikuo","Yasui","Kikuo Yasui","Chief Operating Officer","Heartseed Inc.","Shinjuku, Japan","12","","Research","https://app.apollo.io/#/contacts/65f6d36f1fb3c703004c7d44","http://www.linkedin.com/in/kikuo-yasui-17648110",,,"http://www.linkedin.com/company/heartseed-inc","http://www.heartseed.jp/","stem cell, regenerative medicine, cardiovascular",kikuo.yasui@heartseed.jp,
"Luc","Henry","Luc Henry","Founder and CEO","Limula","Lausanne, Switzerland","17","","Research","https://app.apollo.io/#/contacts/65f6d9098211c20300ca202c","http://www.linkedin.com/in/luc-henry",,"https://twitter.com/limulab","http://www.linkedin.com/company/limula","http://www.limula.ch/","bioproduction, immunooncology, cell therapy, biotechnolgoy, manufacturing, cart",luc.henry@limula.ch,
"Sarah","Mota","Sarah Mota","Business Development","Limula","Geneva, Switzerland","17","","Research","https://app.apollo.io/#/contacts/65f6d9098211c20300ca202b","http://www.linkedin.com/in/sarahdelamota",,"https://twitter.com/limulab","http://www.linkedin.com/company/limula","http://www.limula.ch/","bioproduction, immunooncology, cell therapy, biotechnolgoy, manufacturing, cart",sarah.mota@limula.ch,
"Madan","Jagasia","Madan Jagasia","Chief Executive Officer","Obsidian Therapeutics","Nashville, Tennessee","110","(646) 942-5631","Research","https://app.apollo.io/#/contacts/65f6da63f0664f01c61e1efc","http://www.linkedin.com/in/madan-jagasia-3255754",,"https://twitter.com/Obsidian_Tx","http://www.linkedin.com/company/obsidian-therapeutics","http://www.obsidiantx.com/","N/A",mjagasia@obsidiantx.com,madjag@gmail.com
"Deby","Pan","Deby Pan","Sr. Director Of Operations","NexImmune, Inc.","Rockville, Maryland","38","(301) 825-9810","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6da37f0664f01c61e1e29","http://www.linkedin.com/in/deby-pan-2169a17","https://facebook.com/NexImmune/","https://twitter.com/neximmune","http://www.linkedin.com/company/neximmune-inc.","http://www.neximmune.com/","biotechnology, life sciences",dpan@neximmune.com,
"Matt","Schiller","Matt Schiller","Head Of Business Development","NexImmune, Inc.","Boston, Massachusetts","38","(301) 825-9810","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6da37f0664f01c61e1e27","http://www.linkedin.com/in/matt-schiller-49a7883","https://facebook.com/NexImmune/","https://twitter.com/neximmune","http://www.linkedin.com/company/neximmune-inc.","http://www.neximmune.com/","biotechnology, life sciences",mschiller@neximmune.com,maschil85@gmail.com
"Grace","L","Grace L","Director of Operations","Adcentrx Therapeutics","San Diego, California","29","","Research","https://app.apollo.io/#/contacts/65f6cdd672334001c6369aba","",,,"http://www.linkedin.com/company/adcentrx-therapeutics","http://www.adcentrx.com/","N/A",grace.liu@adcentrx.com,graceyuhongliu@yahoo.com
"Cammie","Kelly","Cammie Kelly","Associate Director, Corporate Operations","Instil Bio","Dallas, Texas","140","(449) 724-993350","Biotechnology","https://app.apollo.io/#/contacts/65f6db1ff0664f01c61e227e","http://www.linkedin.com/in/cammiekelly",,"https://twitter.com/InstilBio","http://www.linkedin.com/company/instil-bio","http://www.instilbio.com/","N/A",cammie.kelly@instilbio.com,
"Patrick","B","Patrick B","Chief Business Officer","Shape Therapeutics Inc.","San Rafael, California","150","(626) 390-2679","Research","https://app.apollo.io/#/contacts/65f6dc168a58670302f72a0f","",,"https://twitter.com/ShapeTx","http://www.linkedin.com/company/shapetx","http://www.shapetx.com/","gene editing, gene therapy, rna editing",patrick@shapetx.com,patbigot@yahoo.com
"Sejal","H","Sejal H","Strategy and Operations","Tune Therapeutics","San Francisco, California","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb2","",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",sejal.hall@tunetx.com,
"Hans","Pieringer","Hans Pieringer","Chief Executive Officer and Founder","PhageLab","Chile","120","(562) 223-99701","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e2ef3b1dca01ae0683fe","http://www.linkedin.com/in/hans-pieringer-aa84b225",,"https://twitter.com/phagetech","http://www.linkedin.com/company/phagelab","http://www.phage-lab.com/","food & beverages, biotechnology, agriculture, veterinary, life sciences, technology, science",pieringer@pht.cl,
"Abhijit","B","Abhijit B","Chief Operating Officer (COO)","Rakuten Medical","San Diego, California","130","(833) 725-8633","Biotechnology","https://app.apollo.io/#/contacts/65f6e501a9b03301c6723b69","",,,"http://www.linkedin.com/company/rakuten-medical","http://www.rakuten-med.com/","biotechnology, cancer therapeutics, clinical research",abhijit.bhatia@rakutenaspyrian.com,
"Cassie","C","Cassie C","Operations","NewLimit","San Francisco, California","25","","Research","https://app.apollo.io/#/contacts/65f2d442434e0801c6a7a5a7","",,"https://twitter.com/newlimit","http://www.linkedin.com/company/newlimit","http://www.newlimit.com/","N/A",cassie@newlimit.com,
"Osvaldo","Tappero","Osvaldo Tappero","sales manager","Cellino","Turin, Italy","78","(951) 961-0666","Research","https://app.apollo.io/#/contacts/65f2d78a68a36e01c65c7c8e","http://www.linkedin.com/in/osvaldo-tappero-39576912",,,"http://www.linkedin.com/company/cellinobio","http://www.cellinobio.com/","N/A",osvaldo.tappero@cellino-group.it,
"Jannick","Bendtsen","Jannick Bendtsen","Co-founder | CEO","PipeBio","Aarhus, Denmark","12","(455) 120-9694","Research","https://app.apollo.io/#/contacts/65f2d7ba68a36e01c65c7e38","http://www.linkedin.com/in/jannickbendtsen",,"https://twitter.com/pipe_bio","http://www.linkedin.com/company/pipebio","http://www.pipebio.com/","N/A",jannick@pipebio.com,
"Antonio","Marques","Antonio Marques","Chief Operating Officer","Touchlight","Oxford, United Kingdom","160","(442) 084-819200","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2c94820117a01c6276133","http://www.linkedin.com/in/antonio-marques",,"https://twitter.com/touchlightdna","http://www.linkedin.com/company/touchlight-ltd","http://www.touchlight.com/","genetic medicine, dna therapeutics, dna vaccines, dna vectors, dna amplification, enzymatic technology, contract manufacturing, innovation, oncology, infectious diseases, aav, mrna, cdmo, enzymatic dna, synthetic dna, lentivirus, gene therapy, dna, genome editing, biotechnology",antonio.marques@touchlight.com,
"Joanna","Lorenzo-Harrell","Joanna Lorenzo-Harrell","Associate Director, Thought Leader Strategic Marketing Liaison","Calliditas Therapeutics","West Palm Beach, Florida","230","(468) 411-3005","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6d44a1fb3c704394c69c7","http://www.linkedin.com/in/j-harrell-rn-bsn",,"https://twitter.com/calliditas1","http://www.linkedin.com/company/calliditas-therapeutics","http://www.calliditas.se/","N/A",joanna.lorenzo-harrell@calliditas.com,
"Lynn-Allison","Durham","Lynn-Allison Durham","CEO and Founder","STALICLA","Geneva, Switzerland","N/A","(412) 254-51242","N/A","https://app.apollo.io/#/contacts/65f6d62140263f01c6c3dcba","http://www.linkedin.com/in/lynndurhamch",,,"http://www.linkedin.com/company/stalicla","http://www.stalicla.com/","N/A",lynn.durham@stalicla.com,
"Adrian","Gottschalk","Adrian Gottschalk","CEO","Foghorn Therapeutics Inc.","Boston, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b65","http://www.linkedin.com/in/adrian-gottschalk-93a4a8a",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",agottschalk@foghorntx.com,
"Benjamin","Frempah","Benjamin Frempah","Director, Business Development","Omega Therapeutics","Boston, Massachusetts","N/A","(617) 949-4360","N/A","https://app.apollo.io/#/contacts/65f6dd8ef0664f01c61e2bf0","http://www.linkedin.com/in/benjamin-frempah-ph-d-80a4094a",,"https://twitter.com/omegatx","http://www.linkedin.com/company/omega-therapeutics","http://www.omegatherapeutics.com/","N/A",bfrempah@omegatx.com,
"Heather","Wolff","Heather Wolff","Head/VP Development Operations","Sionna Therapeutics","Waltham, Massachusetts","30","(212) 253-8881","Biotechnology, Research, Pharmaceuticals","https://app.apollo.io/#/contacts/65f6e3813b1dca041d0656e4","http://www.linkedin.com/in/haldrichwolff",,"https://twitter.com/sionna_tx","http://www.linkedin.com/company/sionna-therapeutics","http://www.sionnatx.com/","life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, rare disease",heather.wolff@sionnatx.com,hmw927@gmail.com
"Minmin","Yen","Minmin Yen","Chief Executive Officer, Co-Founder","PhagePro","Boston, Massachusetts","N/A","(617) 713-3800","N/A","https://app.apollo.io/#/contacts/65f6e2b93b1dca041d06562f","http://www.linkedin.com/in/minmin-yen",,,"http://www.linkedin.com/company/phagepro","http://www.phageproinc.com/","N/A",myen@phageproinc.com,
"Kristi","Jones","Kristi Jones","Chief Executive Officer","NexImmune, Inc.","Bethesda, Maryland","38","(301) 825-9810","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6da37f0664f01c61e1e2b","http://www.linkedin.com/in/kristi-jones-1190807","https://facebook.com/NexImmune/","https://twitter.com/neximmune","http://www.linkedin.com/company/neximmune-inc.","http://www.neximmune.com/","biotechnology, life sciences",kjones@neximmune.com,kristi.jonesph@gmail.com
"Ilise","Lombardo","Ilise Lombardo","Chief Executive Officer","Noema Pharma","United States","N/A","","N/A","https://app.apollo.io/#/contacts/65f6bfad63db9001c6ecfa22","http://www.linkedin.com/in/ilise-lombardo-a7ab7738",,,"http://www.linkedin.com/company/noema-pharma-ag","http://www.noemapharma.com/","N/A",ilombardo@noemapharma.com,
"Diane","Tager","Diane Tager","COO & Co-founder","Volastra Therapeutics","New York, New York","N/A","","N/A","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfadf","http://www.linkedin.com/in/diane-tager-9238ab12",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",dtager@volastratx.com,dtager@gmail.com
"Shraddha","Thakkar","Shraddha Thakkar","Associate Director of Sales","MIMETAS","Rotterdam, Netherlands","N/A","(318) 588-83161","N/A","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc038","http://www.linkedin.com/in/shraddha-tina-thakkar-0291105","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","N/A",,
"Hannah","M","Hannah M","Executive Director, Marketing","Forge Biologics","Columbus, Ohio","310","(617) 792-3937","Research","https://app.apollo.io/#/contacts/65f6a3775a3231030061560f","","https://facebook.com/forgebiologics",,"http://www.linkedin.com/company/forge-biologics","http://www.forgebiologics.com/","aav, gene therapy, biotech, cgmp",hmunizza@forgebiologics.com,
"Andrew","Y","Andrew Y","Chief Business Officer","Neuron23","South San Francisco, California","N/A","(310) 403-8951","N/A","https://app.apollo.io/#/contacts/65f6a3f55a323101c66160e0","",,"https://twitter.com/neuron233","http://www.linkedin.com/company/neuron23-inc","http://www.neuron23.com/","N/A",andrew.yost@neuron23.com,andrewjyost@gmail.com
"Ritikesh","Kumar","Ritikesh Kumar","Executive Director, Business Development","Clade Therapeutics","Boston, Massachusetts","61","(415) 886-7710","Research","https://app.apollo.io/#/contacts/65f6a913c95d0d01aed120e9","http://www.linkedin.com/in/kumarritikesh",,"https://twitter.com/CladeTx","http://www.linkedin.com/company/clade-therapeutics","http://www.cladetx.com/","N/A",ritikesh.kumar@cladetx.com,ritikeshkr@gmail.com
"Sabrina","Schecher","Sabrina Schecher","Senior Director Investor Relations","Immatics","Munich, Germany","460","(497) 071-53970","Research, Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6a5007a4b6906d31f4082","http://www.linkedin.com/in/sabrina-schecher-5970579b",,"http://www.twitter.com/immatics","http://www.linkedin.com/company/immatics","http://www.immatics.com/","biotechnology, life sciences, discovery of hlarestricted tumorassociated peptides as cancer targets, biomarkers, immunomonitoring, peptidomics, mass spectrometry, standardized pbmc collection, bioinformatics, immunology, tcr discovery, bispecific development, tcrbased immunotherapies, adoptive cell therapy, tcr bispecifics, cancer",sabrina.schecher@immatics.com,
"Caspar","Foghsgaard","Caspar Foghsgaard","Sr. VP Commercial and Business Development","EXACT Therapeutics","Oslo, Norway","18","","Research","https://app.apollo.io/#/contacts/65f6ce5572334001c6369c2a","http://www.linkedin.com/in/caspar-foghsgaard-b725b4",,"https://twitter.com/ExactTx","http://www.linkedin.com/company/exact-tx","http://www.exact-tx.com/","microbubbles, ultrasound, research, cancertherapy, drugdelivery, precisionhealth, act",caspar.foghsgaard@exact-tx.com,casparfoghsgaard@hotmail.com
"Sarada","Loock","Sarada Loock","Head of Marketing Communications","Qubit Pharmaceuticals","Dublin, Ireland","56","","Information Technology & Services","https://app.apollo.io/#/contacts/65f6cf1072334002ff368f2a","http://www.linkedin.com/in/saradaloock",,"https://twitter.com/qubit_pharma","http://www.linkedin.com/company/qubit-pharmaceuticals","http://www.qubit-pharmaceuticals.com/","drug discover, computational chemistry, molecular dynamics simulation, quantum physics",sarada@qubit-pharmaceuticals.com,
"Yanda","Lai","Yanda Lai","Director Of Operations","Acepodia","Taiwan","46","(415) 366-7822","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6cf7d72334002ff3690c1","http://www.linkedin.com/in/yanda-lai-7348ab195",,"https://twitter.com/AcepodiaInc","http://www.linkedin.com/company/acepodia","http://www.acepodia.com/","oncology, cancer cell immunotherapy, allogeneic, offtheshelf, nk cells, biotechnology, interdisciplinary technology, car, cell therapy",yanda@acepodiabio.com,
"Julien","Veys","Julien Veys","Chief Business Development Officer","Theranexus","Paris, France","20","","Research","https://app.apollo.io/#/contacts/65f6d2cd1fb3c701c64ca29a","http://www.linkedin.com/in/julien-veys-98225a4",,"https://twitter.com/theranexus","http://www.linkedin.com/company/theranexus","http://www.theranexus.com/","N/A",julien.veys@theranexus.com,
"Karine","Charton","Karine Charton","Chief Business Officer","PHAXIAM Therapeutics","Lyon, France","90","(334) 787-44438","Biotechnology","https://app.apollo.io/#/contacts/65f6d26b1fb3c703004c7a8f","http://www.linkedin.com/in/karine-charton-85282712",,"https://twitter.com/PHAXIAM","http://www.linkedin.com/company/phaxiam","http://www.phaxiam.com/","biotechnology, phage, innovation, bacterial infection, viruses, staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, phxm",karine.charton@erytech.com,
"Tatsuo","Satoh","Tatsuo Satoh","Operations Director","Versameb AG","Basel, Switzerland","N/A","(416) 163-82360","N/A","https://app.apollo.io/#/contacts/65f6d6db40263f0300c3bd0f","http://www.linkedin.com/in/satoh",,"https://twitter.com/versameb","http://www.linkedin.com/company/versameb","http://www.versameb.com/","N/A",tatsuo.satoh@versameb.com,
"Charlotte","Broennimann","Charlotte Broennimann","Business Development Manager","SEED Biosciences","Lausanne, Switzerland","N/A","","N/A","https://app.apollo.io/#/contacts/65f6d93e8211c20300ca2127","http://www.linkedin.com/in/charlottebroennimann","https://www.facebook.com/SEED-Biosciences-506247149844620/",,"http://www.linkedin.com/company/seedbiosciences","http://www.seedbiosciences.com/","N/A",cbroennimann@seedbiosciences.com,
"Georges","Muller","Georges Muller","CEO and cofounder","SEED Biosciences","Lausanne, Switzerland","N/A","","N/A","https://app.apollo.io/#/contacts/65f6d93e8211c20300ca2126","http://www.linkedin.com/in/georges-muller-scientrepreneur","https://www.facebook.com/SEED-Biosciences-506247149844620/",,"http://www.linkedin.com/company/seedbiosciences","http://www.seedbiosciences.com/","N/A",georges@seedbiosciences.com,
"Jean-Jacques","Mention","Jean-Jacques Mention","Chief Business Officer","OSE Immunotherapeutics","Paris, France","64","(332) 282-91010","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d1d497cfd001c693c9f1","http://www.linkedin.com/in/jean-jacques-a-p-mention-54139529",,"https://twitter.com/oseimmuno","http://www.linkedin.com/company/ose-immunotherapeutics","http://www.ose-immuno.com/","immunooncologie, immunotherapie, maladies autoimmunes, nsclc, checkpoint inhibitor, developpement clinique, biotechnologie, neoepitopes, sirpalpha, mdsc, rectocolite hemorragique, polyarthrite rhumatoide",jean-jacques.mention@ose-immuno.com,
"Romain","Gret","Romain Gret","Director of Business Development, Global Market and Competitive intelligence","OSE Immunotherapeutics","Grenoble, France","64","(332) 282-91010","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d1d497cfd001c693c9f3","http://www.linkedin.com/in/gretromain",,"https://twitter.com/oseimmuno","http://www.linkedin.com/company/ose-immunotherapeutics","http://www.ose-immuno.com/","immunooncologie, immunotherapie, maladies autoimmunes, nsclc, checkpoint inhibitor, developpement clinique, biotechnologie, neoepitopes, sirpalpha, mdsc, rectocolite hemorragique, polyarthrite rhumatoide",romain.gret@ose-immuno.com,
"Antoine","Prestat","Antoine Prestat","Co-founder & CEO","PEP-Therapy","Paris, France","N/A","(331) 817-07682","N/A","https://app.apollo.io/#/contacts/65f6d1ff97cfd001c693cbc4","http://www.linkedin.com/in/antoine-prestat-5384454",,,"http://www.linkedin.com/company/pep-therapy","http://www.pep-therapy.com/","N/A",antoine.prestat@pep-therapy.com,
"Gilles","Avenard","Gilles Avenard","CEO","Acticor Biotech","Île-de-France, France","37","(339) 704-68640","Biotechnology","https://app.apollo.io/#/contacts/65f6d11097cfd00302939e2a","http://www.linkedin.com/in/gillesavenard",,"https://twitter.com/acticorbiotech","http://www.linkedin.com/company/acticor-biotech","http://www.acticor-biotech.com/","biotechnology, monoclonal antibody, drug development, thrombosis, stroke, tia, avc, healthcare",gilles.avenard@acticor-biotech.com,
"Stephanie","Monlezun","Stephanie Monlezun","Chief Operating Officer","AELIS FARMA","Bordeaux, France","26","(335) 575-73770","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d13697cfd00302939e7c","http://www.linkedin.com/in/st%c3%a9phanie-monlezun-22034029",,"https://twitter.com/AelisFarma","http://www.linkedin.com/company/aelis-farma","http://www.aelisfarma.com/","biotechnology, central nervous system, innovative signaling specific drugs, cb1 receptor, allosteric modulator, cannabis addiction, cognitive disorders, down syndrome, fragil x syndrom",s.monlezun@aelisfarma.com,
"Carrie","Cook","Carrie Cook","Chief Business Officer","Sitryx","Cambridge, Massachusetts","49","(442) 037-095700","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b2","http://www.linkedin.com/in/carrie-cook-5075891",,,"http://www.linkedin.com/company/sitryx-therapeutics-limited","http://www.sitryx.com/","N/A",carrie.cook@sitryx.com,
"Swethajit","Biswas","Swethajit Biswas","Chief Medical Officer (CMO)","CDR-Life Inc.","Cambridge, United Kingdom","66","(415) 555-55555","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d4f540263f01c6c3d807","http://www.linkedin.com/in/swethajit-biswas-77a295222",,,"http://www.linkedin.com/company/cdr-life-inc.","http://www.cdr-life.com/","antibody fragments, ophthalmology, immunooncology, biotechnology, drug development, entrepreneurship, team culture, targeted immunotherapies, oncology, cancer",swethajit.biswas@cdr-life.com,
"Christiane","Hyvert","Christiane Hyvert","People & Culture Business Partner, Investor Relations","Endogena Therapeutics, Inc.","Zurich, Switzerland","10","","Research","https://app.apollo.io/#/contacts/65f6d51640263f01c6c3d833","http://www.linkedin.com/in/chyvert",,,"http://www.linkedin.com/company/endogena","http://www.endogena.com/","N/A",christiane@endogena.com,
"Koenraad","Wiedhaup","Koenraad Wiedhaup","Co-founder and CEO","Leyden Labs","Amsterdam, Netherlands","83","","Research","https://app.apollo.io/#/contacts/65f6e71b73806f01ae7dbda7","http://www.linkedin.com/in/koenraad-wiedhaup",,"https://twitter.com/LeydenLabs","http://www.linkedin.com/company/leydenlabs","http://www.leydenlabs.com/","infectious disease & immunology",koenraad.wiedhaup@leydenlabs.com,
"Brady","J","Brady J","SVP, Finance and Operations","Tentarix Biotherapeutics","San Diego, California","35","(858) 866-8832","Biotechnology","https://app.apollo.io/#/contacts/65f2cf31e458f102e83674da","",,,"http://www.linkedin.com/company/tentarix-biotherapeutics","http://www.tentarix.com/","oncology, immunology, autoimmune",bjohnson@tentarix.com,
"Cheralyn","Crokaerts","Cheralyn Crokaerts","Office Operations Manager","Ansa Biotechnologies, Inc.","United States","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb7","http://www.linkedin.com/in/cheralyn-cher-mcclurg-crokaerts-8363327",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",cheralyn@ansabio.com,
"Nicholas","Porcaro","Nicholas Porcaro","Owner - CEO","Ansa Biotechnologies, Inc.","Brookline, Massachusetts","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb1","http://www.linkedin.com/in/nicholas-porcaro-374a3a9",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",ncp@smcmgtco.com,
"Collin","Todd","Collin Todd","Head of Strategy & Business Development","Odyssey Therapeutics","Saint Petersburg, Florida","170","","Research","https://app.apollo.io/#/contacts/65f2ca1d20117a01c62764ab","http://www.linkedin.com/in/collin-todd-3271b234",,"https://twitter.com/odyssey_tx","http://www.linkedin.com/company/odyssey-tx","http://www.odysseytx.com/","N/A",collin@odysseytx.com,
"Alinda","Fernandes","Alinda Fernandes","Senior Manager, Business Development","AviadoBio","London, United Kingdom","69","(443) 125-432881","Research","https://app.apollo.io/#/contacts/65f2c99320117a01c6276280","http://www.linkedin.com/in/alindafernandes",,"https://twitter.com/AviadoBio","http://www.linkedin.com/company/aviadobio","http://www.aviadobio.com/","N/A",afernandes@aviadobio.com,
"Adam","Ingber","Adam Ingber","Senior Manager, Business Development","HilleVax","Cambridge, Massachusetts","88","(888) 340-4544","Research","https://app.apollo.io/#/contacts/65f2cb3c20117a01c627676b","http://www.linkedin.com/in/apingber",,"https://twitter.com/HilleVax","http://www.linkedin.com/company/hillevax","http://www.hillevax.com/","N/A",aingber@hillevax.com,
"Darrin","Miles","Darrin Miles","Chief Executive Officer","Nested Therapeutics","Boston, Massachusetts","51","","Research","https://app.apollo.io/#/contacts/65f2cad820117a0302272037","http://www.linkedin.com/in/darrinmiles",,"https://twitter.com/nestedtx","http://www.linkedin.com/company/nestedtx","http://www.nestedtx.com/","oncology & precision medicine",darrin@nestedtx.com,
"Geordie","D","Geordie D","Senior Manager, Digital Marketing","Seer","La Mesa, California","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2c","",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",gdudley@seer.bio,geo2185@gmail.com
"Peter","Graf","Peter Graf","Director of Sales, Eastern US and Canada","Seer","Toronto, Canada","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2a","http://www.linkedin.com/in/grafpeterw",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",pgraf@seer.bio,
"Helmut","Keyserling","Helmut Keyserling","Executive Business Manager, DACH","Seer","Berlin, Germany","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2e","http://www.linkedin.com/in/helmutvonkeyserling",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",hkeyserling@seer.bio,
"Sergio","Ruiz","Sergio Ruiz","CoFounder & Chief Operating Officer","Turn Biotechnologies","Alexandria, Virginia","33","(833) 887-6246","Biotechnology","https://app.apollo.io/#/contacts/65f2d3c1434e080438a7930d","http://www.linkedin.com/in/sergio-ruiz",,,"http://www.linkedin.com/company/turnbio","http://www.turn.bio/","cell reprogramming, biotechnology, cellular programming, scnt, mrna, aging, dermatology, ophthalmology, osteoarthritis, research & development, r, d",sergio.ruiz@turn.bio,
"Roger","Frechette","Roger Frechette","Chief Business Officer","Concerto Biosciences","Boston, Massachusetts","31","(617) 544-7044","Research","https://app.apollo.io/#/contacts/65f2d5fa68a36e01c65c7845","http://www.linkedin.com/in/rogerfrechette",,"https://twitter.com/concertobio","http://www.linkedin.com/company/concerto-biosciences","http://www.concertobio.com/","N/A",roger@concertobio.com,
"Alec","Nielsen","Alec Nielsen","Founder & CEO","Asimov","Boston, Massachusetts","120","(425) 750-4182","Research","https://app.apollo.io/#/contacts/65f2d5e568a36e04385bdd8c","http://www.linkedin.com/in/alec-nielsen",,"https://twitter.com/asimovbio","http://www.linkedin.com/company/asimov","http://www.asimov.com/","N/A",alec@asimov.com,alecnielsen@gmail.com
"Gudarz","Davar","Gudarz Davar","EVP, Head of Research and Development, CMO","Autobahn Therapeutics, Inc.","Princeton, New Jersey","22","(858) 257-3418","Research","https://app.apollo.io/#/contacts/65f2d65068a36e04385bddff","http://www.linkedin.com/in/gudarz-davar-b547285",,,"http://www.linkedin.com/company/autobahn-therapeutics-inc","http://www.autobahntx.com/","N/A",gdavar@autobahntx.com,gudarz.davar@gmail.com
"Jen","Beachell","Jen Beachell","Chief Operating Officer","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de01e","http://www.linkedin.com/in/jbeachell",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",jen.beachell@upstreambio.com,
"Mia","Tobias","Mia Tobias","Associate Director, Investor Relations","Chroma Medicine","New York, New York","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc99","http://www.linkedin.com/in/miatobias",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",mia.tobias@chromamedicine.com,
"Rohan","Lathia","Rohan Lathia","Business Development and Market Insights","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de024","http://www.linkedin.com/in/rlathia",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",rohan.lathia@upstreambio.com,rlathia@gmail.com
"Thaminda","Ramanayake","Thaminda Ramanayake","Chief Business Officer","Affini-T Therapeutics","Cambridge, Massachusetts","93","(619) 826-4657","Research","https://app.apollo.io/#/contacts/65f2d05de458f102e8367755","http://www.linkedin.com/in/thaminda19",,"https://twitter.com/affinit_tx","http://www.linkedin.com/company/affini-t-therapeutics","http://www.affinittx.com/","N/A",thaminda@affinittx.com,thaminda19@gmail.com
"Samantha","Singer","Samantha Singer","President & Chief Executive Officer","Abata Therapeutics","Boston, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec4","http://www.linkedin.com/in/samanthasinger",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",ssinger@abatatx.com,
"Gilles","Avenard","Gilles Avenard","CEO","Acticor Biotech","Île-de-France, France","37","(339) 704-68640","Biotechnology","https://app.apollo.io/#/contacts/65f6d11097cfd00302939e2a","http://www.linkedin.com/in/gillesavenard",,"https://twitter.com/acticorbiotech","http://www.linkedin.com/company/acticor-biotech","http://www.acticor-biotech.com/","biotechnology, monoclonal antibody, drug development, thrombosis, stroke, tia, avc, healthcare",gilles.avenard@acticor-biotech.com,
"Stephanie","Monlezun","Stephanie Monlezun","Chief Operating Officer","AELIS FARMA","Bordeaux, France","26","(335) 575-73770","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d13697cfd00302939e7c","http://www.linkedin.com/in/st%c3%a9phanie-monlezun-22034029",,"https://twitter.com/AelisFarma","http://www.linkedin.com/company/aelis-farma","http://www.aelisfarma.com/","biotechnology, central nervous system, innovative signaling specific drugs, cb1 receptor, allosteric modulator, cannabis addiction, cognitive disorders, down syndrome, fragil x syndrom",s.monlezun@aelisfarma.com,
"Carrie","Cook","Carrie Cook","Chief Business Officer","Sitryx","Cambridge, Massachusetts","49","(442) 037-095700","Research","https://app.apollo.io/#/contacts/65f6d0f797cfd001c693c7b2","http://www.linkedin.com/in/carrie-cook-5075891",,,"http://www.linkedin.com/company/sitryx-therapeutics-limited","http://www.sitryx.com/","N/A",carrie.cook@sitryx.com,
"Swethajit","Biswas","Swethajit Biswas","Chief Medical Officer (CMO)","CDR-Life Inc.","Cambridge, United Kingdom","66","(415) 555-55555","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d4f540263f01c6c3d807","http://www.linkedin.com/in/swethajit-biswas-77a295222",,,"http://www.linkedin.com/company/cdr-life-inc.","http://www.cdr-life.com/","antibody fragments, ophthalmology, immunooncology, biotechnology, drug development, entrepreneurship, team culture, targeted immunotherapies, oncology, cancer",swethajit.biswas@cdr-life.com,
"Christiane","Hyvert","Christiane Hyvert","People & Culture Business Partner, Investor Relations","Endogena Therapeutics, Inc.","Zurich, Switzerland","10","","Research","https://app.apollo.io/#/contacts/65f6d51640263f01c6c3d833","http://www.linkedin.com/in/chyvert",,,"http://www.linkedin.com/company/endogena","http://www.endogena.com/","N/A",christiane@endogena.com,
"Koenraad","Wiedhaup","Koenraad Wiedhaup","Co-founder and CEO","Leyden Labs","Amsterdam, Netherlands","83","","Research","https://app.apollo.io/#/contacts/65f6e71b73806f01ae7dbda7","http://www.linkedin.com/in/koenraad-wiedhaup",,"https://twitter.com/LeydenLabs","http://www.linkedin.com/company/leydenlabs","http://www.leydenlabs.com/","infectious disease & immunology",koenraad.wiedhaup@leydenlabs.com,
"Brady","J","Brady J","SVP, Finance and Operations","Tentarix Biotherapeutics","San Diego, California","35","(858) 866-8832","Biotechnology","https://app.apollo.io/#/contacts/65f2cf31e458f102e83674da","",,,"http://www.linkedin.com/company/tentarix-biotherapeutics","http://www.tentarix.com/","oncology, immunology, autoimmune",bjohnson@tentarix.com,
"Cheralyn","Crokaerts","Cheralyn Crokaerts","Office Operations Manager","Ansa Biotechnologies, Inc.","United States","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb7","http://www.linkedin.com/in/cheralyn-cher-mcclurg-crokaerts-8363327",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",cheralyn@ansabio.com,
"Nicholas","Porcaro","Nicholas Porcaro","Owner - CEO","Ansa Biotechnologies, Inc.","Brookline, Massachusetts","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb1","http://www.linkedin.com/in/nicholas-porcaro-374a3a9",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",ncp@smcmgtco.com,
"Collin","Todd","Collin Todd","Head of Strategy & Business Development","Odyssey Therapeutics","Saint Petersburg, Florida","170","","Research","https://app.apollo.io/#/contacts/65f2ca1d20117a01c62764ab","http://www.linkedin.com/in/collin-todd-3271b234",,"https://twitter.com/odyssey_tx","http://www.linkedin.com/company/odyssey-tx","http://www.odysseytx.com/","N/A",collin@odysseytx.com,
"Alinda","Fernandes","Alinda Fernandes","Senior Manager, Business Development","AviadoBio","London, United Kingdom","69","(443) 125-432881","Research","https://app.apollo.io/#/contacts/65f2c99320117a01c6276280","http://www.linkedin.com/in/alindafernandes",,"https://twitter.com/AviadoBio","http://www.linkedin.com/company/aviadobio","http://www.aviadobio.com/","N/A",afernandes@aviadobio.com,
"Adam","Ingber","Adam Ingber","Senior Manager, Business Development","HilleVax","Cambridge, Massachusetts","88","(888) 340-4544","Research","https://app.apollo.io/#/contacts/65f2cb3c20117a01c627676b","http://www.linkedin.com/in/apingber",,"https://twitter.com/HilleVax","http://www.linkedin.com/company/hillevax","http://www.hillevax.com/","N/A",aingber@hillevax.com,
"Darrin","Miles","Darrin Miles","Chief Executive Officer","Nested Therapeutics","Boston, Massachusetts","51","","Research","https://app.apollo.io/#/contacts/65f2cad820117a0302272037","http://www.linkedin.com/in/darrinmiles",,"https://twitter.com/nestedtx","http://www.linkedin.com/company/nestedtx","http://www.nestedtx.com/","oncology & precision medicine",darrin@nestedtx.com,
"Geordie","D","Geordie D","Senior Manager, Digital Marketing","Seer","La Mesa, California","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2c","",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",gdudley@seer.bio,geo2185@gmail.com
"Peter","Graf","Peter Graf","Director of Sales, Eastern US and Canada","Seer","Toronto, Canada","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2a","http://www.linkedin.com/in/grafpeterw",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",pgraf@seer.bio,
"Helmut","Keyserling","Helmut Keyserling","Executive Business Manager, DACH","Seer","Berlin, Germany","160","(650) 453-0000","Research","https://app.apollo.io/#/contacts/65f2d4f1434e0802ffa79b2e","http://www.linkedin.com/in/helmutvonkeyserling",,"https://twitter.com/seer_bio","http://www.linkedin.com/company/seerbio","http://www.seer.bio/","proteomics, omics, innovation, large scale studies, life sciences, multiomics",hkeyserling@seer.bio,
"Sergio","Ruiz","Sergio Ruiz","CoFounder & Chief Operating Officer","Turn Biotechnologies","Alexandria, Virginia","33","(833) 887-6246","Biotechnology","https://app.apollo.io/#/contacts/65f2d3c1434e080438a7930d","http://www.linkedin.com/in/sergio-ruiz",,,"http://www.linkedin.com/company/turnbio","http://www.turn.bio/","cell reprogramming, biotechnology, cellular programming, scnt, mrna, aging, dermatology, ophthalmology, osteoarthritis, research & development, r, d",sergio.ruiz@turn.bio,
"Roger","Frechette","Roger Frechette","Chief Business Officer","Concerto Biosciences","Boston, Massachusetts","31","(617) 544-7044","Research","https://app.apollo.io/#/contacts/65f2d5fa68a36e01c65c7845","http://www.linkedin.com/in/rogerfrechette",,"https://twitter.com/concertobio","http://www.linkedin.com/company/concerto-biosciences","http://www.concertobio.com/","N/A",roger@concertobio.com,
"Alec","Nielsen","Alec Nielsen","Founder & CEO","Asimov","Boston, Massachusetts","120","(425) 750-4182","Research","https://app.apollo.io/#/contacts/65f2d5e568a36e04385bdd8c","http://www.linkedin.com/in/alec-nielsen",,"https://twitter.com/asimovbio","http://www.linkedin.com/company/asimov","http://www.asimov.com/","N/A",alec@asimov.com,alecnielsen@gmail.com
"Gudarz","Davar","Gudarz Davar","EVP, Head of Research and Development, CMO","Autobahn Therapeutics, Inc.","Princeton, New Jersey","22","(858) 257-3418","Research","https://app.apollo.io/#/contacts/65f2d65068a36e04385bddff","http://www.linkedin.com/in/gudarz-davar-b547285",,,"http://www.linkedin.com/company/autobahn-therapeutics-inc","http://www.autobahntx.com/","N/A",gdavar@autobahntx.com,gudarz.davar@gmail.com
"Jen","Beachell","Jen Beachell","Chief Operating Officer","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de01e","http://www.linkedin.com/in/jbeachell",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",jen.beachell@upstreambio.com,
"Mia","Tobias","Mia Tobias","Associate Director, Investor Relations","Chroma Medicine","New York, New York","140","(781) 248-6114","Research","https://app.apollo.io/#/contacts/65f2d169e99fbe03000dbc99","http://www.linkedin.com/in/miatobias",,"https://twitter.com/chromamedicine","http://www.linkedin.com/company/chroma-medicine","http://www.chromamedicine.com/","N/A",mia.tobias@chromamedicine.com,
"Rohan","Lathia","Rohan Lathia","Business Development and Market Insights","Upstream Bio","Boston, Massachusetts","33","(590) 019-0524","Research","https://app.apollo.io/#/contacts/65f2d0ece99fbe01c60de024","http://www.linkedin.com/in/rlathia",,"https://twitter.com/UpstreamBio","http://www.linkedin.com/company/upstreambio","http://www.upstreambio.com/","inflammation & allergic",rohan.lathia@upstreambio.com,rlathia@gmail.com
"Thaminda","Ramanayake","Thaminda Ramanayake","Chief Business Officer","Affini-T Therapeutics","Cambridge, Massachusetts","93","(619) 826-4657","Research","https://app.apollo.io/#/contacts/65f2d05de458f102e8367755","http://www.linkedin.com/in/thaminda19",,"https://twitter.com/affinit_tx","http://www.linkedin.com/company/affini-t-therapeutics","http://www.affinittx.com/","N/A",thaminda@affinittx.com,thaminda19@gmail.com
"Samantha","Singer","Samantha Singer","President & Chief Executive Officer","Abata Therapeutics","Boston, Massachusetts","49","(617) 585-2000","Research","https://app.apollo.io/#/contacts/65f2d07fe458f101ae367ec4","http://www.linkedin.com/in/samanthasinger",,"https://twitter.com/AbataTx","http://www.linkedin.com/company/abata-therapeutics","http://www.abatatx.com/","N/A",ssinger@abatatx.com,
"Vincent","Adiceam","Vincent Adiceam","Vice President - Chief of Staff to the CEO","ProQR Therapeutics","The Hague, Netherlands","170","(318) 816-67000","Research","https://app.apollo.io/#/contacts/65f6e65fa9b03301c672444b","http://www.linkedin.com/in/vincent-adic%c3%a9am-155b824","https://www.facebook.com/ProQRTx","https://twitter.com/proqr","http://www.linkedin.com/company/proqr-therapeutics","http://www.proqr.com/","rna therapeutics, drug development, rare diseases, genetic diseases, orphan drugs, pharmaceuticals, rna editing",vadiceam@proqr.com,
"Sebastian","Franzinger","Sebastian Franzinger","Head of Business Development","Scenic Biotech","Jersey City, New Jersey","58","(312) 070-59990","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e6aaa9b03306c171f5d6","http://www.linkedin.com/in/sebastian-franzinger-a9950761",,"https://twitter.com/BiotechScenic","http://www.linkedin.com/company/scenic-biotech","http://www.scenicbiotech.com/","medicine, disease, immunooncology, oncology, rare disease, science, technology, pharmaceuticals, biology, biotechnology",sebastian.franzinger@scenicbiotech.com,
"Shannon","Grace","Shannon Grace","Executive Assistant To Chief Executive Officer & Leadership Team","Tune Therapeutics","Boston, Massachusetts","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb3","http://www.linkedin.com/in/shannon-grace-2388475",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",shannon.grace@tunetx.com,shangrace17@gmail.com
"James","Salierno","James Salierno","Director, Investor Relations","Wave Life Sciences","Cambridge, Massachusetts","320","(617) 949-2900","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6be7be6063701ae70507d","http://www.linkedin.com/in/james-salierno-079b5513b",,"https://twitter.com/wavelifesci","http://www.linkedin.com/company/wave-life-sciences","http://www.wavelifesciences.com/","biotechnology, oligonucleotides, genetic medicines, rna editing, rnai",jsalierno@wavelifesci.com,
"Greg","Mullen","Greg Mullen","Chief Operating Officer","Ariceum Therapeutics","Geneva, Switzerland","34","(493) 094-893360","Research","https://app.apollo.io/#/contacts/65f6d02e97cfd00302939da7","http://www.linkedin.com/in/mullengreg",,"https://twitter.com/Ariceum_Tx","http://www.linkedin.com/company/ariceum-therapeutics","http://www.ariceum-therapeutics.com/","N/A",g.mullen@ariceum-therapeutics.com,
"Herve","Do","Herve Do","VP Business Development & CFO","PEPTINOV","France","15","(331) 588-08820","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d16397cfd00302939f5c","http://www.linkedin.com/in/herve-do-41b23b3",,,"http://www.linkedin.com/company/peptinov","http://www.peptinov.fr/","biotechnology, immunotherapy, vaccine, drug design",herve.do@peptinov.fr,
"Joakim","Sorensen","Joakim Sorensen","Operations","Notify Therapeutics","Copenhagen, Denmark","6","","Hospital & Health Care","https://app.apollo.io/#/contacts/65f6d0de97cfd001c693c77c","http://www.linkedin.com/in/joakim-sorensen",,,"http://www.linkedin.com/company/notifytherapeutics","http://www.notifytherapeutics.com/","N/A",joakim@notifytherapeutics.com,
"Jacob","Barnaby","Jacob Barnaby","Associate Director of Strategic Operations","HiFiBiO Therapeutics","Somerville, Massachusetts","78","","Biotechnology","https://app.apollo.io/#/contacts/65f6d19597cfd00302939ff3","http://www.linkedin.com/in/jacob-barnaby-73436a45",,"https://twitter.com/hifibio","http://www.linkedin.com/company/hifibiotherapeutics","http://www.hifibio.com/","microfluidics, singlecell, antibodies, therapeutics, drug discovery, target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation",j.barnaby@hifibio.com,
"Weiqing","Zhou","Weiqing Zhou","Co-founder & COO","LifeMine Therapeutics","Boston, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75364","http://www.linkedin.com/in/weiqing-zhou-aa53a523",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",wzhou@lifeminetx.com,qingqing_zhoude@yahoo.de
"Marcia","Moore","Marcia Moore","Chief Operating Officer","Cardurion Pharmaceuticals","Old Lyme, Connecticut","44","(617) 996-1433","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d32c1fb3c703004c7b2a","http://www.linkedin.com/in/marcia-moore-69931510",,,"http://www.linkedin.com/company/cardurion","http://www.cardurion.com/","biotechnology, therapeutics, cardiovascular, heart failure, cardiology",marcia.moore@cardurion.com,
"Jeremy","Benattar","Jeremy Benattar","Marketing & Strategy Director","ADOCIA","Lyon, France","88","(334) 726-10610","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d24c1fb3c704394c689f","http://www.linkedin.com/in/jeremy-benattar",,"https://twitter.com/Adocia_Biotech","http://www.linkedin.com/company/adocia","http://www.adocia.com/","biotechnology, life sciences, therapeutic proteins, biochaperone, nextgeneration injectables for diabetes treatment, ultrarapid insulin, multiagents injectable combination, diabetes, metabolic diseases, amylin, innovative protein formulations, glucagon",j.benattar@adocia.com,
"Rick","Batycky","Rick Batycky","President & CEO","Nocion Therapeutics, Inc.","Boston, Massachusetts","14","(781) 819-2877","Biotechnology","https://app.apollo.io/#/contacts/65f6e4b3a9b03301c6723abd","http://www.linkedin.com/in/rick-batycky-221a7011",,,"http://www.linkedin.com/company/nocion-therapeutics-inc","http://www.nociontx.com/","N/A",rick@nociontx.com,rbatycky@yahoo.com
"Sophie","Phillips","Sophie Phillips","Business Development & Strategy","Treeline Biosciences","New York, New York","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270335","http://www.linkedin.com/in/sophie-phillips-67a3ab28",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",sphillips@treeline.bio,sophiezp@yahoo.com
"Phil","C","Phil C","Co-Founder, President and CEO","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765e0","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",phil@neomorph.com,
"Angela","Follett","Angela Follett","Senior Director, Legal IP & Contract Operations, IP","Treeline Biosciences","Minneapolis, Minnesota","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270339","http://www.linkedin.com/in/angela-follett-ph-d-46287710",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",afollett@treeline.bio,
"Sally","Millwood","Sally Millwood","Administrative Manager","Treeline Biosciences","Boston, Massachusetts","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270333","http://www.linkedin.com/in/sallymillwood",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",smillwood@treeline.bio,smillwood@mac.com
"Cheryl","Gault","Cheryl Gault","Chief Operating Officer","Rapport Therapeutics","Cambridge, Massachusetts","50","(857) 321-8020","Research","https://app.apollo.io/#/contacts/65f2caff20117a0302272086","http://www.linkedin.com/in/cheryl-gault-92b11410",,,"http://www.linkedin.com/company/rapport-therapeutics","http://www.rapportrx.com/","N/A",cgault@rapportrx.com,cherylgault@gmail.com
"Jocelyn","C","Jocelyn C","Executive Business Partner, CEO","CARGO Therapeutics","San Francisco, California","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeb3","",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",jchapman@cargo-tx.com,jocechapman@yahoo.com
"John","M","John M","Chief Executive Officer and President","Velia","San Francisco, California","42","","Research","https://app.apollo.io/#/contacts/65f2cf57e458f101ae367920","",,,"http://www.linkedin.com/company/veliatx","http://www.veliatx.com/","N/A",johnmch@veliatx.com,
"Patrick","Trojer","Patrick Trojer","Chief Executive Officer & President","TRIANA Biomedicines","Reading, Massachusetts","42","(781) 317-4414","Research","https://app.apollo.io/#/contacts/65f2cfd9e458f101ae367b29","http://www.linkedin.com/in/patrick-trojer-phd-3b76a539",,,"http://www.linkedin.com/company/trianabio","http://www.trianabio.com/","N/A",patrick@trianabio.com,
"Gregg","York","Gregg York","Operations","Photys Therapeutics","Waltham, Massachusetts","47","","Biotechnology","https://app.apollo.io/#/contacts/65f2cfabe458f102e83675ec","http://www.linkedin.com/in/gregg-york",,,"http://www.linkedin.com/company/photys","http://www.photys.com/","N/A",gyork@photys.com,gyork37@gmail.com
"Brent","Rice","Brent Rice","Head of CMC Operations and Strategic Planning","Affini-T Therapeutics","Durham, North Carolina","93","(619) 826-4657","Research","https://app.apollo.io/#/contacts/65f2d05de458f102e836775b","http://www.linkedin.com/in/brent-rice-0b89302",,"https://twitter.com/affinit_tx","http://www.linkedin.com/company/affini-t-therapeutics","http://www.affinittx.com/","N/A",brent.rice@affinittx.com,
"Ali","Siam","Ali Siam","Chief Business Officer","Rubedo Life Sciences","Boston, Massachusetts","25","","Biotechnology","https://app.apollo.io/#/contacts/65f2d3a8434e0801c6a7a464","http://www.linkedin.com/in/alisiam",,,"http://www.linkedin.com/company/rubedo-life-sciences","http://www.rubedolife.com/","N/A",alisiam@rubedolife.com,alihsiam@gmail.com
"Cindy","New","Cindy New","Head of People Strategy & Operations","Arrive Bio","Singapore, Singapore","9","","Research","https://app.apollo.io/#/contacts/65f2d45b434e0801c6a7a5c6","http://www.linkedin.com/in/cindy-new-122639216",,,"http://www.linkedin.com/company/arrivebio","http://www.arrivebio.com/","aging, aibiotech, biology",cindy@arrivebio.com,
"David","Mantus","David Mantus","President, US Operations","Pulmocide","Bolton, Massachusetts","24","(442) 037-639484","Research","https://app.apollo.io/#/contacts/65f2c44bbd668b06bb26bcac","http://www.linkedin.com/in/davemantus",,"https://twitter.com/pulmocideltd","http://www.linkedin.com/company/pulmocide","http://www.pulmocide.com/","severe respiratory diseases, inhaled therapeutics, pulmonary aspergillosis, pharmaceuticals, acute & chronic lung infections, pulmonary",dmantus@pulmocide.com,mantusd@gmail.com
"Vincent","Adiceam","Vincent Adiceam","Vice President - Chief of Staff to the CEO","ProQR Therapeutics","The Hague, Netherlands","170","(318) 816-67000","Research","https://app.apollo.io/#/contacts/65f6e65fa9b03301c672444b","http://www.linkedin.com/in/vincent-adic%c3%a9am-155b824","https://www.facebook.com/ProQRTx","https://twitter.com/proqr","http://www.linkedin.com/company/proqr-therapeutics","http://www.proqr.com/","rna therapeutics, drug development, rare diseases, genetic diseases, orphan drugs, pharmaceuticals, rna editing",vadiceam@proqr.com,
"Sebastian","Franzinger","Sebastian Franzinger","Head of Business Development","Scenic Biotech","Jersey City, New Jersey","58","(312) 070-59990","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e6aaa9b03306c171f5d6","http://www.linkedin.com/in/sebastian-franzinger-a9950761",,"https://twitter.com/BiotechScenic","http://www.linkedin.com/company/scenic-biotech","http://www.scenicbiotech.com/","medicine, disease, immunooncology, oncology, rare disease, science, technology, pharmaceuticals, biology, biotechnology",sebastian.franzinger@scenicbiotech.com,
"Shannon","Grace","Shannon Grace","Executive Assistant To Chief Executive Officer & Leadership Team","Tune Therapeutics","Boston, Massachusetts","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb3","http://www.linkedin.com/in/shannon-grace-2388475",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",shannon.grace@tunetx.com,shangrace17@gmail.com
"James","Salierno","James Salierno","Director, Investor Relations","Wave Life Sciences","Cambridge, Massachusetts","320","(617) 949-2900","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6be7be6063701ae70507d","http://www.linkedin.com/in/james-salierno-079b5513b",,"https://twitter.com/wavelifesci","http://www.linkedin.com/company/wave-life-sciences","http://www.wavelifesciences.com/","biotechnology, oligonucleotides, genetic medicines, rna editing, rnai",jsalierno@wavelifesci.com,
"Greg","Mullen","Greg Mullen","Chief Operating Officer","Ariceum Therapeutics","Geneva, Switzerland","34","(493) 094-893360","Research","https://app.apollo.io/#/contacts/65f6d02e97cfd00302939da7","http://www.linkedin.com/in/mullengreg",,"https://twitter.com/Ariceum_Tx","http://www.linkedin.com/company/ariceum-therapeutics","http://www.ariceum-therapeutics.com/","N/A",g.mullen@ariceum-therapeutics.com,
"Herve","Do","Herve Do","VP Business Development & CFO","PEPTINOV","France","15","(331) 588-08820","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d16397cfd00302939f5c","http://www.linkedin.com/in/herve-do-41b23b3",,,"http://www.linkedin.com/company/peptinov","http://www.peptinov.fr/","biotechnology, immunotherapy, vaccine, drug design",herve.do@peptinov.fr,
"Joakim","Sorensen","Joakim Sorensen","Operations","Notify Therapeutics","Copenhagen, Denmark","6","","Hospital & Health Care","https://app.apollo.io/#/contacts/65f6d0de97cfd001c693c77c","http://www.linkedin.com/in/joakim-sorensen",,,"http://www.linkedin.com/company/notifytherapeutics","http://www.notifytherapeutics.com/","N/A",joakim@notifytherapeutics.com,
"Jacob","Barnaby","Jacob Barnaby","Associate Director of Strategic Operations","HiFiBiO Therapeutics","Somerville, Massachusetts","78","","Biotechnology","https://app.apollo.io/#/contacts/65f6d19597cfd00302939ff3","http://www.linkedin.com/in/jacob-barnaby-73436a45",,"https://twitter.com/hifibio","http://www.linkedin.com/company/hifibiotherapeutics","http://www.hifibio.com/","microfluidics, singlecell, antibodies, therapeutics, drug discovery, target discovery, biomarker discovery, artificial intelligence, machine learning, immune modulation",j.barnaby@hifibio.com,
"Weiqing","Zhou","Weiqing Zhou","Co-founder & COO","LifeMine Therapeutics","Boston, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75364","http://www.linkedin.com/in/weiqing-zhou-aa53a523",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",wzhou@lifeminetx.com,qingqing_zhoude@yahoo.de
"Marcia","Moore","Marcia Moore","Chief Operating Officer","Cardurion Pharmaceuticals","Old Lyme, Connecticut","44","(617) 996-1433","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d32c1fb3c703004c7b2a","http://www.linkedin.com/in/marcia-moore-69931510",,,"http://www.linkedin.com/company/cardurion","http://www.cardurion.com/","biotechnology, therapeutics, cardiovascular, heart failure, cardiology",marcia.moore@cardurion.com,
"Jeremy","Benattar","Jeremy Benattar","Marketing & Strategy Director","ADOCIA","Lyon, France","88","(334) 726-10610","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d24c1fb3c704394c689f","http://www.linkedin.com/in/jeremy-benattar",,"https://twitter.com/Adocia_Biotech","http://www.linkedin.com/company/adocia","http://www.adocia.com/","biotechnology, life sciences, therapeutic proteins, biochaperone, nextgeneration injectables for diabetes treatment, ultrarapid insulin, multiagents injectable combination, diabetes, metabolic diseases, amylin, innovative protein formulations, glucagon",j.benattar@adocia.com,
"Rick","Batycky","Rick Batycky","President & CEO","Nocion Therapeutics, Inc.","Boston, Massachusetts","14","(781) 819-2877","Biotechnology","https://app.apollo.io/#/contacts/65f6e4b3a9b03301c6723abd","http://www.linkedin.com/in/rick-batycky-221a7011",,,"http://www.linkedin.com/company/nocion-therapeutics-inc","http://www.nociontx.com/","N/A",rick@nociontx.com,rbatycky@yahoo.com
"Sophie","Phillips","Sophie Phillips","Business Development & Strategy","Treeline Biosciences","New York, New York","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270335","http://www.linkedin.com/in/sophie-phillips-67a3ab28",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",sphillips@treeline.bio,sophiezp@yahoo.com
"Phil","C","Phil C","Co-Founder, President and CEO","Neomorph, Inc.","San Diego, California","57","(589) 018-0129","Research","https://app.apollo.io/#/contacts/65f2ca8620117a01c62765e0","",,"https://twitter.com/neomorphinc","http://www.linkedin.com/company/neomorph-llc","http://www.neomorph.com/","targeted protein degradation & molecular glue degraders",phil@neomorph.com,
"Angela","Follett","Angela Follett","Senior Director, Legal IP & Contract Operations, IP","Treeline Biosciences","Minneapolis, Minnesota","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270339","http://www.linkedin.com/in/angela-follett-ph-d-46287710",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",afollett@treeline.bio,
"Sally","Millwood","Sally Millwood","Administrative Manager","Treeline Biosciences","Boston, Massachusetts","160","(203) 489-5700","Biotechnology","https://app.apollo.io/#/contacts/65f2ca6320117a0449270333","http://www.linkedin.com/in/sallymillwood",,"https://twitter.com/treelinebio","http://www.linkedin.com/company/treeline-biosciences","http://www.treeline.bio/","N/A",smillwood@treeline.bio,smillwood@mac.com
"Cheryl","Gault","Cheryl Gault","Chief Operating Officer","Rapport Therapeutics","Cambridge, Massachusetts","50","(857) 321-8020","Research","https://app.apollo.io/#/contacts/65f2caff20117a0302272086","http://www.linkedin.com/in/cheryl-gault-92b11410",,,"http://www.linkedin.com/company/rapport-therapeutics","http://www.rapportrx.com/","N/A",cgault@rapportrx.com,cherylgault@gmail.com
"Jocelyn","C","Jocelyn C","Executive Business Partner, CEO","CARGO Therapeutics","San Francisco, California","120","(650) 379-6143","Research","https://app.apollo.io/#/contacts/65f2cb8a20117a058c26eeb3","",,"https://twitter.com/CargoTx","http://www.linkedin.com/company/cargo-tx-inc","http://www.cargo-tx.com/","N/A",jchapman@cargo-tx.com,jocechapman@yahoo.com
"John","M","John M","Chief Executive Officer and President","Velia","San Francisco, California","42","","Research","https://app.apollo.io/#/contacts/65f2cf57e458f101ae367920","",,,"http://www.linkedin.com/company/veliatx","http://www.veliatx.com/","N/A",johnmch@veliatx.com,
"Patrick","Trojer","Patrick Trojer","Chief Executive Officer & President","TRIANA Biomedicines","Reading, Massachusetts","42","(781) 317-4414","Research","https://app.apollo.io/#/contacts/65f2cfd9e458f101ae367b29","http://www.linkedin.com/in/patrick-trojer-phd-3b76a539",,,"http://www.linkedin.com/company/trianabio","http://www.trianabio.com/","N/A",patrick@trianabio.com,
"Gregg","York","Gregg York","Operations","Photys Therapeutics","Waltham, Massachusetts","47","","Biotechnology","https://app.apollo.io/#/contacts/65f2cfabe458f102e83675ec","http://www.linkedin.com/in/gregg-york",,,"http://www.linkedin.com/company/photys","http://www.photys.com/","N/A",gyork@photys.com,gyork37@gmail.com
"Brent","Rice","Brent Rice","Head of CMC Operations and Strategic Planning","Affini-T Therapeutics","Durham, North Carolina","93","(619) 826-4657","Research","https://app.apollo.io/#/contacts/65f2d05de458f102e836775b","http://www.linkedin.com/in/brent-rice-0b89302",,"https://twitter.com/affinit_tx","http://www.linkedin.com/company/affini-t-therapeutics","http://www.affinittx.com/","N/A",brent.rice@affinittx.com,
"Ali","Siam","Ali Siam","Chief Business Officer","Rubedo Life Sciences","Boston, Massachusetts","25","","Biotechnology","https://app.apollo.io/#/contacts/65f2d3a8434e0801c6a7a464","http://www.linkedin.com/in/alisiam",,,"http://www.linkedin.com/company/rubedo-life-sciences","http://www.rubedolife.com/","N/A",alisiam@rubedolife.com,alihsiam@gmail.com
"Cindy","New","Cindy New","Head of People Strategy & Operations","Arrive Bio","Singapore, Singapore","9","","Research","https://app.apollo.io/#/contacts/65f2d45b434e0801c6a7a5c6","http://www.linkedin.com/in/cindy-new-122639216",,,"http://www.linkedin.com/company/arrivebio","http://www.arrivebio.com/","aging, aibiotech, biology",cindy@arrivebio.com,
"David","Mantus","David Mantus","President, US Operations","Pulmocide","Bolton, Massachusetts","24","(442) 037-639484","Research","https://app.apollo.io/#/contacts/65f2c44bbd668b06bb26bcac","http://www.linkedin.com/in/davemantus",,"https://twitter.com/pulmocideltd","http://www.linkedin.com/company/pulmocide","http://www.pulmocide.com/","severe respiratory diseases, inhaled therapeutics, pulmonary aspergillosis, pharmaceuticals, acute & chronic lung infections, pulmonary",dmantus@pulmocide.com,mantusd@gmail.com
"Brian","McVeigh","Brian McVeigh","Chairman, Chief Executive Officer, and Co-Founder","Code Biotherapeutics","Philadelphia, Pennsylvania","40","(215) 996-3006","Research","https://app.apollo.io/#/contacts/65f6a9acaac7670428c01cb5","http://www.linkedin.com/in/brian-mcveigh-6562555",,"https://www.twitter.com/CodeBioTx/","http://www.linkedin.com/company/code-biotherapeutics","http://www.codebiotx.com/","N/A",bmcveigh@codebiotx.com,
"Stephanie","Sousa","Stephanie Sousa","Senior Vice President Operations","Aera Therapeutics","Malden, Massachusetts","67","(857) 600-1547","Research","https://app.apollo.io/#/contacts/65f6be47e60637056f6fea9c","http://www.linkedin.com/in/stephanie-sousa-ab300a25b",,"https://twitter.com/AeraTx","http://www.linkedin.com/company/aera-therapeutics","http://www.aeratx.com/","N/A",stephanie.sousa@aeratx.com,stephsousa1@gmail.com
"Rachel","Schwartz","Rachel Schwartz","Chief Business Officer & Head of Operations","Volastra Therapeutics","United States","41","","Biotechnology","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfade","http://www.linkedin.com/in/rachel-zolot-schwartz",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",rzolot@volastratx.com,
"Cindy","O.","Cindy O.","Senior Director, Clinical & Business Operations","Volastra Therapeutics","New York, New York","41","","Biotechnology","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfae0","http://www.linkedin.com/in/cindyoh",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",coh@volastratx.com,
"Matthew","Calistri","Matthew Calistri","Vice President - Investor Relations","Cerevel Therapeutics","Natick, Massachusetts","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a17599","http://www.linkedin.com/in/matthewcalistri","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",matthew.calistri@cerevel.com,
"Eva","Kalias","Eva Kalias","Head Investor Relations & Communications","Santhera Pharmaceuticals","Zurich, Switzerland","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececf8","http://www.linkedin.com/in/eva-kalias-39495724","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",eva.kalias@santhera.com,
"Frederic","Chapuis","Frederic Chapuis","Global Marketing Lead","Santhera Pharmaceuticals","Zurich, Switzerland","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececfa","http://www.linkedin.com/in/frederic-chapuis","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",frederic.chapuis@santhera.com,
"Janna","Muhlhausen","Janna Muhlhausen","Vice President, Business Operations","Cerevel Therapeutics","Cambridge, Massachusetts","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a17595","http://www.linkedin.com/in/janna-muhlhausen-670b6b","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",janna.muhlhausen@cerevel.com,jmuhlhausen@yahoo.com
"Guenther","Metz","Guenther Metz","Head Business Development, EVP","Santhera Pharmaceuticals","Lörrach, Germany","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececf6","http://www.linkedin.com/in/g%c3%bcnther-metz-3b1a91208","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",guenther.metz@santhera.com,
"Belen","Blazquez","Belen Blazquez","Vice President Operations","Comanche Biopharma","Cambridge, Massachusetts","N/A","(617) 206-3776","N/A","https://app.apollo.io/#/contacts/65f6dc958a586701c6f751e6","http://www.linkedin.com/in/belenvicenteblazquez",,,"http://www.linkedin.com/company/comanche-biopharma","http://www.comanchebiopharma.com/","N/A",belen@comanchebiopharma.com,
"Lynn","S","Lynn S","President & Chief Executive Officer","Lyell Immunopharma","San Francisco, California","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9f0","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",lseely@lyell.com,
"Matt","Kane","Matt Kane","CEO","Tune Therapeutics","Durham, North Carolina","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb1","http://www.linkedin.com/in/matt-kane-ab3ba0",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",matt.kane@tunetx.com,
"Lizz","Allan","Lizz Allan","Administrative Business Partner","LifeMine Therapeutics","Boston, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75360","http://www.linkedin.com/in/lizz-allan-49240b51",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",lallan@lifeminetx.com,
"Mahesh","Karande","Mahesh Karande","CEO and President, Member of Board","Omega Therapeutics","Cambridge, Massachusetts","120","(617) 949-4360","Research","https://app.apollo.io/#/contacts/65f6dd8ef0664f01c61e2bee","http://www.linkedin.com/in/mahesh-karande-8189155",,"https://twitter.com/omegatx","http://www.linkedin.com/company/omega-therapeutics","http://www.omegatherapeutics.com/","N/A",mkarande@omegatx.com,mahesh.karande@gmail.com
"Danielle","Carmeli","Danielle Carmeli","Operations Business Partner","LifeMine Therapeutics","Basel, Switzerland","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75362","http://www.linkedin.com/in/danielle-carmeli-b6211b77",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",dcarmeli@lifeminetx.com,
"Chiwan","Chiang","Chiwan Chiang","Marketing Specialist","MIMETAS","Rijswijk, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc040","http://www.linkedin.com/in/chiwan-chiang","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"Mieke","Doornbos","Mieke Doornbos","Vice President Sales and Marketing","MIMETAS","Leiden, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc042","http://www.linkedin.com/in/miekesprangers","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"David","Shiri","David Shiri","Sr. Director Of Operations","BiomX Inc","Tel Aviv-Yafo, Israel","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c70","http://www.linkedin.com/in/david-shiri","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",davids@biomx.com,
"Neil","Clelland","Neil Clelland","Chief Executive Officer","NexaBiome","Glasgow, United Kingdom","N/A","(441) 419-455156","N/A","https://app.apollo.io/#/contacts/65f6e3263b1dca01ae06843f","http://www.linkedin.com/in/neil-clelland-88993213",,"https://twitter.com/NexaBiome","http://www.linkedin.com/company/fixed-phage","http://www.nexabiome.com/","N/A",neil.clelland@fixed-phage.com,
"Chris","Bindon","Chris Bindon","Chief Operating Officer","NexaBiome","Glasgow, United Kingdom","N/A","(441) 419-455156","N/A","https://app.apollo.io/#/contacts/65f6e3263b1dca01ae06843d","http://www.linkedin.com/in/chrisbindon",,"https://twitter.com/NexaBiome","http://www.linkedin.com/company/fixed-phage","http://www.nexabiome.com/","N/A",chris.bindon@fixed-phage.com,
"Paige","Swanson","Paige Swanson","Associate Director Of Operations","Dyno Therapeutics","Cambridge, Massachusetts","130","(914) 204-6412","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d6b768a36e06b05bb573","http://www.linkedin.com/in/paigeswanson",,"https://twitter.com/dyno_tx","http://www.linkedin.com/company/dynotx","http://www.dynotx.com/","aav engineering, machine learning, synthetic biology, ngs, data science, gene therapy, genome editing, aav, software engineering",,
"Richard","Y","Richard Y","Co-founder and CEO","Abalone Bio","San Francisco, California","N/A","(510) 288-8776","N/A","https://app.apollo.io/#/contacts/65f2d7ab68a36e02ff5c0c84","",,,"http://www.linkedin.com/company/abalone-bio-inc","http://www.abalonebio.com/","N/A",ryu@abalonebio.com,rich_yu@yahoo.com
"John","Scott","John Scott","Sales & Marketing Consultant","Ansa Biotechnologies, Inc.","Bend, Oregon","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb5","http://www.linkedin.com/in/john-scott-26713",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",j.scott@ansabio.com,jscott_4@sbcglobal.net
"Heather","S","Heather S","SVP Development Operations","Autobahn Therapeutics, Inc.","San Diego, California","22","(858) 257-3418","Research","https://app.apollo.io/#/contacts/65f2d65068a36e04385bde01","",,,"http://www.linkedin.com/company/autobahn-therapeutics-inc","http://www.autobahntx.com/","N/A",hsmith@autobahntx.com,hdsmitty@cox.net
"Imroz","G","Imroz G","Senior Director Business Development","Asimov","Danville, California","120","(425) 750-4182","Research","https://app.apollo.io/#/contacts/65f2d5e568a36e04385bdd90","",,"https://twitter.com/asimovbio","http://www.linkedin.com/company/asimov","http://www.asimov.com/","N/A",imroz@asimov.com,imrozghangas@yahoo.com
"Brian","McVeigh","Brian McVeigh","Chairman, Chief Executive Officer, and Co-Founder","Code Biotherapeutics","Philadelphia, Pennsylvania","40","(215) 996-3006","Research","https://app.apollo.io/#/contacts/65f6a9acaac7670428c01cb5","http://www.linkedin.com/in/brian-mcveigh-6562555",,"https://www.twitter.com/CodeBioTx/","http://www.linkedin.com/company/code-biotherapeutics","http://www.codebiotx.com/","N/A",bmcveigh@codebiotx.com,
"Stephanie","Sousa","Stephanie Sousa","Senior Vice President Operations","Aera Therapeutics","Malden, Massachusetts","67","(857) 600-1547","Research","https://app.apollo.io/#/contacts/65f6be47e60637056f6fea9c","http://www.linkedin.com/in/stephanie-sousa-ab300a25b",,"https://twitter.com/AeraTx","http://www.linkedin.com/company/aera-therapeutics","http://www.aeratx.com/","N/A",stephanie.sousa@aeratx.com,stephsousa1@gmail.com
"Rachel","Schwartz","Rachel Schwartz","Chief Business Officer & Head of Operations","Volastra Therapeutics","United States","41","","Biotechnology","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfade","http://www.linkedin.com/in/rachel-zolot-schwartz",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",rzolot@volastratx.com,
"Cindy","O.","Cindy O.","Senior Director, Clinical & Business Operations","Volastra Therapeutics","New York, New York","41","","Biotechnology","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfae0","http://www.linkedin.com/in/cindyoh",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",coh@volastratx.com,
"Matthew","Calistri","Matthew Calistri","Vice President - Investor Relations","Cerevel Therapeutics","Natick, Massachusetts","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a17599","http://www.linkedin.com/in/matthewcalistri","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",matthew.calistri@cerevel.com,
"Eva","Kalias","Eva Kalias","Head Investor Relations & Communications","Santhera Pharmaceuticals","Zurich, Switzerland","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececf8","http://www.linkedin.com/in/eva-kalias-39495724","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",eva.kalias@santhera.com,
"Frederic","Chapuis","Frederic Chapuis","Global Marketing Lead","Santhera Pharmaceuticals","Zurich, Switzerland","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececfa","http://www.linkedin.com/in/frederic-chapuis","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",frederic.chapuis@santhera.com,
"Janna","Muhlhausen","Janna Muhlhausen","Vice President, Business Operations","Cerevel Therapeutics","Cambridge, Massachusetts","340","(844) 304-2048","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6c15e94188f01c6a17595","http://www.linkedin.com/in/janna-muhlhausen-670b6b","https://www.facebook.com/cereveltherapeutics/","https://twitter.com/cereveltx","http://www.linkedin.com/company/cerevel","http://www.cerevel.com/","N/A",janna.muhlhausen@cerevel.com,jmuhlhausen@yahoo.com
"Guenther","Metz","Guenther Metz","Head Business Development, EVP","Santhera Pharmaceuticals","Lörrach, Germany","71","(416) 190-68950","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f6c0a863db900300ececf6","http://www.linkedin.com/in/g%c3%bcnther-metz-3b1a91208","https://www.facebook.com/pages/Anthera-Pharmaceuticals/288882497805689","https://twitter.com/santhera","http://www.linkedin.com/company/santhera-pharmaceuticals-ltd","http://www.santhera.com/","healthcare, biotechnology, life sciences",guenther.metz@santhera.com,
"Belen","Blazquez","Belen Blazquez","Vice President Operations","Comanche Biopharma","Cambridge, Massachusetts","21","(617) 206-3776","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dc958a586701c6f751e6","http://www.linkedin.com/in/belenvicenteblazquez",,,"http://www.linkedin.com/company/comanche-biopharma","http://www.comanchebiopharma.com/","N/A",belen@comanchebiopharma.com,
"Lynn","S","Lynn S","President & Chief Executive Officer","Lyell Immunopharma","San Francisco, California","250","(650) 695-0677","Research","https://app.apollo.io/#/contacts/65f6db89f0664f04391df9f0","",,,"http://www.linkedin.com/company/lyell","http://www.lyell.com/","N/A",lseely@lyell.com,
"Matt","Kane","Matt Kane","CEO","Tune Therapeutics","Durham, North Carolina","94","","Biotechnology","https://app.apollo.io/#/contacts/65f6dbf78a586701c6f74fb1","http://www.linkedin.com/in/matt-kane-ab3ba0",,"https://twitter.com/tunetx_news","http://www.linkedin.com/company/tunetx","http://www.tunetx.com/","biotechnology, epigenetics, cell therapy, gene therapy",matt.kane@tunetx.com,
"Lizz","Allan","Lizz Allan","Administrative Business Partner","LifeMine Therapeutics","Boston, Massachusetts","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75360","http://www.linkedin.com/in/lizz-allan-49240b51",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",lallan@lifeminetx.com,
"Mahesh","Karande","Mahesh Karande","CEO and President, Member of Board","Omega Therapeutics","Cambridge, Massachusetts","120","(617) 949-4360","Research","https://app.apollo.io/#/contacts/65f6dd8ef0664f01c61e2bee","http://www.linkedin.com/in/mahesh-karande-8189155",,"https://twitter.com/omegatx","http://www.linkedin.com/company/omega-therapeutics","http://www.omegatherapeutics.com/","N/A",mkarande@omegatx.com,mahesh.karande@gmail.com
"Danielle","Carmeli","Danielle Carmeli","Operations Business Partner","LifeMine Therapeutics","Basel, Switzerland","120","(617) 665-5000","Biotechnology","https://app.apollo.io/#/contacts/65f6dced8a586701c6f75362","http://www.linkedin.com/in/danielle-carmeli-b6211b77",,,"http://www.linkedin.com/company/lifemine-therapeutics","http://www.lifeminetx.com/","N/A",dcarmeli@lifeminetx.com,
"Chiwan","Chiang","Chiwan Chiang","Marketing Specialist","MIMETAS","Rijswijk, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc040","http://www.linkedin.com/in/chiwan-chiang","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"Mieke","Doornbos","Mieke Doornbos","Vice President Sales and Marketing","MIMETAS","Leiden, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc042","http://www.linkedin.com/in/miekesprangers","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"David","Shiri","David Shiri","Sr. Director Of Operations","BiomX Inc","Tel Aviv-Yafo, Israel","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c70","http://www.linkedin.com/in/david-shiri","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",davids@biomx.com,
"Neil","Clelland","Neil Clelland","Chief Executive Officer","NexaBiome","Glasgow, United Kingdom","16","(441) 419-455156","Research","https://app.apollo.io/#/contacts/65f6e3263b1dca01ae06843f","http://www.linkedin.com/in/neil-clelland-88993213",,"https://twitter.com/NexaBiome","http://www.linkedin.com/company/fixed-phage","http://www.nexabiome.com/","aquaculture, poultry, shelf life extension, formaldehyde replacement, antibiotic resistance, agriscience, mrsa, campylobacter, tilapia, listeria, zinc oxide replacement, active packaging, salmonids, pseudomonas, probiotic feeds, food wastage, microbiome, veterinary health, ecoli",neil.clelland@fixed-phage.com,
"Chris","Bindon","Chris Bindon","Chief Operating Officer","NexaBiome","Glasgow, United Kingdom","16","(441) 419-455156","Research","https://app.apollo.io/#/contacts/65f6e3263b1dca01ae06843d","http://www.linkedin.com/in/chrisbindon",,"https://twitter.com/NexaBiome","http://www.linkedin.com/company/fixed-phage","http://www.nexabiome.com/","aquaculture, poultry, shelf life extension, formaldehyde replacement, antibiotic resistance, agriscience, mrsa, campylobacter, tilapia, listeria, zinc oxide replacement, active packaging, salmonids, pseudomonas, probiotic feeds, food wastage, microbiome, veterinary health, ecoli",chris.bindon@fixed-phage.com,
"Paige","Swanson","Paige Swanson","Associate Director Of Operations","Dyno Therapeutics","Cambridge, Massachusetts","130","(914) 204-6412","Research, Biotechnology","https://app.apollo.io/#/contacts/65f2d6b768a36e06b05bb573","http://www.linkedin.com/in/paigeswanson",,"https://twitter.com/dyno_tx","http://www.linkedin.com/company/dynotx","http://www.dynotx.com/","aav engineering, machine learning, synthetic biology, ngs, data science, gene therapy, genome editing, aav, software engineering",,
"Richard","Y","Richard Y","Co-founder and CEO","Abalone Bio","San Francisco, California","20","(510) 288-8776","Research","https://app.apollo.io/#/contacts/65f2d7ab68a36e02ff5c0c84","",,,"http://www.linkedin.com/company/abalone-bio-inc","http://www.abalonebio.com/","N/A",ryu@abalonebio.com,rich_yu@yahoo.com
"John","Scott","John Scott","Sales & Marketing Consultant","Ansa Biotechnologies, Inc.","Bend, Oregon","88","(248) 227-5556","Research","https://app.apollo.io/#/contacts/65f2d73f68a36e04385bdeb5","http://www.linkedin.com/in/john-scott-26713",,"https://twitter.com/AnsaBio","http://www.linkedin.com/company/ansabio","http://www.ansabio.com/","dna",j.scott@ansabio.com,jscott_4@sbcglobal.net
"Heather","S","Heather S","SVP Development Operations","Autobahn Therapeutics, Inc.","San Diego, California","22","(858) 257-3418","Research","https://app.apollo.io/#/contacts/65f2d65068a36e04385bde01","",,,"http://www.linkedin.com/company/autobahn-therapeutics-inc","http://www.autobahntx.com/","N/A",hsmith@autobahntx.com,hdsmitty@cox.net
"Imroz","G","Imroz G","Senior Director Business Development","Asimov","Danville, California","120","(425) 750-4182","Research","https://app.apollo.io/#/contacts/65f2d5e568a36e04385bdd90","",,"https://twitter.com/asimovbio","http://www.linkedin.com/company/asimov","http://www.asimov.com/","N/A",imroz@asimov.com,imrozghangas@yahoo.com
"Jean-Marc","H.","Jean-Marc H.","Head of Operations","STALICLA","Geneva, Switzerland","26","(412) 254-51242","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d62140263f01c6c3dcbc","http://www.linkedin.com/in/jean-marc-h-2845401a",,,"http://www.linkedin.com/company/stalicla","http://www.stalicla.com/","biotechnology, neuroscience, research, financing research, autism, big data, innovation, personalized medicine, neurodevelopmental disorders, asd, ndds",jean-marc.hyvelin@stalicla.com,
"Philippe","Villain-Guillot","Philippe Villain-Guillot","CEO and founder","Nosopharm","Lyon, France","N/A","(334) 117-16185","N/A","https://app.apollo.io/#/contacts/65f6cf2a72334002ff368ff0","http://www.linkedin.com/in/pvillainguillot",,"https://twitter.com/nosopharm","http://www.linkedin.com/company/nosopharm","http://www.nosopharm.com/","N/A",p.villainguillot@nosopharm.com,
"Sara","Dolcetti","Sara Dolcetti","Vice President of Business Development","Qubit Pharmaceuticals","Boston, Massachusetts","56","","Information Technology & Services","https://app.apollo.io/#/contacts/65f6cf1072334002ff368f29","http://www.linkedin.com/in/sdolcetti",,"https://twitter.com/qubit_pharma","http://www.linkedin.com/company/qubit-pharmaceuticals","http://www.qubit-pharmaceuticals.com/","drug discover, computational chemistry, molecular dynamics simulation, quantum physics",sara.dolcetti@qubit-pharmaceuticals.com,
"Karine","Rossignol","Karine Rossignol","CEO and co founder","Smart Immune","Paris, France","36","","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6cecd72334001c6369d8a","http://www.linkedin.com/in/karine-rossignol-76711514a",,"https://twitter.com/SmartImmune_off","http://www.linkedin.com/company/smartimmune","http://www.smart-immune.com/","biotechnology, cell therapy, car t, immunooncology, nk cells, t cells, immune reconstitution, t cell progenitors, lymphoid progenitors, naive cells, hsc differentiation, thymic selection",karine.rossignol@smart-immune.com,
"Rodolphe","Clerval","Rodolphe Clerval","Chief Executive Officer","Coave Therapeutics","Paris, France","40","","Research","https://app.apollo.io/#/contacts/65f6d21e97cfd001c693cbef","http://www.linkedin.com/in/rodolphe-clerval-7a5638",,,"http://www.linkedin.com/company/coavetx","http://www.coavetx.com/","medecine, therapie genique, ophtalmologie, gene therapy, rare ocular disease, cns disease",rclerval@coavetx.com,
"Mathieu","Charveriat","Mathieu Charveriat","CEO & Co-founder","Theranexus","Paris, France","20","","Research","https://app.apollo.io/#/contacts/65f6d2cd1fb3c701c64ca298","http://www.linkedin.com/in/charveriat",,"https://twitter.com/theranexus","http://www.linkedin.com/company/theranexus","http://www.theranexus.com/","N/A",mathieu.charveriat@theranexus.com,
"Kenneth","Petersen","Kenneth Petersen","COO and Founder","Hoba Therapeutics","Copenhagen, Denmark","15","(453) 110-1285","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d3461fb3c704394c6931","http://www.linkedin.com/in/kenneth-ahrend-petersen-2286004",,,"http://www.linkedin.com/company/hoba-therapeutics","http://www.hobatherapeutics.com/","biotechnology, biologics, pharmaceutical industry, pain, cns, neurophatic pain, hearing loss, cipn",keap@hobatherapeutics.com,
"Hui","L","Hui L","President & CEO","Adcentrx Therapeutics","San Diego, California","29","","Research","https://app.apollo.io/#/contacts/65f6cdd672334001c6369abc","",,,"http://www.linkedin.com/company/adcentrx-therapeutics","http://www.adcentrx.com/","N/A",hui.li@adcentrx.com,
"Sarah","Milsom","Sarah Milsom","Chief Operating Officer","EyeBio","United Kingdom","N/A","(447) 827-330296","N/A","https://app.apollo.io/#/contacts/65f6ce7572334001c6369c55","http://www.linkedin.com/in/sarah-milsom",,,"http://www.linkedin.com/company/eyebio","http://www.eyebiotech.com/","N/A",s.milsom@eyebiotech.com,
"Jesus","Garcia","Jesus Garcia","Chairman and CEO","GeNeuro SA","Plan-les-Ouates, Switzerland","N/A","(412) 255-24800","N/A","https://app.apollo.io/#/contacts/65f6d1ec97cfd0030293a042","http://www.linkedin.com/in/jesusmartingarcia",,"https://twitter.com/GeneuroO","http://www.linkedin.com/company/geneuro-sa","http://www.geneuro.com/","N/A",jmg@geneuro.com,
"Max","Wraae","Max Wraae","Business Development Associate","Bactolife","Copenhagen, Denmark","N/A","(452) 815-0114","N/A","https://app.apollo.io/#/contacts/65f6c2e1fe160f03000f5890","http://www.linkedin.com/in/max-wraae",,,"http://www.linkedin.com/company/bactolife","http://www.bactolife.com/","N/A",msw@bactolife.com,
"Tara","O'Meara","Tara O'Meara","Senior Vice President, Development Operations","Hemab Therapeutics","Boston, Massachusetts","40","","Research","https://app.apollo.io/#/contacts/65f6c236fe160f01c60f6dd1","http://www.linkedin.com/in/taraomearabiotech",,"https://twitter.com/hemab_tx","http://www.linkedin.com/company/hemabaps","http://www.hemab.com/","biotech",tara@hemab.com,tmurph_02139@yahoo.com
"Paul","Bolno","Paul Bolno","President and CEO","Wave Life Sciences","Cambridge, Massachusetts","320","(617) 949-2900","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6be7be6063701ae70507f","http://www.linkedin.com/in/paul-bolno-4506a19",,"https://twitter.com/wavelifesci","http://www.linkedin.com/company/wave-life-sciences","http://www.wavelifesciences.com/","biotechnology, oligonucleotides, genetic medicines, rna editing, rnai",pbolno@wavelifesci.com,pbolno@gmail.com
"Akin","Akinc","Akin Akinc","Chief Executive Officer","Aera Therapeutics","United States","67","(857) 600-1547","Research","https://app.apollo.io/#/contacts/65f6be47e60637056f6fea9e","http://www.linkedin.com/in/akin-akinc-38b15145",,"https://twitter.com/AeraTx","http://www.linkedin.com/company/aera-therapeutics","http://www.aeratx.com/","N/A",akin.akinc@aeratx.com,abakinc@gmail.com
"Kenneth","Hess","Kenneth Hess","Director, Business Development and Commercial","Volastra Therapeutics","New York, New York","41","","Biotechnology","https://app.apollo.io/#/contacts/65f6c01063db9001c6ecfadd","http://www.linkedin.com/in/kenneth-hess-45662634",,"https://twitter.com/VolastraTx","http://www.linkedin.com/company/volastra-therapeutics","http://www.volastratx.com/","N/A",khess@volastratx.com,
"Giovanni","Salerno","Giovanni Salerno","Chief Executive Officer","Sundew","Copenhagen, Denmark","N/A","","N/A","https://app.apollo.io/#/contacts/65f6cdbc72334001c6369a21","http://www.linkedin.com/in/giovanni-salerno-a993305",,"https://twitter.com/sundewaqua?lang=en","http://www.linkedin.com/company/sundew-aps","http://www.sundew.bio/","N/A",giovannis@sundew.bio,
"Ivo","Grgic","Ivo Grgic","Director Business Development","Numab Therapeutics AG","Zürich, Switzerland","78","(414) 453-30471","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d6bb40263f0300c3bcbb","http://www.linkedin.com/in/ivo-grgic-83117b69",,"https://twitter.com/Numab_Tx","http://www.linkedin.com/company/numab-ag","http://www.numab.com/","N/A",i.grgic@numab.com,
"Sebastian","Meyer","Sebastian Meyer","Chief Operating Officer","Numab Therapeutics AG","Zürich, Switzerland","78","(414) 453-30471","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6d6bb40263f0300c3bcbf","http://www.linkedin.com/in/sebastian-meyer-17528980",,"https://twitter.com/Numab_Tx","http://www.linkedin.com/company/numab-ag","http://www.numab.com/","N/A",s.meyer@numab.com,
"David","F","David F","Chief Operating and Business Officer","Umoja Biopharma","Seattle, Washington","200","(206) 705-7687","Pharmaceuticals","https://app.apollo.io/#/contacts/65f6dbc5f0664f01c61e2717","",,"https://twitter.com/UmojaBiopharma","http://www.linkedin.com/company/umoja-biopharma","http://www.umoja-biopharma.com/","N/A",david.fontana@umoja-biopharma.com,djfontana@comcast.net
"Gregory","Dearborn","Gregory Dearborn","Sr. Director, FP&A and Investor Relations","Foghorn Therapeutics Inc.","Boston, Massachusetts","140","(617) 586-3100","Research","https://app.apollo.io/#/contacts/65f6dd28f0664f01c61e2b5f","http://www.linkedin.com/in/gregorydearborn",,"https://twitter.com/foghorntx","http://www.linkedin.com/company/foghorn-therapeutics","http://www.foghorntx.com/","N/A",gdearborn@foghorntx.com,gregory.dearborn@gmail.com
"Peter","Silverman","Peter Silverman","EVP, Chief Operating Officer and General Counsel","Merus N.V.","New York, New York","250","(313) 025-38800","Research","https://app.apollo.io/#/contacts/65f6e59ba9b03301c6723dbf","http://www.linkedin.com/in/peter-b-silverman-1423a51",,"https://twitter.com/MerusNV","http://www.linkedin.com/company/merus","http://www.merus.nl/","immunooncology, oncology, immunology, antibody engineering, antibody discovery, cell biology, in vivo, biomarker development, early discovery, protein production, robotics, functional assays",p.silverman@merus.nl,peteysils@hotmail.com
"Kathleen","Farren","Kathleen Farren","Associate Director Investor Relations & Corporate Communications","Merus N.V.","United States","250","(313) 025-38800","Research","https://app.apollo.io/#/contacts/65f6e59ba9b03301c6723dc5","http://www.linkedin.com/in/kathleen-farren-5bb80397",,"https://twitter.com/MerusNV","http://www.linkedin.com/company/merus","http://www.merus.nl/","immunooncology, oncology, immunology, antibody engineering, antibody discovery, cell biology, in vivo, biomarker development, early discovery, protein production, robotics, functional assays",k.farren@merus.nl,
"Sherri","Spear","Sherri Spear","VP Investor Relations & Corporate Communications","Merus N.V.","Brookline, Massachusetts","250","(313) 025-38800","Research","https://app.apollo.io/#/contacts/65f6e59ba9b03301c6723dc3","http://www.linkedin.com/in/sherri-spear1234",,"https://twitter.com/MerusNV","http://www.linkedin.com/company/merus","http://www.merus.nl/","immunooncology, oncology, immunology, antibody engineering, antibody discovery, cell biology, in vivo, biomarker development, early discovery, protein production, robotics, functional assays",s.spear@merus.nl,sherri.spear@gmail.com
"Takashi","Toraishi","Takashi Toraishi","Co-CEO and President","Rakuten Medical","Tokyo, Japan","130","(833) 725-8633","Biotechnology","https://app.apollo.io/#/contacts/65f6e501a9b03301c6723b67","http://www.linkedin.com/in/takashitoraishi",,,"http://www.linkedin.com/company/rakuten-medical","http://www.rakuten-med.com/","biotechnology, cancer therapeutics, clinical research",takashi.toraishi@rakuten-med.com,
"Mary","Wu","Mary Wu","Executive Director Business Development","Merus N.V.","Washington, District of Columbia","250","(313) 025-38800","Research","https://app.apollo.io/#/contacts/65f6e59ba9b03301c6723dbd","http://www.linkedin.com/in/mary-wu-3a7a384",,"https://twitter.com/MerusNV","http://www.linkedin.com/company/merus","http://www.merus.nl/","immunooncology, oncology, immunology, antibody engineering, antibody discovery, cell biology, in vivo, biomarker development, early discovery, protein production, robotics, functional assays",m.wu@merus.nl,
"Paul","Vulto","Paul Vulto","Chief Executive Officer, board member, founder","MIMETAS","The Hague, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc03c","http://www.linkedin.com/in/paul-vulto-5a427818","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"Lisa","Grosser","Lisa Grosser","Digital Marketing Specialist","MIMETAS","Amsterdam, Netherlands","120","(318) 588-83161","Research","https://app.apollo.io/#/contacts/65f6e7c673806f01ae7dc036","http://www.linkedin.com/in/lisa-grosser","https://facebook.com/mimetas","https://twitter.com/mimetas_3d","http://www.linkedin.com/company/mimetas","http://www.mimetas.com/","organonachip, microfluidics, 3d cell culture, cellbased assays, toxicology, tissue models, disease models, microphysiological systems, mps, organoids, bloodbrain barrier, liver, brain models, liver models, kidney models, 3d, disease modeling, phenotypic screening, highthroughput",,
"Oscar","Izeboud","Oscar Izeboud","Chief Executive Officer","Scenic Biotech","Amsterdam, Netherlands","58","(312) 070-59990","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e6aaa9b03306c171f5d4","http://www.linkedin.com/in/oscar-izeboud-5b05181",,"https://twitter.com/BiotechScenic","http://www.linkedin.com/company/scenic-biotech","http://www.scenicbiotech.com/","medicine, disease, immunooncology, oncology, rare disease, science, technology, pharmaceuticals, biology, biotechnology",oscar.izeboud@scenicbiotech.com,
"Naomi","Zak","Naomi Zak","President and COO","BiomX Inc","Israel","81","(972) 723-942377","Research, Biotechnology","https://app.apollo.io/#/contacts/65f6e27c3b1dca06c4063c6e","http://www.linkedin.com/in/naomi-zak-b4970211","https://facebook.com/people/Biomx/100080447359931/","https://twitter.com/BiomX_Inc","http://www.linkedin.com/company/biomxbio","http://www.biomx.com/","microbiome, biotechnology, drug discovery, phage therapies",naomiz@biomx.com,
First Name,Last Name,Full Name,Job Title,Company Name,Location,Employee Count,Phone,Industry,URL,LinkedIn URL,Facebook URL,Twitter URL,Company LinkedIn URL,Company URL,Keywords,Email 1,Email 2
"Andy","M","Andy M","Chief Business Officer","Janux Therapeutics","San Francisco, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc5","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",ameyer@januxrx.com,
"Per","Hellsund","Per Hellsund","President & CEO","Cybrexa Therapeutics","Old Saybrook, Connecticut","23","(860) 717-2731","Research","https://app.apollo.io/#/contacts/65f7063340263f01c6c46f16","http://www.linkedin.com/in/per-hellsund-860b20b",,"https://twitter.com/Cybrexa?lang=en","http://www.linkedin.com/company/cybrexa-therapeutics","http://www.cybrexa.com/","biotech, oncology, phase i, parp inhibitor, ddr, drug development",phellsund@cybrexa.com,
"Siddharth","Singh","Siddharth Singh","Global Channel Sales Manager","Parse Biosciences","Singapore, Singapore","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cf","http://www.linkedin.com/in/siddharth-singh-phd-75826a2",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ssingh@pacificbiosciences.com,
"Todd","Smith","Todd Smith","Head of Marketing & Brand Lead","Lykos Therapeutics (formerly MAPS PBC)","Lancaster, Pennsylvania","170","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948023","http://www.linkedin.com/in/todd-e-smith-mba-pmp-aa365252","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",todd.smith@jazzpharma.com,
"Ramon","M","Ramon M","Director, Digital Marketing","Parse Biosciences","San Francisco, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483d1","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",ramon@parsebiosciences.com,ramon.m@gmail.com
"Srinivas","Parthasarathy","Srinivas Parthasarathy","Senior Director, Business Development and Portfolio Strategy, and Chief of Staff","Accent Therapeutics, Inc.","Sudbury, Massachusetts","54","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c694812b","http://www.linkedin.com/in/srinivas-parthasarathy-55559096",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",sparthasarathy@accenttx.com,
"Conley","Chee","Conley Chee","Chief Executive Officer","Syros Pharmaceuticals","New York, New York","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f7","http://www.linkedin.com/in/conleychee",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",cchee@syros.com,conleychee@hotmail.com
"Elaine","C","Elaine C","Chief Business Officer","Moonwalk Biosciences","San Mateo, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb5","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",elaine.cheung@moonwalk.bio,
"Arran","C","Arran C","Social Media Marketing Manager","Biomea Fusion","San Jose, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e181","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",achahal@biomeafusion.com,
"Sarah","Q.","Sarah Q.","Associate Director of Investor Relations","Brii Biosciences","United States","120","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9e","http://www.linkedin.com/in/sarah-q-94b49923",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",sarah.q@briibio.com,
"Kristen","Baugher","Kristen Baugher","Senior Product Manager, Patient Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd1","http://www.linkedin.com/in/kristen-baugher-a24566245","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",kristen.baugher@mirumpharma.com,
"Lorna","D","Lorna D","Senior Vice President Development Operations","HI-Bio","South San Francisco, California","49","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f6","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",lorna@hibio.com,
"Jorge","Moreno","Jorge Moreno","RAM ( Sales and Market Acces Manager ) East, North Spain and Portugal. Rare Diseases","Mirum Pharmaceuticals, Inc.","Barcelona, Spain","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd9","http://www.linkedin.com/in/jorgemorenogonzalez","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jorge@mirumpharma.com,
"Daniel","Couto","Daniel Couto","Chief Operating Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f2","http://www.linkedin.com/in/daniel-couto-966bb24",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",dcouto@vedantabio.com,
"Sanjeev","Luther","Sanjeev Luther","President & CEO","Eterna Therapeutics","New York, New York","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf380","http://www.linkedin.com/in/sanjeev-luther-3103949",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",sanjeev.luther@eternatx.com,
"Jennifer","Chow","Jennifer Chow","Chief Executive Officer and Managing Director","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91125","http://www.linkedin.com/in/jennchow8","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",jchow@chimerictherapeutics.com,jenniferchowarpa@yahoo.com
"Tina","Tingting","Tina Tingting","COO & CMO","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e02","http://www.linkedin.com/in/tina-wang-tingting-8bb5b4a4","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",tinawang@liontcr.com,
"Ola","Melin","Ola Melin","Chief Operating Officer","Circio Holding ASA","Stockholm, Sweden","23","(479) 226-1624","Research","https://app.apollo.io/#/contacts/65f73e2767dba60300985cfc","http://www.linkedin.com/in/ola-melin-2981593",,"https://twitter.com/targovax","http://www.linkedin.com/company/circio","http://www.circio.com/","N/A",ola.melin@targovax.com,
"Angela","Silva","Angela Silva","Executive Assistant Administrative Operations Manager","AlloVir","Boston, Massachusetts","91","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91284","http://www.linkedin.com/in/angela-silva-91a27727",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",asilva@allovir.com,
"Morgan","L","Morgan L","Director, Portfolio Strategy and Operations","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686976","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",mlandes@annexonbio.com,
"Jennifer","M","Jennifer M","Executive Director, Porfolio Strategy and Operations","Annexon Biosciences","San Diego, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696e","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jmcalpine@annexonbio.com,mcalpj@gmail.com
"Justin","C","Justin C","Manager, CMC Operations and Project Management","Annexon Biosciences","San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e7169030068696c","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",jchun@annexonbio.com,justinvchun@gmail.com
"Douglas","L","Douglas L","President & CEO","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686974","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",doug@annexonbio.com,
"Roman","Necina","Roman Necina","Chief Operating Officer","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f8","http://www.linkedin.com/in/roman-necina-71a6751b",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",roman.necina@hookipapharma.com,
"Asia","C","Asia C","VP, Product Strategy and Operations","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda01b","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",asia.chang@freenome.com,
"Katie","McManus","Katie McManus","Senior Manager, Marketing & Communications","Trevi Therapeutics, Inc.","United States","24","(203) 304-2499","Research","https://app.apollo.io/#/contacts/65f7068940263f01c6c47064","http://www.linkedin.com/in/katie-mcmanus","https://facebook.com/trevitherapeutics","http://www.twitter.com/TreviThera","http://www.linkedin.com/company/trevi-therapeutics-inc-","http://www.trevitherapeutics.com/","N/A",katie.mcmanus@trevitherapeutics.com,
"Marcelo","Bigal","Marcelo Bigal","President and CEO","Ventus Therapeutics","New Hope, Pennsylvania","92","(514) 397-9517","Research","https://app.apollo.io/#/contacts/65f705c440263f01c6c46cc8","http://www.linkedin.com/in/marcelo-bigal-md-phd-228a8b38",,"https://twitter.com/Ventus_Tx?","http://www.linkedin.com/company/ventus-therapeutics","http://www.ventustx.com/","N/A",marcelobigal@ventustx.com,
"Shawn","Hillier","Shawn Hillier","Chief Operating Officer","Ratio Therapeutics","Boston, Massachusetts","36","(617) 371-8898","Pharmaceuticals","https://app.apollo.io/#/contacts/65f706fba1f7ef0300d4e04d","http://www.linkedin.com/in/shawnhillier",,"https://twitter.com/Ratio_Tx","http://www.linkedin.com/company/ratio-therapeutics","http://www.ratiotx.com/","N/A",shillier@ratiotx.com,shawnhillier@gmail.com
"Gerri","Henwood","Gerri Henwood","CEO & President","Baudax Bio","Malvern, Pennsylvania","17","(484) 395-2470","Pharmaceuticals","https://app.apollo.io/#/contacts/65f70782a1f7ef0300d4e11e","http://www.linkedin.com/in/gerri-henwood-6663a511",,,"http://www.linkedin.com/company/baudaxbio","http://www.baudaxbio.com/","N/A",ghenwood@baudaxbio.com,
"Derek","K","Derek K","Vice President, Business Development","Lineage Cell Therapeutics","San Diego, California","30","(510) 521-3390","Research","https://app.apollo.io/#/contacts/65f7172062502003000b7372","","https://www.facebook.com/LineageCell/","https://twitter.com/LineageCell","http://www.linkedin.com/company/lineagecell","http://www.lineagecell.com/","N/A",dkelaita@lineagecell.com,
"Olivier","Gouedard","Olivier Gouedard","Chief Operating Officer","Cytovia Therapeutics","Summit, New Jersey","22","(786) 591-7001","Research","https://app.apollo.io/#/contacts/65f7176e62502003000b7481","http://www.linkedin.com/in/oliviergouedard","https://facebook.com/CytoviaTherapeutics","https://twitter.com/CytoviaTX","http://www.linkedin.com/company/cytoviatherapeutics","http://www.cytoviatx.com/","N/A",olivier.gouedard@cytoviatx.com,ogouedard@yahoo.com
"Patrick","Weaver","Patrick Weaver","National Sales Director","Trevena, Inc.","Destin, Florida","38","(610) 354-8840","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7165d4e99d40300571064","http://www.linkedin.com/in/patrick-weaver-1415a33",,"https://twitter.com/trevenainc","http://www.linkedin.com/company/trevena-inc","http://www.trevena.com/","biotechnology, life sciences, drug discovery, development, gpcrs, pain medicine, acute care medicine, cns disorders",pweaver@trevena.com,dalena.weaver@gmail.com
"Alicia","Szretter","Alicia Szretter","Director of CMC Operations","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f6","http://www.linkedin.com/in/alicia-leece-szretter",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",aszretter@vedantabio.com,
"Sath","Shukla","Sath Shukla","President and CEO","Spero Therapeutics","Boston, Massachusetts","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a80","http://www.linkedin.com/in/sath-shukla-32948a8",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",sshukla@sperotherapeutics.com,satyavrat.shukla@yahoo.com
"Esther","Rajavelu","Esther Rajavelu","Chief Financial Officer and Chief Business Officer","Spero Therapeutics","New York, New York","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a7c","http://www.linkedin.com/in/esther-rajavelu-955262b",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",erajavelu@sperotherapeutics.com,esther.rajavelu@gmail.com
"Ted","Jenkins","Ted Jenkins","Vice President, Head of Investor Relations","Spero Therapeutics","Cambridge, Massachusetts","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a78","http://www.linkedin.com/in/ted-jenkins2017",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",tjenkins@sperotherapeutics.com,
"Jessica","G","Jessica G","Associate Director, Marketing","Mirum Pharmaceuticals, Inc.","San Diego, California","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cc7","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jessica.goshgarian@mirumpharma.com,j_siegel_12@yahoo.com
"Chunyi","Zhao","Chunyi Zhao","Associate Director, Investor Relations & Corporate Development","Biomea Fusion","United States","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e17d","http://www.linkedin.com/in/chunyi-zhao-80a488130","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",czhao@biomeafusion.com,
"Brian","Cook","Brian Cook","VP, Business Development & Strategy","Flare Therapeutics","Caldwell, New Jersey","55","(857) 706-4400","Research","https://app.apollo.io/#/contacts/65f70b4697cfd0057493bde4","http://www.linkedin.com/in/brianpcook1",,,"http://www.linkedin.com/company/flare-therapeutics","http://www.flaretx.com/","N/A",bcook@flaretx.com,
"Alex","Blyth","Alex Blyth","Founder & CEO","LIfT BioSciences","England, United Kingdom","21","(448) 712-261201","Research","https://app.apollo.io/#/contacts/65f73f3f6e9eba01c6d911a5","http://www.linkedin.com/in/alex-blyth-a33b7a","https://www.facebook.com/LIfTBioSciences","https://twitter.com/liftbiosciences","http://www.linkedin.com/company/lift-biosciences","http://www.liftbiosciences.com/","oncology, cell therapy, solid tumours, firstinclass, unique, neutrophils, curative, pancreatic, lung, biotech",ablyth@liftbiosciences.com,
"Callum","Fiske","Callum Fiske","Head of Operations","TC BioPharm","Dunblane, United Kingdom","62","(441) 414-337557","Research","https://app.apollo.io/#/contacts/65f73e3f67dba60300985d58","http://www.linkedin.com/in/callum-fiske-285a0162","https://facebook.com/people/Tc-Biopharm-Limited/100066900577503/","https://twitter.com/TCBioPharm","http://www.linkedin.com/company/tc-biopharm-limited","http://www.tcbiopharm.com/","clinical grade cell therapy, cancer immonotherapy, regenerative medicine, stratified medicine",c.fiske@tcbiopharm.com,
"Carina","Dahlstrom","Carina Dahlstrom","Manager Operation Support","Anocca","Trosa, Sweden","100","(468) 410-80750","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73e9767dba601c699746b","http://www.linkedin.com/in/carina-dahlstr%c3%b6m-a21075206",,,"http://www.linkedin.com/company/anocca-ab","http://www.anocca.com/","biotechnology, immunotherapeutics, drug discovery, drug development, immunology, immunotechnology, immunooncology",carina.dahlstrom@anocca.com,
"Eliot","Bourk","Eliot Bourk","Chief Business Officer","Chimeric Therapeutics","New York, New York","12","(613) 982-45254","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73ef16e9eba01c6d91123","http://www.linkedin.com/in/eliotbourk","https://facebook.com/Chimeric.Therapeutics.ASXCHM/","https://twitter.com/Chimeric","http://www.linkedin.com/company/chimeric-therapeutics","http://www.chimerictherapeutics.com/","cell therapy, immunotherapy, immunooncology, biotechnology, biotech, cancer research, life sciences, drug development",ebourk@chimerictherapeutics.com,eliot.bourk@gmail.com
"Lori","T","Lori T","Senior Vice President, Portfolio Strategy and Operations","Annexon Biosciences","South San Francisco, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686972","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",,
"Cecilia","O","Cecilia O","Senior Vice President CMC Operations","Annexon Biosciences","Los Angeles, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686978","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",coliyai@annexonbio.com,coliyai@gmail.com
"Sabrina","J","Sabrina J","President and CEO","Daré Bioscience, Inc.","San Diego, California","27","(858) 926-7655","Research, Biotechnology","https://app.apollo.io/#/contacts/65f741946b6fe00300462d61","",,"https://twitter.com/DareBioscience","http://www.linkedin.com/company/dare-bioscience","http://www.darebioscience.com/","womens reproductive health, womens health, fertility, contraception, vaginal health, biotechnology, innovation",sjohnson@darebioscience.com,sabrina.martucci.johnson@gmail.com
"Kristin","A","Kristin A","Associate Director, Product Marketing","Freenome","Santa Monica, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda019","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",kristin.andreassen@freenome.com,
"Ivy","C","Ivy C","Associate Director, Business Development","BioAge Labs","San Francisco, California","85","(541) 745-5116","Research, Biotechnology","https://app.apollo.io/#/contacts/65f742de7747510300dcf678","",,"https://twitter.com/bioagelabs","http://www.linkedin.com/company/bioage-labs","http://www.bioagelabs.com/","aging, longevity, biotechnology",ivy.chen@bioagelabs.com,
"Brian","O'Callaghan","Brian O'Callaghan","Chief Executive Officer","Deep Genomics","United States","99","(647) 598-8879","Research","https://app.apollo.io/#/contacts/65f744537747510300dcf8a5","http://www.linkedin.com/in/brian-o-callaghan-43459a16","https://facebook.com/pages/Deep-Genomics/2316965025085458","https://twitter.com/deepgenomics","http://www.linkedin.com/company/deep-genomics","http://www.deepgenomics.com/","N/A",brian@deepgenomics.com,bhrianoc@gmail.com
"Peter","R","Peter R","President & Chief Operating Officer","Mirum Pharmaceuticals, Inc.","Burlingame, California","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cc5","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",pradovich@mirumpharma.com,
"Nina","Y","Nina Y","Senior Manager, Investor Relations","Mirum Pharmaceuticals, Inc.","Los Angeles, California","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd5","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",nina.yun@mirumpharma.com,ninayun128@gmail.com
"Travis","M","Travis M","President & CEO","HI-Bio","San Francisco, California","49","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5fc","",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",tmurdoch@hibio.com,travis.murdoch@gmail.com
"Karen","Yenovkian","Karen Yenovkian","Executive Business Partner to CIO","Seres Therapeutics","Cambridge, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a8","http://www.linkedin.com/in/karenyenovkian","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",kyenovkian@serestherapeutics.com,
"Brian","R.","Brian R.","VP Commercial & Business Development","Zynerba Pharmaceuticals","Philadelphia, Pennsylvania","19","(484) 581-7505","Pharmaceuticals","https://app.apollo.io/#/contacts/65f716b54e99d40300571113","http://www.linkedin.com/in/brosenberger4",,"https://twitter.com/ZynerbaPharma","http://www.linkedin.com/company/zynerba-pharmaceuticals","http://www.zynerba.com/","drug development, cannabinoids, fragile x syndrome, epilepsy, specialty pharmaceuticals, fragile x, transdermal gel",rosenbergerb@zynerba.com,rosestemnc@hotmail.com
"Agnete","Fredriksen","Agnete Fredriksen","Chief Business Officer","Nykode Therapeutics","Oslo, Norway","190","(472) 295-8193","Research, Biotechnology","https://app.apollo.io/#/contacts/65f717eb62502001c60bf5b3","http://www.linkedin.com/in/agnete-fredriksen-628a3a3b",,,"http://www.linkedin.com/company/nykode","http://www.nykode.com/","immunotherapy, immunooncology, neoantigens, dna vaccine, hpv16, neoepitopes, oncology",abfredriksen@nykode.com,
"Armin","Rath","Armin Rath","Chief Operating Officer","Cytovia Therapeutics","United States","22","(786) 591-7001","Research","https://app.apollo.io/#/contacts/65f7176e62502003000b747f","http://www.linkedin.com/in/dr-armin-rath-4786179","https://facebook.com/CytoviaTherapeutics","https://twitter.com/CytoviaTX","http://www.linkedin.com/company/cytoviatherapeutics","http://www.cytoviatx.com/","N/A",armin.rath@cytoviatx.com,
"Adil","Duru","Adil Duru","Director of Business Development","Glycostem Therapeutics","Netherlands","30","(314) 122-11001","Biotechnology","https://app.apollo.io/#/contacts/65f7181ebe769703009b8085","http://www.linkedin.com/in/adil-doganay-duru-98aa0663",,,"http://www.linkedin.com/company/glycostem-therapeutics","http://www.glycostem.com/","N/A",adil@glycostem.com,
"Kirsten","F","Kirsten F","Sr Director of Business Operations","T-knife Therapeutics","San Diego, California","99","(493) 094-892432","Research","https://app.apollo.io/#/contacts/65f7185667dba601c698328b","",,,"http://www.linkedin.com/company/t-knife","http://www.t-knife.com/","immunoncology, tumor immunology, t cell receptor, adoptive t cell therapy, cell therapy, gene therapy, tcr gene transfer, tcr generation, tcr characterization, cancer testis antigens, tumor antigens, target selection, retroviral vectors, neoepitopes, neoantigens",kirsten.flanagan@t-knife.com,kirstenflanagan@yahoo.com
"Megan","B","Megan B","Senior Vice President and Chief Operating Officer","T-knife Therapeutics","San Francisco, California","99","(493) 094-892432","Research","https://app.apollo.io/#/contacts/65f7185667dba601c698328d","",,,"http://www.linkedin.com/company/t-knife","http://www.t-knife.com/","immunoncology, tumor immunology, t cell receptor, adoptive t cell therapy, cell therapy, gene therapy, tcr gene transfer, tcr generation, tcr characterization, cancer testis antigens, tumor antigens, target selection, retroviral vectors, neoepitopes, neoantigens",megan.baierlein@t-knife.com,megbaierlein@gmail.com
"Graham","B","Graham B","Sales Development Representative","Parse Biosciences","Seattle, Washington","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cb","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",graham@parsebiosciences.com,
"Howard","Berman","Howard Berman","Founder and Chief Executive Officer","Coya Therapeutics, Inc.","Houston, Texas","11","(800) 587-8170","Research","https://app.apollo.io/#/contacts/65f70751a1f7ef0300d4e0d2","http://www.linkedin.com/in/howard-berman-phd-8b19681b8",,"https://twitter.com/CoyaTx","http://www.linkedin.com/company/coya-therapeutics","http://www.coyatherapeutics.com/","N/A",howard@coyatherapeutics.com,
"Derek","Chalmers","Derek Chalmers","President &CEO","Cara Therapeutics","Shelton, Connecticut","88","(203) 406-3700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706e1a1f7ef057bd4990f","http://www.linkedin.com/in/derek-chalmers-33491713","https://www.facebook.com/pages/Cara-Therapeutics/164668313559992","https://twitter.com/caratherapinc","http://www.linkedin.com/company/cara-therapeutics","http://www.caratherapeutics.com/","healthcare, biotechnology, life sciences",dchalmers@caratherapeutics.com,
"Bob","Duggan","Bob Duggan","Chief Executive Officer","Summit Therapeutics, Inc.","Florida, US","120","(441) 235-443939","Research","https://app.apollo.io/#/contacts/65f708fea1f7ef01c6d53e19","http://www.linkedin.com/in/boduggan","https://www.facebook.com/smmttxinc","https://twitter.com/Summitplc","http://www.linkedin.com/company/summit-therapeutics","http://www.smmttx.com/","oncology, clinical trials, health care",bob.duggan@summitplc.com,
"Mark","Cockett","Mark Cockett","CEO and President R&D","Alphina Therapeutics","New Haven, Connecticut","16","","Research","https://app.apollo.io/#/contacts/65f7066640263f0300c3ff26","http://www.linkedin.com/in/mark-cockett-2a0112",,"https://twitter.com/alphinatx","http://www.linkedin.com/company/alphina-therapeutics","http://www.alphinatx.com/","N/A",mark.cockett@alphinatx.com,
"Sandra","Lobo","Sandra Lobo","Director of Business and R&D Operations","Alphina Therapeutics","Newtown, Connecticut","16","","Research","https://app.apollo.io/#/contacts/65f7066640263f0300c3ff27","http://www.linkedin.com/in/sandra-lobo-59827433",,"https://twitter.com/alphinatx","http://www.linkedin.com/company/alphina-therapeutics","http://www.alphinatx.com/","N/A",sandra.lobo@alphinatx.com,sandra.lobo6@gmail.com
"Jacinta","Nagler","Jacinta Nagler","Corporate Business Development","LIfT BioSciences","United States","21","(448) 712-261201","Research","https://app.apollo.io/#/contacts/65f73f3f6e9eba01c6d911a3","http://www.linkedin.com/in/jacintanagler","https://www.facebook.com/LIfTBioSciences","https://twitter.com/liftbiosciences","http://www.linkedin.com/company/lift-biosciences","http://www.liftbiosciences.com/","oncology, cell therapy, solid tumours, firstinclass, unique, neutrophils, curative, pancreatic, lung, biotech",jnagler@liftbiosciences.com,jacinta.nagler@gmail.com
"Jake","Hao","Jake Hao","Business Development Manager","HebeCell Corp","Brookline, Massachusetts","20","(508) 545-0056","Biotechnology","https://app.apollo.io/#/contacts/65f7408f6e7169059268641c","http://www.linkedin.com/in/jake-hao-b213a3a6",,,"http://www.linkedin.com/company/hebecell","http://www.hebecellcorp.com/","N/A",jhao@hebecell.com,
"John","Lu","John Lu","President and CEO","HebeCell Corp","Natick, Massachusetts","20","(508) 545-0056","Biotechnology","https://app.apollo.io/#/contacts/65f7408f6e7169059268641a","http://www.linkedin.com/in/john-lu-799583b5",,,"http://www.linkedin.com/company/hebecell","http://www.hebecellcorp.com/","N/A",jlu@hebecell.com,
"Jane","Gajsiewicz","Jane Gajsiewicz","Associate Director, Business Development and Corporate Strategy","Life Edit Therapeutics","Boston, Massachusetts","97","(919) 590-4205","Biotechnology","https://app.apollo.io/#/contacts/65f740256e9eba043dd8df08","http://www.linkedin.com/in/jane-klann-gajsiewicz-phd-13786166",,"https://twitter.com/lifeedittx","http://www.linkedin.com/company/lifeedit","http://www.lifeeditinc.com/","N/A",jgajsiewicz@lifeeditinc.com,
"Jason","Park","Jason Park","Chief Executive Officer","Empress Therapeutics","Cambridge, Massachusetts","36","(858) 344-8091","Research","https://app.apollo.io/#/contacts/65f742bf77475101c6dd9b73","http://www.linkedin.com/in/jason-park-8a3216a",,,"http://www.linkedin.com/company/empresstx","http://www.empresstx.com/","N/A",jpark@empresstx.com,
"Rebecca","W","Rebecca W","Director, Marketing","Freenome","Seattle, Washington","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda011","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",rebecca.weiss@freenome.com,rebeccabweiss@gmail.com
"Reagan","Jarvis","Reagan Jarvis","Chief Executive Officer / Co-founder","Anocca","Södertälje, Sweden","100","(468) 410-80750","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73e9767dba601c6997469","http://www.linkedin.com/in/reagan-jarvis-063984142",,,"http://www.linkedin.com/company/anocca-ab","http://www.anocca.com/","biotechnology, immunotherapeutics, drug discovery, drug development, immunology, immunotechnology, immunooncology",reagan.jarvis@anocca.com,
"David","Yepes","David Yepes","Sales Specialist","Nkarta, Inc.","Haßfurt, Germany","170","(415) 582-4923","Research","https://app.apollo.io/#/contacts/65f742946e71690300686ab9","http://www.linkedin.com/in/david-yepes-585a66213","https://facebook.com/Nkarta-Therapeutics-108731114207664/","https://twitter.com/nkartatx","http://www.linkedin.com/company/nkarta-inc","http://www.nkartatx.com/","cell therapy & immunooncology",dyepes@nkartatx.com,
"Tom","Masterson","Tom Masterson","Chief Operating Officer","Deep Genomics","Toronto, Canada","99","(647) 598-8879","Research","https://app.apollo.io/#/contacts/65f744537747510300dcf8a3","http://www.linkedin.com/in/mastersonthomas","https://facebook.com/pages/Deep-Genomics/2316965025085458","https://twitter.com/deepgenomics","http://www.linkedin.com/company/deep-genomics","http://www.deepgenomics.com/","N/A",tom.masterson@deepgenomics.com,tmasterson3@gmail.com
"Dinesh","P","Dinesh P","CEO","Protagonist Therapeutics","Fremont, California","120","(510) 474-0170","Biotechnology","https://app.apollo.io/#/contacts/65f708c7a1f7ef01c6d53dc2","",,"https://twitter.com/ProtagonistTx","http://www.linkedin.com/company/protagonist-therapeutics","http://www.protagonist-inc.com/","N/A",d.patel@protagonist-inc.com,
"Rebecca","Cohen","Rebecca Cohen","Head of Investor Relations and Corporate Communications","Ikena Oncology","Boston, Massachusetts","58","(857) 273-8343","Research","https://app.apollo.io/#/contacts/65f70719a1f7ef01c6d53ba3","http://www.linkedin.com/in/rebeccamaracohen",,"https://twitter.com/ikenaoncology","http://www.linkedin.com/company/ikenaoncology","http://www.ikenaoncology.com/","targeted oncology, cancer therapeutics development, small molecule drug design, cancer biology, translational science & biomarkers",rcohen@ikenaoncology.com,
"Justin","N","Justin N","Director of Corporate Development and Investor Relations","Terns Pharmaceuticals","San Francisco, California","66","(650) 275-4254","Pharmaceuticals","https://app.apollo.io/#/contacts/65f707a1a1f7ef01c6d53c1b","",,"https://twitter.com/TernsPharma","http://www.linkedin.com/company/ternspharmaceuticals","http://www.ternspharma.com/","pharmaceuticals, liver disease, life sciences, biopharmaceuticals",jng@ternspharma.com,
"Jack","Hoppin","Jack Hoppin","CEO","Ratio Therapeutics","Boston, Massachusetts","36","(617) 371-8898","Pharmaceuticals","https://app.apollo.io/#/contacts/65f706fba1f7ef0300d4e04b","http://www.linkedin.com/in/jack-hoppin-a1b9007",,"https://twitter.com/Ratio_Tx","http://www.linkedin.com/company/ratio-therapeutics","http://www.ratiotx.com/","N/A",jhoppin@ratiotx.com,
"Dinesh","P","Dinesh P","CEO","Protagonist Therapeutics","Fremont, California","120","(510) 474-0170","Biotechnology","https://app.apollo.io/#/contacts/65f708c7a1f7ef01c6d53dc2","",,"https://twitter.com/ProtagonistTx","http://www.linkedin.com/company/protagonist-therapeutics","http://www.protagonist-inc.com/","N/A",d.patel@protagonist-inc.com,
"Jamie","C","Jamie C","Head of Sales & Marketing Operations","CymaBay Therapeutics","San Francisco, California","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70882a1f7ef0439d4ad4e","","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",jcooper@cymabay.com,sfjamiejones@gmail.com
"Dave","Gancarz","Dave Gancarz","Chief Business & Strategy Officer","Summit Therapeutics, Inc.","Boston, Massachusetts","120","(441) 235-443939","Research","https://app.apollo.io/#/contacts/65f708fea1f7ef01c6d53e1b","http://www.linkedin.com/in/davegancarz","https://www.facebook.com/smmttxinc","https://twitter.com/Summitplc","http://www.linkedin.com/company/summit-therapeutics","http://www.smmttx.com/","oncology, clinical trials, health care",david.gancarz@summitplc.com,gancarz.dave@gmail.com
"Zhi","Hong","Zhi Hong","Co-Founder and CEO","Brii Biosciences","Chapel Hill, North Carolina","120","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53ca0","http://www.linkedin.com/in/zhi-hong-18a77927",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",zhi.hong@briibio.com,
"Heow","T","Heow T","Chief Operational Officer","Biomea Fusion","Cupertino, California","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e183","","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",ht@biomeafusion.com,
"Edison","M","Edison M","VP of Operations","Pulse Biosciences, Inc.","San Jose, California","71","(833) 257-3393","Medical Devices","https://app.apollo.io/#/contacts/65f70924a1f7ef01c6d53ee5","","https://facebook.com/pulsebio/","https://twitter.com/pulsebionps","http://www.linkedin.com/company/pulse-biosciences-inc.","http://www.pulsebiosciences.com/","immunooncology, innovation, atrial fibrillation, cardiac surgery, cardiology, biology, nanosecond pulsing",edison.manuel@pulsebiosciences.com,edisonmanuelmie81@yahoo.com
"Catherine","Loiselle","Catherine Loiselle","Director - International Marketing & Commercial Planning","Mirum Pharmaceuticals, Inc.","Zürich, Switzerland","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947ccb","http://www.linkedin.com/in/catherine-loiselle-634b6713","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",catherine.loiselle@mirumpharma.com,
"Carl","Enell","Carl Enell","Chief Operating Officer","HI-Bio","United States","49","(867) 578-6231102","Research","https://app.apollo.io/#/contacts/65f709ed97cfd0043b93d5f8","http://www.linkedin.com/in/carlhenell",,"https://twitter.com/HIBiosciences","http://www.linkedin.com/company/hibio","http://www.hibio.com/","N/A",carl@hibio.com,carl_henrik_enell@mac.com
"Mary","Norton","Mary Norton","Director, HCP Product Marketing","Mirum Pharmaceuticals, Inc.","Louisville, Kentucky","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947ccf","http://www.linkedin.com/in/mary-norton-73732b67","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",mary.norton@mirumpharma.com,
"Justin","Quinn","Justin Quinn","External Reporting and Investor Relations Senior Manager","Spero Therapeutics","Boston, Massachusetts","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a7e","http://www.linkedin.com/in/justinq",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",jquinn@sperotherapeutics.com,justinquinn1992@gmail.com
"Daphne","Karydas","Daphne Karydas","COO and CFO","Flare Therapeutics","New York, New York","55","(857) 706-4400","Research","https://app.apollo.io/#/contacts/65f70b4697cfd0057493bde6","http://www.linkedin.com/in/daphne-karydas-493b17",,,"http://www.linkedin.com/company/flare-therapeutics","http://www.flaretx.com/","N/A",dkarydas@flaretx.com,dkarydas@yahoo.com
"Carol","P","Carol P","Technical Sales Manager","Parse Biosciences","Seattle, Washington","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483bf","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",carol@parsebiosciences.com,
"John","W","John W","Vice President of Marketing","Parse Biosciences","San Diego, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483c3","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",john@parsebiosciences.com,mr.jpwalsh@gmail.com
"Julie","G","Julie G","Vice President of Business Development & Strategy","Parse Biosciences","San Diego, California","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483cd","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",julie@parsebiosciences.com,jvgerardi@yahoo.com
"Bridget","Carey","Bridget Carey","Director, Head of Internal Operations and Manufacturing","Seres Therapeutics","Boston, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d29e","http://www.linkedin.com/in/bridget-carey-5540035","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",bcarey@serestherapeutics.com,
"Rebecca","Servais","Rebecca Servais","Director of Operations","Seres Therapeutics","Boston, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d29c","http://www.linkedin.com/in/rebecca-servais-47a58221","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",rservais@serestherapeutics.com,
"Pariyaporn","Chenthanyakorn","Pariyaporn Chenthanyakorn","Business Controller","Nykode Therapeutics","Oslo, Norway","190","(472) 295-8193","Research, Biotechnology","https://app.apollo.io/#/contacts/65f717eb62502001c60bf5b5","http://www.linkedin.com/in/pchenthanyakorn",,,"http://www.linkedin.com/company/nykode","http://www.nykode.com/","immunotherapy, immunooncology, neoantigens, dna vaccine, hpv16, neoepitopes, oncology",pchenthanyakorn@vaccibody.com,
"Erin","McDonald","Erin McDonald","Director of Operations","Incendia Therapeutics","Boston, Massachusetts","39","(617) 870-3363","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7178f501be201c675d325","http://www.linkedin.com/in/erinmcdonald1",,,"http://www.linkedin.com/company/incendiatherapeutics","http://www.incendiatx.com/","systems biology, pharmacology, single cell, machine learning, biotechnology, drug discovery, clinical development, cell signaling, oncology, immunology, diabetes, precision medicine, network, patient, precision oncology",erin.mcdonald@parthenontx.com,erinmcdonald1@gmail.com
"Greg","Boschetto","Greg Boschetto","Territory Business Manager","Nabriva Therapeutics plc","Philadelphia, Pennsylvania","40","(353) 164-92000","Research, Biotechnology","https://app.apollo.io/#/contacts/65f716334e99d401c65777df","http://www.linkedin.com/in/greg-boschetto-6815a817",,"https://twitter.com/nabriva","http://www.linkedin.com/company/nabriva-therapeutics","http://www.nabriva.com/","biotechnology, life sciences",greg.boschetto@nabriva.com,
"Boaz","Zafrani","Boaz Zafrani","Product and Operations specialist","Cell Cure Neurosciences Ltd.","Israel","40","(510) 521-3390","Research","https://app.apollo.io/#/contacts/65f741116e716903006869b6","http://www.linkedin.com/in/boaz-zafrani-mba-376ba7123",,,"http://www.linkedin.com/company/cell-cure-neurosciences-ltd-","http://www.cellcureneurosciences.com/","embryonic stem cell research, development, pluripotent stem cell research, research, development related to agerelated macular degeneration, development related to degenerative diseases of the eye",boaz.zafrani@cellcureneurosciences.com,
"Jessica","Alderton","Jessica Alderton","Senior Manager/Business Partner US & Scientific","HOOKIPA Pharma Inc.","Austria","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f4","http://www.linkedin.com/in/jessica-alderton-bb8356122",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",jessica.alderton@hookipapharma.com,
"Johan","Liwing","Johan Liwing","Chief Executive Officer","XNK Therapeutics","Stockholm, Sweden","35","","Pharmaceuticals, Hospital & Health Care, Biotechnology","https://app.apollo.io/#/contacts/65f73e7a67dba60300985d9d","http://www.linkedin.com/in/johan-liwing-726a1161",,,"http://www.linkedin.com/company/xnktherapeutics","http://www.xnktherapeutics.com/","immunotherapy, autologous cell therapy, biotechnology, cellular therapeutics, nk cell therapy, oncology, cell therapy, biopharmaceutical",johan.liwing@xnktherapeutics.com,
"Angela","Scott","Angela Scott","Founder and Chief Operating Officer","TC BioPharm","Edinburgh, United Kingdom","62","(441) 414-337557","Research","https://app.apollo.io/#/contacts/65f73e3f67dba60300985d5a","http://www.linkedin.com/in/angela-scott-b2357912","https://facebook.com/people/Tc-Biopharm-Limited/100066900577503/","https://twitter.com/TCBioPharm","http://www.linkedin.com/company/tc-biopharm-limited","http://www.tcbiopharm.com/","clinical grade cell therapy, cancer immonotherapy, regenerative medicine, stratified medicine",a.scott@tcbiopharm.com,
"Danielle","Malloy","Danielle Malloy","Associate Director, Business and Legal Operations","AlloVir","Houston, Texas","91","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91286","http://www.linkedin.com/in/danielle-malloy-cp-1a7492133",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",dmalloy@allovir.com,
"Michael","Henning","Michael Henning","Senior Director Business Development","Tome Biosciences","Cambridge, Massachusetts","150","","Research","https://app.apollo.io/#/contacts/65f742ad7747510300dcf655","http://www.linkedin.com/in/michael-henning-3ba42117",,"https://twitter.com/tome_bio","http://www.linkedin.com/company/tome-biosciences","http://www.tome.bio/","N/A",michael.henning@tome.bio,michael.henning28@gmail.com
"Sam","Galindo","Sam Galindo","Senior Manager of Business Development","Verge Genomics","New York, New York","78","(650) 752-3100","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7440f77475101c6dda0b7","http://www.linkedin.com/in/samgalindo",,"https://twitter.com/VergeGenomics","http://www.linkedin.com/company/verge-genomics","http://www.vergegenomics.com/","biotechnology, pharmaceuticals, neuroscience, drug discovery, life sciences, bioinformatics, genomics",sam@vergegenomics.com,
"Eric","M","Eric M","COO, co-founder","BioAge Labs","San Francisco, California","85","(541) 745-5116","Research, Biotechnology","https://app.apollo.io/#/contacts/65f742de7747510300dcf67a","",,"https://twitter.com/bioagelabs","http://www.linkedin.com/company/bioage-labs","http://www.bioagelabs.com/","aging, longevity, biotechnology",eric.morgen@bioagelabs.com,eric.morgen@gmail.com
"Abraham","H","Abraham H","Co-Founder and CEO","Atomwise","San Francisco, California","65","(415) 890-5703","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7442977475101c6dda125","",,"https://twitter.com/atomwiseinc","http://www.linkedin.com/company/atomwise","http://www.atomwise.com/","artificial intelligence, machine learning, biotechnology, pharmaceuticals, life sciences, deep information technology, information technology, drug discovery, computer aided drug design",aheifets@atomwise.com,
"Amy","B","Amy B","Chief Executive Officer","Terns Pharmaceuticals","San Francisco, California","66","(650) 275-4254","Pharmaceuticals","https://app.apollo.io/#/contacts/65f707a1a1f7ef01c6d53c1d","",,"https://twitter.com/TernsPharma","http://www.linkedin.com/company/ternspharmaceuticals","http://www.ternspharma.com/","pharmaceuticals, liver disease, life sciences, biopharmaceuticals",amyb@ternspharma.com,
"Mark","M","Mark M","Head of Marketing","CymaBay Therapeutics","San Francisco, California","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70882a1f7ef0439d4ad52","","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",mmclaughlin@cymabay.com,mmclaughlin1983@hotmail.co.uk
"Marshall","F","Marshall F","Founder and CEO","Vera Therapeutics, Inc.","San Francisco, California","61","(650) 770-0077","Biotechnology","https://app.apollo.io/#/contacts/65f7083ca1f7ef057bd4998c","",,"https://twitter.com/Official_VeraTx","http://www.linkedin.com/company/veratx","http://www.veratx.com/","N/A",marshall.fordyce@veratx.com,marshall.fordyce@gmail.com
"Juli","Monteiro","Juli Monteiro","Patient Advocacy, Communications and Business Operations Manager","Summit Therapeutics, Inc.","Oxford, United Kingdom","120","(441) 235-443939","Research","https://app.apollo.io/#/contacts/65f708fea1f7ef01c6d53e17","http://www.linkedin.com/in/julipm","https://www.facebook.com/smmttxinc","https://twitter.com/Summitplc","http://www.linkedin.com/company/summit-therapeutics","http://www.smmttx.com/","oncology, clinical trials, health care",juli.monteiro@summitplc.com,
"Kevin","Danahy","Kevin Danahy","President & Chief Executive Officer","Pulse Biosciences, Inc.","Boston, Massachusetts","71","(833) 257-3393","Medical Devices","https://app.apollo.io/#/contacts/65f70924a1f7ef01c6d53ee3","http://www.linkedin.com/in/kevin-danahy-61a59110","https://facebook.com/pulsebio/","https://twitter.com/pulsebionps","http://www.linkedin.com/company/pulse-biosciences-inc.","http://www.pulsebiosciences.com/","immunooncology, innovation, atrial fibrillation, cardiac surgery, cardiology, biology, nanosecond pulsing",kevin.danahy@pulsebiosciences.com,
"Colleen","C","Colleen C","Senior Manager, Executive Administration & Business Operations","Pulse Biosciences, Inc.","Hayward, California","71","(833) 257-3393","Medical Devices","https://app.apollo.io/#/contacts/65f70924a1f7ef01c6d53ee1","","https://facebook.com/pulsebio/","https://twitter.com/pulsebionps","http://www.linkedin.com/company/pulse-biosciences-inc.","http://www.pulsebiosciences.com/","immunooncology, innovation, atrial fibrillation, cardiac surgery, cardiology, biology, nanosecond pulsing",ccarrion@pulsebiosciences.com,colleen_carrion@yahoo.com
"Scott","Boyle","Scott Boyle","Chief Business Officer","C4 Therapeutics, Inc.","Boston, Massachusetts","130","(617) 231-0700","Biotechnology","https://app.apollo.io/#/contacts/65f705f240263f0300c3fe12","http://www.linkedin.com/in/scottnboyle",,"https://twitter.com/C4Therapeutics","http://www.linkedin.com/company/c4-therapeutics-inc.","http://www.c4therapeutics.com/","biotechnology, cell biology, protein chemistry, cell pharmacology, protein degradation",sboyle@c4therapeutics.com,scottnboyle@gmail.com
"David","C","David C","President, CEO & Director (Founder)","Janux Therapeutics","San Diego, California","67","(858) 750-4700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706b040263f0300c3ffc3","",,"https://twitter.com/januxrx","http://www.linkedin.com/company/janux-therapeutics","http://www.januxrx.com/","biotechnology",dcampbell@januxrx.com,
"Courtney","Solberg","Courtney Solberg","Senior Manager, Investor Relations","C4 Therapeutics, Inc.","Boston, Massachusetts","130","(617) 231-0700","Biotechnology","https://app.apollo.io/#/contacts/65f705f240263f0300c3fe10","http://www.linkedin.com/in/courtney-solberg-791b83ab",,"https://twitter.com/C4Therapeutics","http://www.linkedin.com/company/c4-therapeutics-inc.","http://www.c4therapeutics.com/","biotechnology, cell biology, protein chemistry, cell pharmacology, protein degradation",csolberg@c4therapeutics.com,
"Amanda","Hayward","Amanda Hayward","Global Head of BD","Rallybio","Madison, Connecticut","52","(203) 859-3820","Research","https://app.apollo.io/#/contacts/65f7064e40263f01c6c46f50","http://www.linkedin.com/in/amanda-hayward-a827491",,"https://twitter.com/rallybio","http://www.linkedin.com/company/rallybio","http://www.rallybio.com/","rare disease",ahayward@rallybio.com,
"Sara","Mathews","Sara Mathews","N/A","Syros Pharmaceuticals","Boston, Massachusetts","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486fb","http://www.linkedin.com/in/sara-mathews-1202586",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",smathews@syros.com,semanoli@gmail.com
"Seth","Feldman","Seth Feldman","Vice President, Marketing and New Product Development","Syros Pharmaceuticals","Baltimore, Maryland","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f5","http://www.linkedin.com/in/sethfeldman-biopharma",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",sfeldman@syros.com,emailsethfeldman@gmail.com
"Shakti","Narayan","Shakti Narayan","Chief Executive Officer","Accent Therapeutics, Inc.","Cambridge, Massachusetts","54","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c6948127","http://www.linkedin.com/in/shakti-narayan-1ab69a5",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",snarayan@accenttx.com,shakti.narayan@gmail.com
"David","Brower","David Brower","Chief Business Officer","Accent Therapeutics, Inc.","Cambridge, Massachusetts","54","(202) 587-2580","Research","https://app.apollo.io/#/contacts/65f70a8c97cfd001c6948129","http://www.linkedin.com/in/david-brower-45700333",,"https://twitter.com/accent_tx","http://www.linkedin.com/company/accenttherapeutics","http://www.accenttx.com/","N/A",dbrower@accenttx.com,dpbrower@gmail.com
"Danah","Kirsh","Danah Kirsh","Recruitment & Marketing Operations Supervisor","Seres Therapeutics","Phoenix, Arizona","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d29a","http://www.linkedin.com/in/danah-kirsh-mph-1176ba148","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",dkirsh@serestherapeutics.com,
"David","Arkowitz","David Arkowitz","CFO and Head of Business Development","Seres Therapeutics","Lexington, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a4","http://www.linkedin.com/in/david-arkowitz-3677b42","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",darkowitz@serestherapeutics.com,davidarkowitz@verizon.net
"Carrie","Bourdow","Carrie Bourdow","Chief Executive Officer","Trevena, Inc.","King of Prussia, Pennsylvania","38","(610) 354-8840","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7165d4e99d40300571068","http://www.linkedin.com/in/carrie-bourdow-a8177733",,"https://twitter.com/trevenainc","http://www.linkedin.com/company/trevena-inc","http://www.trevena.com/","biotechnology, life sciences, drug discovery, development, gpcrs, pain medicine, acute care medicine, cns disorders",cbourdow@trevena.com,cbourdow@gmail.com
"Lee","P","Lee P","Territory Business Manager","Nabriva Therapeutics plc","Birmingham, Alabama","40","(353) 164-92000","Research, Biotechnology","https://app.apollo.io/#/contacts/65f716334e99d401c65777e1","",,"https://twitter.com/nabriva","http://www.linkedin.com/company/nabriva-therapeutics","http://www.nabriva.com/","biotechnology, life sciences",lee.posey@nabriva.com,leeposey68@yahoo.com
"Matt","Angel","Matt Angel","Chief Executive Officer","Eterna Therapeutics","Cambridge, Massachusetts","9","(212) 582-1199","Research","https://app.apollo.io/#/contacts/65f7174b62502001c60bf37e","http://www.linkedin.com/in/matt-angel-655ba533",,,"http://www.linkedin.com/company/eterna-therapeutics","http://www.eternatx.com/","cellular reprogramming, synthetic mrna, gene editing, nonviral nucleic acid delivery, human derived mixed cytokines",mangel@brooklynitx.com,
"Dan","G","Dan G","Business Development Manager","Lineage Cell Therapeutics","Carlsbad, California","30","(510) 521-3390","Research","https://app.apollo.io/#/contacts/65f7172062502003000b736e","","https://www.facebook.com/LineageCell/","https://twitter.com/LineageCell","http://www.linkedin.com/company/lineagecell","http://www.lineagecell.com/","N/A",dgiles@lineagecell.com,
"Anders","Holm","Anders Holm","COO & Head of business development","Zelluna Immunotherapy","Oslo, Norway","27","(472) 284-0080","Research","https://app.apollo.io/#/contacts/65f717c1501be20300755305","http://www.linkedin.com/in/immunooncology",,,"http://www.linkedin.com/company/zelluna","http://www.zelluna.com/","cancer treatment, immunotherapy, adoptive cell therapy, t cell receptor technologies, immunooncology, solid tumors",anders.holm@zelluna.com,
"Mark","P","Mark P","Executive Director, Business Development and Strategic Finance","T-knife Therapeutics","San Francisco, California","99","(493) 094-892432","Research","https://app.apollo.io/#/contacts/65f7185667dba601c698328f","",,,"http://www.linkedin.com/company/t-knife","http://www.t-knife.com/","immunoncology, tumor immunology, t cell receptor, adoptive t cell therapy, cell therapy, gene therapy, tcr gene transfer, tcr generation, tcr characterization, cancer testis antigens, tumor antigens, target selection, retroviral vectors, neoepitopes, neoantigens",mark.ponticelli@t-knife.com,
"Alicia","Defrancesco","Alicia Defrancesco","Senior Director, Head of Commercial Strategy and Operations","AlloVir","Boston, Massachusetts","91","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91282","http://www.linkedin.com/in/alicia-defrancesco-90718477",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",adefrancesco@allovir.com,aliciade10@worldnet.att.net
"Carlos","Sousa","Carlos Sousa","Chief Executive Officer","Ultimovacs ASA","Oslo, Norway","33","(474) 138-0080","Biotechnology","https://app.apollo.io/#/contacts/65f73dec67dba60300985c96","http://www.linkedin.com/in/carlosdesousa1",,,"http://www.linkedin.com/company/ultimovacs-as","http://www.ultimovacs.com/","biotech, cancerresearch, immunotherapy, cancervaccine",carlos.desousa@ultimovacs.com,carlos_desousa@yahoo.com
"Priscilla","Wong","Priscilla Wong","Director, Strategy & Business Development (SG & CN)","Lion TCR","Singapore, Singapore","26","(656) 586-9633","Research","https://app.apollo.io/#/contacts/65f73ec667dba60300985e04","http://www.linkedin.com/in/priscilla-wong-86640aa3","https://facebook.com/liontcrSG/",,"http://www.linkedin.com/company/lion-tcr","http://www.liontcr.com/","N/A",priscilla.wong@liontcr.com,
"Bronwyn","Thornburg","Bronwyn Thornburg","Senior Manager of Operations","Life Edit Therapeutics","North Carolina, US","97","(919) 590-4205","Biotechnology","https://app.apollo.io/#/contacts/65f740256e9eba043dd8df06","http://www.linkedin.com/in/bronwynthornburg",,"https://twitter.com/lifeedittx","http://www.linkedin.com/company/lifeedit","http://www.lifeeditinc.com/","N/A",bthornburg@lifeeditinc.com,blthornburg@gmail.com
"Mark","W","Mark W","VP, Operations","Daré Bioscience, Inc.","San Diego, California","27","(858) 926-7655","Research, Biotechnology","https://app.apollo.io/#/contacts/65f741946b6fe00300462d63","",,"https://twitter.com/DareBioscience","http://www.linkedin.com/company/dare-bioscience","http://www.darebioscience.com/","womens reproductive health, womens health, fertility, contraception, vaginal health, biotechnology, innovation",mwalters@darebioscience.com,
"Dheeraj","T","Dheeraj T","Senior Vice President, Marketing and Commercial Strategy","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda017","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",dheeraj.talreja@freenome.com,
"Joyce","L","Joyce L","Head Of Business Development","Nkarta, Inc.","San Mateo, California","170","(415) 582-4923","Research","https://app.apollo.io/#/contacts/65f742946e71690300686ab5","","https://facebook.com/Nkarta-Therapeutics-108731114207664/","https://twitter.com/nkartatx","http://www.linkedin.com/company/nkarta-inc","http://www.nkartatx.com/","cell therapy & immunooncology",jliao@nkartatx.com,
"Daniel","Barvin","Daniel Barvin","VP, Operations and Patient Advocacy","Coya Therapeutics, Inc.","Houston, Texas","11","(800) 587-8170","Research","https://app.apollo.io/#/contacts/65f70758a1f7ef057bd49948","http://www.linkedin.com/in/daniel-barvin-mba-8b25bb24",,"https://twitter.com/CoyaTx","http://www.linkedin.com/company/coya-therapeutics","http://www.coyatherapeutics.com/","N/A",daniel@coyatherapeutics.com,
"Jennifer","Good","Jennifer Good","President and CEO","Trevi Therapeutics, Inc.","New Haven, Connecticut","24","(203) 304-2499","Research","https://app.apollo.io/#/contacts/65f7068940263f01c6c47066","http://www.linkedin.com/in/jennifer-l-good","https://facebook.com/trevitherapeutics","http://www.twitter.com/TreviThera","http://www.linkedin.com/company/trevi-therapeutics-inc-","http://www.trevitherapeutics.com/","N/A",jennifer.good@trevitherapeutics.com,
"Emily","Belfbecker","Emily Belfbecker","Director of Operations","Ratio Therapeutics","Marblehead, Massachusetts","36","(617) 371-8898","Pharmaceuticals","https://app.apollo.io/#/contacts/65f706fba1f7ef0300d4e04f","http://www.linkedin.com/in/emily-belfbecker-04a8603",,"https://twitter.com/Ratio_Tx","http://www.linkedin.com/company/ratio-therapeutics","http://www.ratiotx.com/","N/A",ebelfbecker@ratiotx.com,
"Scott","Yerganian","Scott Yerganian","Senior Director, Business Development & Alliance Management","Ikena Oncology","Boston, Massachusetts","58","(857) 273-8343","Research","https://app.apollo.io/#/contacts/65f70719a1f7ef01c6d53b9f","http://www.linkedin.com/in/scott-yerganian",,"https://twitter.com/ikenaoncology","http://www.linkedin.com/company/ikenaoncology","http://www.ikenaoncology.com/","targeted oncology, cancer therapeutics development, small molecule drug design, cancer biology, translational science & biomarkers",scott.yerganian@ikenaoncology.com,scott.yerganian@gmail.com
"Piotr","Trzonkowski","Piotr Trzonkowski","CEO","PolTREG S.A.","Poland","24","(485) 125-32401","Research","https://app.apollo.io/#/contacts/65f7076ba1f7ef0300d4e105","http://www.linkedin.com/in/piotr-trzonkowski-215097131","https://www.facebook.com/Poltregtech","https://twitter.com/poltreg","http://www.linkedin.com/company/poltreg-s-a","http://www.poltreg.com/","N/A",p.trzonkowski@poltreg.tech,
"David","Snyder","David Snyder","CFO/COO","Coya Therapeutics, Inc.","Austin, Texas","11","(800) 587-8170","Research","https://app.apollo.io/#/contacts/65f70751a1f7ef0300d4e0d0","http://www.linkedin.com/in/david-s-snyder-2aa866",,"https://twitter.com/CoyaTx","http://www.linkedin.com/company/coya-therapeutics","http://www.coyatherapeutics.com/","N/A",david@coyatherapeutics.com,
"Jason","Lettiere","Jason Lettiere","Vice President, Business Development","Terns Pharmaceuticals","New York, New York","66","(650) 275-4254","Pharmaceuticals","https://app.apollo.io/#/contacts/65f707a1a1f7ef01c6d53c19","http://www.linkedin.com/in/jason-lettiere-0a165812",,"https://twitter.com/TernsPharma","http://www.linkedin.com/company/ternspharmaceuticals","http://www.ternspharma.com/","pharmaceuticals, liver disease, life sciences, biopharmaceuticals",jlettiere@ternspharma.com,lettiere.jay@gmail.com
"Traci","Gonzales","Traci Gonzales","Director OmniChannel Marketing, Liver Disease","CymaBay Therapeutics","Dallas, Texas","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70882a1f7ef0439d4ad50","http://www.linkedin.com/in/tracigonzales","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",tgonzales@cymabay.com,
"Carter","K","Carter K","Executive Vice President, Business Development","Protagonist Therapeutics","San Mateo, California","120","(510) 474-0170","Biotechnology","https://app.apollo.io/#/contacts/65f708c7a1f7ef01c6d53dc6","",,"https://twitter.com/ProtagonistTx","http://www.linkedin.com/company/protagonist-therapeutics","http://www.protagonist-inc.com/","N/A",c.king@ptgx-inc.com,carter_king@hotmail.com
"Jeffrey","Murtha","Jeffrey Murtha","Executive Director, US Sales","Mirum Pharmaceuticals, Inc.","Philadelphia, Pennsylvania","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cc9","http://www.linkedin.com/in/jeffrey-murtha-pharmd-rph-17865167","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jeff.murtha@mirumpharma.com,
"Amy","E","Amy E","Chief Executive Officer","Lykos Therapeutics (formerly MAPS PBC)","Fairfax, California","170","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948024","","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",amy@mapsbcorp.com,amyl.emerson@gmail.com
"Gokhan","D","Gokhan D","Product Marketing Manager","Parse Biosciences","Seattle, Washington","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483c5","",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",gokhan@parsebiosciences.com,gdemirkan@gmail.com
"Ioana","H","Ioana H","Senior Director, Investor Relations","Lineage Cell Therapeutics","Carlsbad, California","30","(510) 521-3390","Research","https://app.apollo.io/#/contacts/65f7172062502003000b7370","","https://www.facebook.com/LineageCell/","https://twitter.com/LineageCell","http://www.linkedin.com/company/lineagecell","http://www.lineagecell.com/","N/A",ihone@lineagecell.com,ioana.hone@gmail.com
"Kenneth","Lamontagne","Kenneth Lamontagne","Chief Business Officer","Zelluna Immunotherapy","New York, New York","27","(472) 284-0080","Research","https://app.apollo.io/#/contacts/65f717c1501be20300755303","http://www.linkedin.com/in/kennethlamontagnephdmba",,,"http://www.linkedin.com/company/zelluna","http://www.zelluna.com/","cancer treatment, immunotherapy, adoptive cell therapy, t cell receptor technologies, immunooncology, solid tumors",ken.lamontagne@zelluna.com,ken.lamontagne@hotmail.com
"Bernat","Olle","Bernat Olle","Chief Executive Officer","Vedanta Biosciences, Inc.","Boston, Massachusetts","150","(857) 706-1427","Research","https://app.apollo.io/#/contacts/65f715fc4e99d4043b56d2f4","http://www.linkedin.com/in/bernat",,"https://twitter.com/vedantabio","http://www.linkedin.com/company/vedanta-biosciences-inc-","http://www.vedantabio.com/","human microbiome & mucosal immunology",bolle@vedantabio.com,bernat.olle@gmail.com
"Jennifer","Good","Jennifer Good","President and CEO","Trevi Therapeutics, Inc.","New Haven, Connecticut","24","(203) 304-2499","Research","https://app.apollo.io/#/contacts/65f7068940263f01c6c47066","http://www.linkedin.com/in/jennifer-l-good","https://facebook.com/trevitherapeutics","http://www.twitter.com/TreviThera","http://www.linkedin.com/company/trevi-therapeutics-inc-","http://www.trevitherapeutics.com/","N/A",jennifer.good@trevitherapeutics.com,
"Jaclyn","S","Jaclyn S","Chief of Staff & Head of Operations","ImmuneBridge","San Francisco, California","27","(415) 624-6411","Research","https://app.apollo.io/#/contacts/65f73f1d6e9eba01c6d9115a","",,"http://twitter.com/immunebridge","http://www.linkedin.com/company/immunebridge","http://www.immunebridge.com/","cell therapy, immunotherapy, carnk, natural killer cells, oncology",jaclyn@immunebridge.com,jaclyn.sherry@gmail.com
"Ton","Berkien","Ton Berkien","Chief Business Officer","Ultimovacs ASA","Malmö, Sweden","33","(474) 138-0080","Biotechnology","https://app.apollo.io/#/contacts/65f73dec67dba60300985c94","http://www.linkedin.com/in/ton-berkien-4238661",,,"http://www.linkedin.com/company/ultimovacs-as","http://www.ultimovacs.com/","biotech, cancerresearch, immunotherapy, cancervaccine",ton.berkien@ultimovacs.com,
"Jeannette","O","Jeannette O","Director, Portfolio Strategy & Operations","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686970","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",josterloh@annexonbio.com,
"Phoebe","H","Phoebe H","Senior Director, Product Marketing","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda00f","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",phoebe.hsueh@freenome.com,
"Jessica","Falkowitz","Jessica Falkowitz","Director, Product Marketing","Freenome","Washington, District of Columbia","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda015","http://www.linkedin.com/in/jessicafalkowitz","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",jessica.falkowitz@freenome.com,jessica.goldberg1@gmail.com
"Andrew","T","Andrew T","Business Operations Manager","Nkarta, Inc.","San Francisco, California","170","(415) 582-4923","Research","https://app.apollo.io/#/contacts/65f742946e71690300686ab3","","https://facebook.com/Nkarta-Therapeutics-108731114207664/","https://twitter.com/nkartatx","http://www.linkedin.com/company/nkarta-inc","http://www.nkartatx.com/","cell therapy & immunooncology",atsao@nkartatx.com,andrewtsao24@yahoo.com
"Andrew","Hirsch","Andrew Hirsch","President & CEO","C4 Therapeutics, Inc.","Boston, Massachusetts","130","(617) 231-0700","Biotechnology","https://app.apollo.io/#/contacts/65f705f240263f0300c3fe14","http://www.linkedin.com/in/andrew-hirsch-9532431",,"https://twitter.com/C4Therapeutics","http://www.linkedin.com/company/c4-therapeutics-inc.","http://www.c4therapeutics.com/","biotechnology, cell biology, protein chemistry, cell pharmacology, protein degradation",ahirsch@c4therapeutics.com,
"Suzanne","Nizza","Suzanne Nizza","Senior Director of Business Operations","Ventus Therapeutics","Arlington, Massachusetts","92","(514) 397-9517","Research","https://app.apollo.io/#/contacts/65f705c440263f01c6c46cca","http://www.linkedin.com/in/suzanne-nizza-09378b5",,"https://twitter.com/Ventus_Tx?","http://www.linkedin.com/company/ventus-therapeutics","http://www.ventustx.com/","N/A",snizza@ventustx.com,
"Daniel","Koerwer","Daniel Koerwer","Chief Operating Officer","Ventus Therapeutics","Boston, Massachusetts","92","(514) 397-9517","Research","https://app.apollo.io/#/contacts/65f705c440263f01c6c46cc6","http://www.linkedin.com/in/koerwer",,"https://twitter.com/Ventus_Tx?","http://www.linkedin.com/company/ventus-therapeutics","http://www.ventustx.com/","N/A",dkoerwer@ventustx.com,dan.koerwer@gmail.com
"Ting","Yi","Ting Yi","Director, Head of Business Development Operations","Rallybio","New York, New York","52","(203) 859-3820","Research","https://app.apollo.io/#/contacts/65f7064e40263f01c6c46f4e","http://www.linkedin.com/in/ting-yi-8a3335117",,"https://twitter.com/rallybio","http://www.linkedin.com/company/rallybio","http://www.rallybio.com/","rare disease",,
"Alex","A","Alex A","Chief Executive Officer","Moonwalk Biosciences","San Diego, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb6","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",alex.aravanis@moonwalk.bio,
"Sasha","Blaug","Sasha Blaug","Senior Vice President Corporate Development- Head of Business Development","Biomea Fusion","New York, New York","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e17f","http://www.linkedin.com/in/sasha-blaug-8127b4","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",sb@biomeafusion.com,sblaug@gmail.com
"Susannah","C","Susannah C","Chief Business Officer","Brii Biosciences","San Francisco, California","120","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9c","",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",susannah.cantrell@briibio.com,
"Kenneth","I","Kenneth I","Vice President, Commercial Operations","CymaBay Therapeutics","San Mateo, California","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f7089ca1f7ef0439d4ad67","","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",kikeda@cymabay.com,
"Amit","E","Amit E","Founder and CEO","Alto Neuroscience","Stanford, California","64","(773) 255-5012","Biotechnology","https://app.apollo.io/#/contacts/65f70aa797cfd001c694823c","",,"https://twitter.com/AltoNeuro","http://www.linkedin.com/company/altoneuroscience","http://www.altoneuroscience.com/","N/A",amitetkin@altoneuroscience.com,
"Jonathan","D","Jonathan D","Executive Director Marketing, Bile Acid Portfolio","Mirum Pharmaceuticals, Inc.","California, US","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947ccd","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jon.daugusta@mirumpharma.com,jdaugusta@gmail.com
"Chris","P","Chris P","Chief Executive Officer","Mirum Pharmaceuticals, Inc.","San Francisco, California","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd7","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",cpeetz@mirumpharma.com,
"Eric","Shaff","Eric Shaff","President, Chief Executive Officer","Seres Therapeutics","Cambridge, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a2","http://www.linkedin.com/in/eric-shaff-9179825","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",eshaff@serestherapeutics.com,eric.shaff@gmail.com
"Terri","Young","Terri Young","Executive Vice President, Chief Commercial and Strategy Officer","Seres Therapeutics","Cambridge, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d298","http://www.linkedin.com/in/youngterri","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",tyoung@serestherapeutics.com,ter_young@hotmail.com
"Gerald","Quirk","Gerald Quirk","Chief Legal Officer; Head of Business Development","Syros Pharmaceuticals","Rockport, Maine","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486fd","http://www.linkedin.com/in/gerald-quirk-429b875",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",gquirk@syros.com,
"Tim","Keutzer","Tim Keutzer","Chief Operating Officer, Spero Therapeutics","Spero Therapeutics","Boston, Massachusetts","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a82","http://www.linkedin.com/in/tim-keutzer-6504829",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",tim@sperotherapeutics.com,
"Kyle","Kuvalanka","Kyle Kuvalanka","COO","Syros Pharmaceuticals","Cambridge, Massachusetts","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f9","http://www.linkedin.com/in/kyle-kuvalanka-92420b155",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",kkuvalanka@syros.com,
"Erica","Bush","Erica Bush","Clinical Operations Development Manager","Lykos Therapeutics (formerly MAPS PBC)","Ann Arbor, Michigan","170","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948022","http://www.linkedin.com/in/erica-bush-8680466","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",erica.bush@mapsbcorp.com,busherica74@hotmail.com
"Chris","Nowers","Chris Nowers","Chief Executive Officer","ONK Therapeutics","Beaconsfield, United Kingdom","34","(353) 860-239842","Research","https://app.apollo.io/#/contacts/65f717a7501be204397510cb","http://www.linkedin.com/in/chrisnowers",,"https://twitter.com/onktherapeutics","http://www.linkedin.com/company/onk-therapeutics","http://www.onktherapeutics.com/","N/A",chris.nowers@onktherapeutics.com,
"Jennifer","Good","Jennifer Good","President and CEO","Trevi Therapeutics, Inc.","New Haven, Connecticut","24","(203) 304-2499","Research","https://app.apollo.io/#/contacts/65f7068940263f01c6c47066","http://www.linkedin.com/in/jennifer-l-good","https://facebook.com/trevitherapeutics","http://www.twitter.com/TreviThera","http://www.linkedin.com/company/trevi-therapeutics-inc-","http://www.trevitherapeutics.com/","N/A",jennifer.good@trevitherapeutics.com,
"Jaclyn","S","Jaclyn S","Chief of Staff & Head of Operations","ImmuneBridge","San Francisco, California","27","(415) 624-6411","Research","https://app.apollo.io/#/contacts/65f73f1d6e9eba01c6d9115a","",,"http://twitter.com/immunebridge","http://www.linkedin.com/company/immunebridge","http://www.immunebridge.com/","cell therapy, immunotherapy, carnk, natural killer cells, oncology",jaclyn@immunebridge.com,jaclyn.sherry@gmail.com
"Ton","Berkien","Ton Berkien","Chief Business Officer","Ultimovacs ASA","Malmö, Sweden","33","(474) 138-0080","Biotechnology","https://app.apollo.io/#/contacts/65f73dec67dba60300985c94","http://www.linkedin.com/in/ton-berkien-4238661",,,"http://www.linkedin.com/company/ultimovacs-as","http://www.ultimovacs.com/","biotech, cancerresearch, immunotherapy, cancervaccine",ton.berkien@ultimovacs.com,
"Jeannette","O","Jeannette O","Director, Portfolio Strategy & Operations","Annexon Biosciences","Oakland, California","78","(650) 822-5500","Research","https://app.apollo.io/#/contacts/65f740d76e71690300686970","",,"https://twitter.com/annexonbio","http://www.linkedin.com/company/annexon-biosciences","http://www.annexonbio.com/","neurodegeneration, autoimmune, ophthalmology",josterloh@annexonbio.com,
"Phoebe","H","Phoebe H","Senior Director, Product Marketing","Freenome","San Francisco, California","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda00f","","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",phoebe.hsueh@freenome.com,
"Jessica","Falkowitz","Jessica Falkowitz","Director, Product Marketing","Freenome","Washington, District of Columbia","540","(831) 704-6883","Research, Biotechnology","https://app.apollo.io/#/contacts/65f743fa77475101c6dda015","http://www.linkedin.com/in/jessicafalkowitz","https://www.facebook.com/freenome/","http://twitter.com/@freenome","http://www.linkedin.com/company/freenome","http://www.freenome.com/","technology, biotechnology, diagnostics, life sciences, molecular diagnostics, multiomics, machine learning, cancer screening, oncology, early cancer detection, computational biology",jessica.falkowitz@freenome.com,jessica.goldberg1@gmail.com
"Andrew","T","Andrew T","Business Operations Manager","Nkarta, Inc.","San Francisco, California","170","(415) 582-4923","Research","https://app.apollo.io/#/contacts/65f742946e71690300686ab3","","https://facebook.com/Nkarta-Therapeutics-108731114207664/","https://twitter.com/nkartatx","http://www.linkedin.com/company/nkarta-inc","http://www.nkartatx.com/","cell therapy & immunooncology",atsao@nkartatx.com,andrewtsao24@yahoo.com
"Andrew","Hirsch","Andrew Hirsch","President & CEO","C4 Therapeutics, Inc.","Boston, Massachusetts","130","(617) 231-0700","Biotechnology","https://app.apollo.io/#/contacts/65f705f240263f0300c3fe14","http://www.linkedin.com/in/andrew-hirsch-9532431",,"https://twitter.com/C4Therapeutics","http://www.linkedin.com/company/c4-therapeutics-inc.","http://www.c4therapeutics.com/","biotechnology, cell biology, protein chemistry, cell pharmacology, protein degradation",ahirsch@c4therapeutics.com,
"Suzanne","Nizza","Suzanne Nizza","Senior Director of Business Operations","Ventus Therapeutics","Arlington, Massachusetts","92","(514) 397-9517","Research","https://app.apollo.io/#/contacts/65f705c440263f01c6c46cca","http://www.linkedin.com/in/suzanne-nizza-09378b5",,"https://twitter.com/Ventus_Tx?","http://www.linkedin.com/company/ventus-therapeutics","http://www.ventustx.com/","N/A",snizza@ventustx.com,
"Daniel","Koerwer","Daniel Koerwer","Chief Operating Officer","Ventus Therapeutics","Boston, Massachusetts","92","(514) 397-9517","Research","https://app.apollo.io/#/contacts/65f705c440263f01c6c46cc6","http://www.linkedin.com/in/koerwer",,"https://twitter.com/Ventus_Tx?","http://www.linkedin.com/company/ventus-therapeutics","http://www.ventustx.com/","N/A",dkoerwer@ventustx.com,dan.koerwer@gmail.com
"Ting","Yi","Ting Yi","Director, Head of Business Development Operations","Rallybio","New York, New York","52","(203) 859-3820","Research","https://app.apollo.io/#/contacts/65f7064e40263f01c6c46f4e","http://www.linkedin.com/in/ting-yi-8a3335117",,"https://twitter.com/rallybio","http://www.linkedin.com/company/rallybio","http://www.rallybio.com/","rare disease",,
"Alex","A","Alex A","Chief Executive Officer","Moonwalk Biosciences","San Diego, California","9","","Research","https://app.apollo.io/#/contacts/65f7073ca1f7ef0439d4acb6","",,,"http://www.linkedin.com/company/moonwalk-biosciences","http://www.moonwalk.bio/","N/A",alex.aravanis@moonwalk.bio,
"Sasha","Blaug","Sasha Blaug","Senior Vice President Corporate Development- Head of Business Development","Biomea Fusion","New York, New York","110","(650) 980-9099","Research","https://app.apollo.io/#/contacts/65f707e7a1f7ef0300d4e17f","http://www.linkedin.com/in/sasha-blaug-8127b4","https://facebook.com/biomeafusion","https://twitter.com/biomeafusion","http://www.linkedin.com/company/biomeafusion","http://www.biomeafusion.com/","biotech, oncology, patient friendly therapies, targeted medicine, cancer treatment, acute myeloid leukemia, mll fusion, diabetes mellitus, liquid tumors, solid tumors, innovative medicine, novel mechanism of action, menin, irreversible inhibitors",sb@biomeafusion.com,sblaug@gmail.com
"Susannah","C","Susannah C","Chief Business Officer","Brii Biosciences","San Francisco, California","120","(919) 240-5605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70811a1f7ef01c6d53c9c","",,,"http://www.linkedin.com/company/brii-biosciences","http://www.briibio.com/","biotechnology",susannah.cantrell@briibio.com,
"Kenneth","I","Kenneth I","Vice President, Commercial Operations","CymaBay Therapeutics","San Mateo, California","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f7089ca1f7ef0439d4ad67","","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",kikeda@cymabay.com,
"Amit","E","Amit E","Founder and CEO","Alto Neuroscience","Stanford, California","64","(773) 255-5012","Biotechnology","https://app.apollo.io/#/contacts/65f70aa797cfd001c694823c","",,"https://twitter.com/AltoNeuro","http://www.linkedin.com/company/altoneuroscience","http://www.altoneuroscience.com/","N/A",amitetkin@altoneuroscience.com,
"Jonathan","D","Jonathan D","Executive Director Marketing, Bile Acid Portfolio","Mirum Pharmaceuticals, Inc.","California, US","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947ccd","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",jon.daugusta@mirumpharma.com,jdaugusta@gmail.com
"Chris","P","Chris P","Chief Executive Officer","Mirum Pharmaceuticals, Inc.","San Francisco, California","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd7","","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",cpeetz@mirumpharma.com,
"Eric","Shaff","Eric Shaff","President, Chief Executive Officer","Seres Therapeutics","Cambridge, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a2","http://www.linkedin.com/in/eric-shaff-9179825","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",eshaff@serestherapeutics.com,eric.shaff@gmail.com
"Terri","Young","Terri Young","Executive Vice President, Chief Commercial and Strategy Officer","Seres Therapeutics","Cambridge, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d298","http://www.linkedin.com/in/youngterri","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",tyoung@serestherapeutics.com,ter_young@hotmail.com
"Gerald","Quirk","Gerald Quirk","Chief Legal Officer; Head of Business Development","Syros Pharmaceuticals","Rockport, Maine","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486fd","http://www.linkedin.com/in/gerald-quirk-429b875",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",gquirk@syros.com,
"Tim","Keutzer","Tim Keutzer","Chief Operating Officer, Spero Therapeutics","Spero Therapeutics","Boston, Massachusetts","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a82","http://www.linkedin.com/in/tim-keutzer-6504829",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",tim@sperotherapeutics.com,
"Kyle","Kuvalanka","Kyle Kuvalanka","COO","Syros Pharmaceuticals","Cambridge, Massachusetts","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486f9","http://www.linkedin.com/in/kyle-kuvalanka-92420b155",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",kkuvalanka@syros.com,
"Erica","Bush","Erica Bush","Clinical Operations Development Manager","Lykos Therapeutics (formerly MAPS PBC)","Ann Arbor, Michigan","170","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948022","http://www.linkedin.com/in/erica-bush-8680466","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",erica.bush@mapsbcorp.com,busherica74@hotmail.com
"Chris","Nowers","Chris Nowers","Chief Executive Officer","ONK Therapeutics","Beaconsfield, United Kingdom","34","(353) 860-239842","Research","https://app.apollo.io/#/contacts/65f717a7501be204397510cb","http://www.linkedin.com/in/chrisnowers",,"https://twitter.com/onktherapeutics","http://www.linkedin.com/company/onk-therapeutics","http://www.onktherapeutics.com/","N/A",chris.nowers@onktherapeutics.com,
"Scott","Ibrahim","Scott Ibrahim","Senior Director, CMC Operations","Cara Therapeutics","Boston, Massachusetts","88","(203) 406-3700","Research, Biotechnology","https://app.apollo.io/#/contacts/65f706e1a1f7ef057bd49909","http://www.linkedin.com/in/scott-ibrahim-mba-9638113","https://www.facebook.com/pages/Cara-Therapeutics/164668313559992","https://twitter.com/caratherapinc","http://www.linkedin.com/company/cara-therapeutics","http://www.caratherapeutics.com/","healthcare, biotechnology, life sciences",sibrahim@caratherapeutics.com,
"Jesse","M","Jesse M","Chief Executive Officer","Kartos Therapeutics, Inc.","Sunnyvale, California","91","(650) 542-0130","Research","https://app.apollo.io/#/contacts/65f707bca1f7ef0300d4e151","",,,"http://www.linkedin.com/company/kartos-therapeutics","http://www.kartosthera.com/","N/A",jmcgreivy@kartosthera.com,
"Dan","S","Dan S","Chief Business Development Officer","PolTREG S.A.","Cincinnati, Ohio","24","(485) 125-32401","Research","https://app.apollo.io/#/contacts/65f7076ba1f7ef0300d4e107","","https://www.facebook.com/Poltregtech","https://twitter.com/poltreg","http://www.linkedin.com/company/poltreg-s-a","http://www.poltreg.com/","N/A",d.shelly@poltreg.com,danielashelly@hotmail.com
"Susan","Whoriskey","Susan Whoriskey","Founding Executive Team, Technology Strategy & Business Development","Vera Therapeutics, Inc.","Belmont, Massachusetts","61","(650) 770-0077","Biotechnology","https://app.apollo.io/#/contacts/65f7083ca1f7ef057bd49990","http://www.linkedin.com/in/susanwhoriskey",,"https://twitter.com/Official_VeraTx","http://www.linkedin.com/company/veratx","http://www.veratx.com/","N/A",susan.whoriskey@veratx.com,
"Lauren","F","Lauren F","Chief Business Officer","Vera Therapeutics, Inc.","San Francisco, California","61","(650) 770-0077","Biotechnology","https://app.apollo.io/#/contacts/65f7083ca1f7ef057bd4998e","",,"https://twitter.com/Official_VeraTx","http://www.linkedin.com/company/veratx","http://www.veratx.com/","N/A",lauren.frenz@veratx.com,laurenpflepsen@gmail.com
"Sujal","S","Sujal S","President and CEO","CymaBay Therapeutics","San Francisco, California","120","(510) 293-8800","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70882a1f7ef0439d4ad4c","","https://facebook.com/CymaBay/","https://twitter.com/cymabay","http://www.linkedin.com/company/cymabay-therapeutics","http://www.cymabay.com/","biotechnology, life sciences",sshah@cymabay.com,
"Samantha","Wells","Samantha Wells","Product Manager, US Marketing","Mirum Pharmaceuticals, Inc.","United States","300","(650) 667-4085","Pharmaceuticals","https://app.apollo.io/#/contacts/65f709bb97cfd001c6947cd3","http://www.linkedin.com/in/samantha-wells-50126713b","https://www.facebook.com/mirumpharma","https://twitter.com/mirumpharma","http://www.linkedin.com/company/mirum-pharmaceuticals","http://www.mirumpharma.com/","N/A",samantha.wells@mirumpharma.com,
"Michael","Mullette","Michael Mullette","Chief Operations Officer","Lykos Therapeutics (formerly MAPS PBC)","Cambridge, Massachusetts","170","","Research","https://app.apollo.io/#/contacts/65f70a6797cfd001c6948025","http://www.linkedin.com/in/michael-mullette-b65b9056","https://www.facebook.com/LykosTherapeutics/","https://twitter.com/Lykos_PBC","http://www.linkedin.com/company/lykos-therapeutics","http://www.lykospbc.com/","clinical research, ptsd research, anxiety research, social anxiety research, medical research, schedule i research, drug development, psychedelics, psychedelic research, plant medicine",michael@mapsbcorp.com,mmullette@gmail.com
"Marc","Thibodeau","Marc Thibodeau","Sales Development Representative","Parse Biosciences","Orono, Maine","130","(206) 851-6246","Research","https://app.apollo.io/#/contacts/65f70b0397cfd001c69483c7","http://www.linkedin.com/in/marc-thibodeau-72034b207",,"https://twitter.com/parsebio","http://www.linkedin.com/company/parse-biosciences","http://www.parsebiosciences.com/","N/A",marc@parsebiosciences.com,
"Susan","Redican","Susan Redican","Vice President, Head of Clincal Operations","Spero Therapeutics","Manchester, Vermont","66","(857) 242-1600","Research, Biotechnology","https://app.apollo.io/#/contacts/65f70bc78a586701c6f83a7a","http://www.linkedin.com/in/susan-redican",,"https://twitter.com/Spero_Tx","http://www.linkedin.com/company/spero-therapeutics","http://www.sperotherapeutics.com/","biotechnology, life sciences, infectious disease, antibacterial therapies, novel therapeutics",sredican@sperotherapeutics.com,seredican@gmail.com
"Andrea","M","Andrea M","Vice President & Head of Business Development","Syros Pharmaceuticals","San Francisco, California","95","(617) 744-1340","Pharmaceuticals, Biotechnology","https://app.apollo.io/#/contacts/65f70b8b97cfd001c69486ff","",,"https://twitter.com/syrospharma","http://www.linkedin.com/company/syros-pharmaceuticals","http://www.syros.com/","biotechnology, life sciences",amcneal@syros.com,andi.mcneal@gmail.com
"Jim","Grady","Jim Grady","Business Development","Rallybio","Denver, Colorado","52","(203) 859-3820","Research","https://app.apollo.io/#/contacts/65f7064e40263f01c6c46f4c","http://www.linkedin.com/in/jimgrady1",,"https://twitter.com/rallybio","http://www.linkedin.com/company/rallybio","http://www.rallybio.com/","rare disease",jgrady@rallybio.com,
"Justine","Rovedo","Justine Rovedo","Chief of Staff to CEO","C4 Therapeutics, Inc.","United States","130","(617) 231-0700","Biotechnology","https://app.apollo.io/#/contacts/65f705f240263f0300c3fe16","http://www.linkedin.com/in/justine-rovedo-pmp-a106937",,"https://twitter.com/C4Therapeutics","http://www.linkedin.com/company/c4-therapeutics-inc.","http://www.c4therapeutics.com/","biotechnology, cell biology, protein chemistry, cell pharmacology, protein degradation",jrovedo@c4therapeutics.com,
"Tyler","B","Tyler B","Marketing Specialist","Celltex Therapeutics Corporation","Chicago, Illinois","34","(713) 952-9400","Research, Biotechnology","https://app.apollo.io/#/contacts/65f716e44e99d401c6577a99","","http://www.facebook.com/celltexbank","http://www.twitter.com/CelltexCorp","http://www.linkedin.com/company/celltex-therapeutics-corporation","http://www.celltexbank.com/","biotechnology, life sciences, stem cell banking, stem cell therapy, regenerative medicine, adult stem cells",tbriscoe@celltexbank.com,
"Jennie","S","Jennie S","Marketing & Recruitment","Seres Therapeutics","Del Mar, California","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a6","","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",jstarr@serestherapeutics.com,jennie.starr@gmail.com
"Rob","Windsor","Rob Windsor","Head of Investor Relations","Seres Therapeutics","Hingham, Massachusetts","340","(617) 945-9626","Research, Biotechnology","https://app.apollo.io/#/contacts/65f715b54e99d4043b56d2a0","http://www.linkedin.com/in/rob-windsor-2b9056a","https://www.facebook.com/SeresTherapeutics/","https://twitter.com/SeresTX","http://www.linkedin.com/company/seres-tx","http://www.serestherapeutics.com/","biotechnology, therapeutics, microbiome",rwindsor@serestherapeutics.com,
"Anthony","Deboer","Anthony Deboer","Vice President, Business Development","Synaffix BV","Amsterdam, Netherlands","34","(318) 802-24505","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7183984e3190300771686","http://www.linkedin.com/in/anthonydeboer",,"https://twitter.com/synaffix","http://www.linkedin.com/company/synaffix-bv","http://www.synaffix.com/","antibodydrug conjugates, cell engagers, targeted gene therapy, bispecific antibodies",a.deboer@synaffix.com,
"Michael","Engsig","Michael Engsig","CEO","Nykode Therapeutics","Copenhagen, Denmark","190","(472) 295-8193","Research, Biotechnology","https://app.apollo.io/#/contacts/65f717eb62502001c60bf5b1","http://www.linkedin.com/in/michael-engsig-2004271",,,"http://www.linkedin.com/company/nykode","http://www.nykode.com/","immunotherapy, immunooncology, neoantigens, dna vaccine, hpv16, neoepitopes, oncology",mengsig@vaccibody.com,
"Diana","Brainard","Diana Brainard","CEO","AlloVir","Lexington, Massachusetts","91","(617) 433-2605","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73fc86e9eba01c6d91280","http://www.linkedin.com/in/diana-brainard-22aa347",,"https://twitter.com/allo_vir","http://www.linkedin.com/company/allovir","http://www.allovir.com/","cell therapy, infectious disease, therapeutic developer, biotechnology",dbrainard@allovir.com,dianabrainard@gmail.com
"Viktor","Arnkil","Viktor Arnkil","Head of Operations","Anocca","Stockholm, Sweden","100","(468) 410-80750","Research, Biotechnology","https://app.apollo.io/#/contacts/65f73e9767dba601c6997467","http://www.linkedin.com/in/viktor-arnkil-0250794",,,"http://www.linkedin.com/company/anocca-ab","http://www.anocca.com/","biotechnology, immunotherapeutics, drug discovery, drug development, immunology, immunotechnology, immunooncology",viktor.arnkil@anocca.com,
"Michael","Kaiser","Michael Kaiser","Vice President, Head of Investor Relations and Corporate Communications","HOOKIPA Pharma Inc.","New York, New York","150","(431) 890-6360","Research, Biotechnology","https://app.apollo.io/#/contacts/65f7417d6e716903006869f6","http://www.linkedin.com/in/michael-kaiser-589aa131",,"https://twitter.com/HookipaPharma","http://www.linkedin.com/company/hookipa-pharma-inc","http://www.hookipapharma.com/","biotechnology, life sciences, infectious diseases, immunooncology, immunotherapy",michael.kaiser@hookipapharma.com,mkaiser10@gmail.com
"Greg","Mann","Greg Mann","Public Affairs and Investor Relations","Nkarta, Inc.","N/A","170","(415) 582-4923","Research","https://app.apollo.io/#/contacts/65f742946e71690300686abb","http://www.linkedin.com/in/greg-mann-29b4a81","https://facebook.com/Nkarta-Therapeutics-108731114207664/","https://twitter.com/nkartatx","http://www.linkedin.com/company/nkarta-inc","http://www.nkartatx.com/","cell therapy & immunooncology",gmann@nkartatx.com,gregmann@me.com
"Peng","L","Peng L","Chief Business Officer and Head of Brain Aging","BioAge Labs","San Francisco, California","85","(541) 745-5116","Research, Biotechnology","https://app.apollo.io/#/contacts/65f742de7747510300dcf67c","",,"https://twitter.com/bioagelabs","http://www.linkedin.com/company/bioage-labs","http://www.bioagelabs.com/","aging, longevity, biotechnology",peng@bioagelabs.com,